Hormonal control of spermatogenesis: expression of FSJH receptor and androgen receptor genes by Blok, L.J. (Leen)
HORMONAL CONTROl OF SPERMATOGENESIS: 
EXPRESSION OF FSH RECEPTOR AND 
ANDROGEN RECEPTOR GENES 
(HORMONALE CONTROLE VAN SPERMATOGENESE: 
EXPRESSIE VAN FSH RECEPTOR EN 
ANDROGEEN RECEPTOR GENEN) 
PROEFSCHRIFT 
TER VERKRIJGING VAN DE GRAAD VAN DOCTOR 
AAN DE ERASMUS UNIVERSITEIT ROTTERDAM 
OP GEZAG VAN DE RECTOR MAGNIFICUS 
PROF.DR. C.J. RIJNVOS 
EN VOLGENS BESLUIT VAN HET COLLEGE VAN DEKANEN. 
DE OPEN BARE VERDEDIGING ZAL PLAATSVINDEN OP 
WOENSDAG 28 OKTOBER 1992 OM 13.45 UUR 
DOOR 
LEENDERT JACOBUS BLOK 
GEBOREN TE FIJNAART EN HEIJNINGEN 
PROMOTIECOMMISSIE 
Promotor: 
Overige !eden: 
Prof.dr. J.A. Grootegoed 
Prof.dr. S.W.J. Lamberts 
Prof.dr. F.T. Bosman 
Dr. G. AB 
Dit proefschrift werd bewerkt binnen de Vakgroep Endocrinologie & Voortplanting, Faculteit 
der Geneeskunde en Gezondheidswetenschappen, Erasmus Universitett Rotterdam 
Voor mijn ouders 
Voor Marinka 
2 
CONTENTS 
ABBREVIATIONS 4 
Chapter 1. INTRODUCTION 5 
1.1 The testis 6 
1.1.1 Leydig cells 6 
1.1.2 Peritubular myoid cells 7 
1.1.3 Sertoli cells and germ cells 8 
1.2 Aim and scope of this thesis 10 
1.3 Hormonal regulation of spermatogenesis 11 
1.3.1 FSH receptor 12 
1.3.2 FSH and spermatogenesis 13 
1.3.3 Androgen receptor 14 
1.3.4 Androgens and spermatogenesis 15 
1.4 Methodology 15 
1.4.1 !n vivo versus in vitro 15 
1.4.2 The study of receptor regulation 17 
1.4.3 The EDS model 17 
REFERENCES 20 
Chapter 2. Follicle-stimulating hormone regulates androgen receptor 25 
mRNA in Sertoli cells 
Chaoter 3. Transient down-regulation of androgen receptor mRNA 31 
expression in Sertoli cells by follicle-stimulating hormone is followed by 
up-regulation of androgen receptor mRNA and protein 
3 
Chapter 4. Follitropin receptor down-regulation involves a cAMP-dependent 45 
post-transcriptional decrease of receptor mRNA expression 
Chapter 5. Transcriptional regulation of androgen receptor gene expression 53 
in Sertoli cells and other cell types. 
Chapter 6. A putative Sertoli cell factor regulating androgen receptor mRNA 69 
expression in peritubular myoid cells 
Chapter 7. Effect of testosterone deprivation on expression of the androgen 77 
receptor in rat prostate, epididymis and testis 
Chapter 8. GENERAL DISCUSSION 97 
8.1 Testosterone 98 
8.1.1 The testicular testosterone concentration and spermatogenesis (adult rat) 98 
8.1.2 Androgen effects not mediated via nuclear receptors 101 
8.1.3 Regulation of male fertility 103 
8.2 FSH 104 
8.2.1 Regulation of gonadotropin receptors 105 
8.2.2 FSH regulation of androgen and FSH receptor expression in the testis 106 
8.3 Interaction between peritubular myoid cells and Sertoli cells 108 
REFERENCES 110 
SUMMARY 113 
SAMENVATTING 115 
DANKWOORD 117 
PAPERS RELATED TO THIS THESIS 118 
CURRICULUM VITAE 119 
4 
ABBREVIATIONS 
ABP 
AR 
cAMP 
eDNA 
CG 
dbcAMP 
DHT 
EDS 
EGF 
EGTA 
FSH 
GnRH 
IGF-1 
IU 
kb 
KD 
Kd 
LH 
LHRH 
LNCaP 
mRNA 
PmodS 
R1881 
SBP 
SHBG 
T 
Tim 
TGFa 
TGFB 
TSH 
vit-O 
:androgen binding protein 
:androgen receptor 
:adenosine cyclic-3' :5' -monophosphate 
:complementary deoxyribonucleic acid 
:chorionic gonadotropin 
:dibutyryl adenosine cyclic-3':5' -monophosphate 
:dihydrotestosterone 
:ethane dimethane sulphonate 
:epidermal growth factor 
:ethyleneglycol-2-(2-aminoethyl)-tetracetic acid 
:follicle-stimulating hormone or follitropin 
:gonadotropin releasing hormone 
:insulin-like growth factor I 
:international unit 
:kilo base 
:kilo Dalton 
:binding affinity 
:luteinizing hormone or lutropin 
:luteinizing hormone releasing hormone 
:lymph node carcinoma of the prostate {human) 
:messenger ribonucleic acid 
:a .Eeritubular myoid cell factor which modulates .S.ertoli cell function 
: 178-hydroxy-17 a-methylestra-4,9, 1 Hrien-3-one 
:sex hormone binding protein 
:sex hormone binding globulin 
:testosterone 
:testicular feminization 
:transforming growth factor a 
:transforming growth factor B 
:thyroid-stimulating hormone 
:1,25-dihydroxy-vitamin 03 
Cover :microscopic image of isolated rat spermatocytes 
5 
CHAPTER 1 
INTRODUCTION 
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1.1 The testis 
The mammalian testis consists of two compartments: the interstitium and the semintferous 
tubules. The composition of the interstitium differs between species, but in general it contains: 
Leydig cells, macrophages, lymph space and blood vessels, and endothelial cells (Fawcett, 
1973). The seminiferous tubules are avascular and contain different types of germ cells 
embedded in Sertoli cells (de Kretser and Kerr, 1988). In between the two compartments and 
surrounding the seminiferous tubules, peritubular myoid cells and a basal lamina are located 
(Fig. 1). 
perllubular myoid celfs 
and endothef/al cells 
Fig. 1. Schematic representation of a cross·section through part of the rat testis. 
1.1.1 Leydig cells 
The function of the interstitial Leydig cells is the production and secretion of androgens. 
Testosterone is produced in large amounts to supply the whole body with androgens. In most 
androgen target tissues testosterone is converted to dihydrotestosterone, by the enzyme 5a· 
reductase. Dihydrotestosterone binds to the androgen receptor with a higher affinity than 
testosterone, and is considered to be the more potent androgen. It is, however, accepted that 
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testosterone in high concentrations interacts in the same way with the androgen receptor as 
dihydrotestosterone (Grino et al., 1990). During embryonic development, dihydrotestosterone 
is necessary lor the formation of the male external genitalia and the differentiation of the 
urogenital sinus into prostate, bulbourethral glands, urethra, periurethral glands and part of 
the urinary bladder. In the Wolffian ducts, due to the absence of Sa-reductase activity (until 
late in male differentiation), testosterone is not converted into dihydrotestosterone (Siiteri and 
Wilson, 1974). However, testosterone is an effective androgen in the differentiation of the 
Wolffian duct into epididymis, ductus deferens, seminal vesicle and ejaculatory ducts (Wilson 
and Lasnitzki, 1971 ). Testosterone and dihydrotestosterone are also involved in the 
manifestation of male secondary sexual characteristics, and have an important role to play in 
regulation of spermatogenesis (Hall, 1988). 
Leydig cell function is regulated by luteinizing hormone (LH). The secretion of this 
gonadotropin by the pituitary gland is stimulated by the hypothalamic luteinizing hormone 
releasing hormone or gonadotropin releasing hormone (LHRH, GnRH) (Hodgson et al., 1983, 
Fink, 1988), and down-regulated by testosterone (Fig. 3). For example, when circulating 
testosterone levels are increased by testosterone injection, LH production and secretion by 
the prtuitary gland can be completely blocked, which in turn will result in an almost complete 
inhibiTion of testosterone production by Leydig cells (Cunningham et al., 1979). 
LH is the main regulator of Leydig cell function, but the cells also take part in a 
complicated interplay between different cell types in the testis (Fig. 3). Factors secreted by 
Sertoli cells have been reported to affect Leydig cell mitosis, the number of LH and LHRH 
receptors, and LH-stimulated testosterone secretion in vivo (Kerr and Sharpe, 1985). Several 
Sertoli cell factors that might play a role in this paracrine interaction between Sertoli and 
Leydig cells have been identified. Effects of transforming growth factor a (TGFa) and insulin-
like growth factor I (IGF-1) on mitotic activity of cultured Leydig cells have been described 
recently (Teerds et al., 1992). It should be noted, however, that these putative paracrine 
factors are also produced by peritubular myoid cells, and that regulatory effects of these 
growth factors may originate from this source (Skinner et al., 1989; Skinner, 1991) (Fig. 3). 
1.1.2 Peritubular myoid cells 
Peritubular myoid cells form a layer of flattened cells between the interstitium and the 
seminiferous tubules. They are in close contact with the androgen producing Leydig cells in 
the interstitium (Skinner et al., 1991), and together with the Sertoli cells the peritubular myoid 
cells produce an extracellular matrix and provide structural support for the spermatogenic 
epithelium (Skinner et al., 1985). Furthermore, these cells seem to be involved in contraction 
of the tubules which may play a role in the release and transport of the testicular spermatozoa 
(Clermont, 1958; Fritz and Tung, 1986). 
Androgens, but also follicle-stimulating hormone (FSH), stimulate the development of 
peritubular cells towards a more mature appearance (Bressler and Ross, 1972). The 
gonadotropic hormone FSH, like LH secreted by the pituitary gland, acts on testicular Sertoli 
cells (Paragraph 1.1.3). Effects of FSH on peritubular myoid cell differentiation, therefore, 
indicate communication between Sertoli cells and peritubular myoid cells (Fig. 3). 
Peritubular myoid cells produce a potential regulator of Sertoli cell function, termed 
PmodS (a feritubular myoid cell factor which modulates ;>ertoli cell function; Skinner and Fritz, 
1985; 1986). In cell cultures, this paracrine factor has a marked impact on a number ol Sertoli 
cell functions: it increases the production of androgen binding protein (ABP, a well known 
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Sertoli cell product; Tung and Fritz, 1980; Hudson and Stocco, 1981), and transferrin (Holmes 
et al., 1984; Skinner and Fritz, 1985), and it affects vectorial secretion of proteins (Janecki and 
Steinberger, 1987; Ailenberg et al., 1988) and alters the histochemical staining of several 
metabolic enzymes in Sertoli cells (Cameron and Snydle, 1985). The current hypothesis is that 
PmodS may play an important role in Sertoli cell function and differentiation (Skinner, 1989) 
(Fig. 3). 
Other, so far identified, peritubular myoid cell products that may influence testicular 
function are: TGFa, TGFB and IGF-1. 
1.1.3 Sertoli cells and germ cells 
Sertoli cells are the only somatic cell type of the spermatogenic epithelium. Together with 
endothelial cells (lining blood vessels and lymph space), peritubular myoid cells and the basal 
lamina, they form blood-testis barriers (Setchell et al., 1969; Dym and Fawcett, 1970; Pl6en 
and Setchell, 1992). The contribution of Sertoli cells to these barriers is important. Tight 
junctions are located in between neighbouring Sertoli cells and divide the seminiferous tubule 
into a basal and an adluminal compartment. These junctional contacts between adjacent 
Sertoli cells restrict the passage of many growth factors, nutrients and hormones from the 
basal to the adluminal compartment of the seminiferous tubule. In fact, the Sertoli cell tight 
junctions establish the functional blood-testis barrier (Sharpe, 1983; Saez et al., 1987; Bardin 
et al., 1988). In rats, the blood-testis barrier is constructed soon after birth but it takes several 
weeks before this barrier is fully effective (Setchell et al., 1981; 1988). The construction of the 
blood-testis barrier is correlated with the onset of spermatogenesis and seminiferous tubule 
fluid production. The tubule fluid may serve as a vehicle lor sperm transport and possibly 
plays a role in further maturation of the testicular spermatozoa (Russell et al., 1989). 
Germ cell development takes place in the protected environment of the seminiferous 
tubules, as a defined series of developmental events, according to a tight schedule in time 
and place (Clermont and Harvey, 1967). The germ cells are arranged in specific cell 
associations, called the stages of the cycle of the seminiferous epithelium. For the rat, 14 
different stages have been defined, which make up one cycle of approximately 13 days 
duration. For its complete development, the germ cell traverses the different stages of the 
cycle 4 times, which takes all together 52 days (Clermont, 1972). Each time the germ cell 
passes through the same stage of the cycle, it is more advanced in its development towards 
a full grown spermatozoa (Fig. 2; Dym and Clermont, 1970). 
At the beginning of the first wave of spermatogenesis, it is thought that the 
seminiferous epithelium shows considerable synchronisation. later, Sertoli cells at adjacent 
parts of the seminiferous epithelium support very different stages of the cycle. 
Spermatogenesis does not seem to rely on direct control of the germ cells by the 
endocrine system, but rather is dependent on hormone action on Sertoli cells, and cell-cell 
interactions between germ cells and Sertoli cells (Jegou et al., 1984; Grootegoed et al., 1985; 
Griswold et al., 1988; Skinner, 1991). In this respect, the Sertoli cell is also referred to as the 
nursing and supporting cell of the germinal epithelium. For example, Sertoli cells provide an 
energy-yielding substrate for the developing germ cells in the form of lactate (Jutte et al., 
1983), play an important role in detoxification of antispermatogenic compounds (Den Boer et 
al., 1989), and are involved in spermatid differentiation (Russell, 1980). 
Testosterone and FSH are considered to be the most important hormonal regulators 
of spermatogenesis (Clermont and Harvey, 1967; Steinberger, 1971; Hansson et al., 1975; 
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Fig. 2. Diagram illustrating the cell associations in the 14 different stages of the cycle of the seminiferous 
epithelium in the rat. The 14 stages are designated by Roman numerals. Abbreviations are: A = type A 
spermatogonia; In = intermediate type spermatogonia; B = type B spermatogonia; R = preleptotene 
spermatocytes; L = leptotene spermatocytes; Z = zygotene spermatocytes; P = pachytene spermatocytes; Di 
= primary spermatocytes at the diplotene stage; 11 = secondary spermatocytes; 1-19 = spermatids at the 
successive steps of spermiogenesis (From Dym and Clermont, 1970}. 
Means et al., 1976; Fritz, 1978; Tindall et al., 1984; Russell et al., 1987). Both hormones can 
exert actions on spermatogenesis by regulating activities of Sertoli cells (Fig. 3) (Means et al., 
1980; Sanborn et al., 1983; Cheng et al., 1986; Roberts and Griswold, 1989). The action of 
FSH on spermatogenesis is certainly direct on Sertoli cells, because this is the only cell type 
in the male body that expresses the FSH receptor (Darrington et al., 1975; Darrington and 
Armstrong, 1979; Bortolussi et al., 1990; Heckert and Griswold, 1991). Androgen action may 
not only involve effects on the Sertoli cells, but also on the androgen receptor containing 
peritubular myoid cells (Buzek and Sanborn, 1988; 1990; Sar et al., 1990, Ruizeveld de Winter 
et al., 1991). Direct action of androgens on germ cells is not very likely, because several 
authors have reported that these cells do not contain androgen receptors (Grootegoed et al., 
1977; Anthony et al., 1989). 
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Fig. 3. Interactions involved in the regulation of spermatogenesis by FSH and testosterone. 
1.2 Aim and scope of this thesis 
FSH and testosterone are the main hormonal regulators of spermatogenesis. The actions of 
androgens and FSH are mediated by their respective receptors. Receptor gene expression 
(mRNA and protein). is an important determinant of hormone action. Biochemical aspects of 
the regulation of androgen and FSH receptor gene expression in the testis were chosen as 
the subject of the studies described in this thesis. Regulation of the expression of the receptor 
genes was studied at the level of gene transcription, and at the level of mRNA and protein 
expression. 
In Chapters 2-4, a detailed characterization is given of the effects of FSH on androgen 
and FSH receptor mRNA and protein expression in cultured immature Sertoli cells. For the 
androgen receptor, these findings were extended by measurements of androgen receptor 
gene transcription initiation rate in cultured immature Sertoli cells and LNCaP Oymph node 
carcinoma of the prostate) cells (Chapter 5). 
Preliminary results concerning a putative paracrine factor, produced by Sertoli cells and 
affecting androgen receptor mRNA expression in peritubular myoid cells, are presented in 
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Chapter 6. 
The effects of testosterone deprivation iD. vivo on androgen receptor mRNA and protein 
expression in the adult rat testis were examined as described in Chapter 7.ffi vitro effects of 
testosterone on androgen receptor gene expression in cultured testicular cells and LNCaP 
cells are described in the Chapters 2, 3 and 5. 
In the General Discussion (Chapter 8) we have considered some aspects of regulation 
of spermatogenesis by FSH and testosterone and have discussed them in relation to our 
experimental data as well as in a broader perspective. This way, we hope that the results 
which we have presented, and discussions which we have tried to initiate, may contribute to 
research concerning hormonal control of spermatogenesis, now and in the future. 
1.3 Hormonal regulation of spermatogenesis 
The emphasis of this thesis will be on the actions of testosterone and FSH on 
spermatogenesis. There are, however, other factors that can also affect spermatogenesis. 
Before going into detail about the role of androgens and FSH, some of these other factors 
are briefly discussed. 
lnhibin is a glycoprotein hormone, which inhibits pituitary gonadotropin production 
and/or secretion, preferentially that of FSH (Burger and Igarashi, 1988). Sertoli cell production 
and secretion of inhibin is considered to be part of the hypophysis/gonad feedback 
mechanism that controls FSH (Fig. 3) (Weinbauer et al., 1989). Van Dissei-Emiliani et al. 
(1989) reported that injections of an excess of inhibin in one of the testes of mice or hamsters, 
resulted in a small but significant reduction in spermatogonial numbers in the treated testes, 
but not in the untreated contralateral testes. Furthermore, Woodruff et al. (1992) reported 
binding of inhibin to isolated rat germ cells. For the inhibin related protein activin, binding to 
germ cells, and induction of spermatogonial proliferation has also been reported (Mather et 
al., 1990; Woodruff et al., 1992). Moreover, activin receptor mRNA has been reported to be 
present in pachytene spermatocytes and round spermatids; the presence of the mRNA in the 
polysomal fraction indicated translation of this mRNA into activin receptor protein (de Winter 
et al., 1992). These reports suggest a local role for inhibin and activin in the regulation of 
spermatogenesis. Furthermore, inhibins, activins, or related proteins, are also synthesized in 
a number of other tissues, and may play a role in various other processes (Grootenhuis, 
1990). 
Epidermal growth factor (EGF), produced in high amounts by the mouse 
submandibular gland, may also play some role in spermatogenesis. It was reported that upon 
removal of the submandibular gland (sialoadenectomy), spermatogenesis in mice became 
impaired (Tsutsumi et al., 1986). When EGF was substituted in physiological concentrations 
to the sialoadenectomized mice, spermatogenesis returned to normal. These data, however, 
could only partly be reproduced (Russell et al., 1990). In Chapter 6, the possible role of EGF 
in the rat model is discussed in more detail. 
Vitamin A (retinol), and its derivatives retinal and retinoic acid, have been reported to 
be of essential importance for reproduction, vision, cell differentiation and normal growth 
(Dicken, 1984). When rats or mice are made vitamin A-deficient, there are two effects in the 
testis: the developing germ cells degenerate, and spermatogenesis is blocked at the level of 
the transition of undifferentiated to differentiated A spermatogonia (van Pelt and de Rooij, 
1990a). The loss of germ cells in vitamin A-deficient rats, is suggested to be caused mainly 
by the disruption of the Sertoli cell barrier (Huang et al., 1988), which is part of a more general 
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effect of vitamin A-deficiency on epithelial cells. The blockade of spermatogonial cell division, 
however, may be caused by the absence of direct effects of retinoic acid on spermatogonial 
cells. Kim and Griswold (1990) and van Pelt (1992) reported localization of retinoic acid 
receptor mRNA (a and ) in spermatogonial cells. These findings suggest that retinoic acid 
may exert a direct effect on spermatogonial cells. On the other hand the Sertoli cell has also 
been denoted as target for retinoic acid (Karl and Griswold, 1980). 
Upon refeeding of vitamin A deficient animals with retinol (Morales and Griswold, 1987; 
van Pelt and de Rooij, 1990a and 1990b) or a high dose of retinoic acid (van Pelt and de 
Rooij, 1991), spermatogonial cells start to divide again, and spermatogenesis returns to 
normal. It should be noted, that in this case a synchronization in the development of different 
stages of the seminiferous tubule is maintained lor some time. 
1.3.1 FSH receptor 
The molecular mechanism of FSH action on spermatogenesis starts with the binding of FSH 
to its receptor in the Sertoli cell plasma membrane. FSH is a member of a family of 4 
glycoprotein hormones (thyroid-stimulating hormone [fSH], chorionic gonadotropin [CG], LH 
and FSH). These hormones are composed of two dissimilar glycoprotein subunits, a and B. 
Within a given species, the a subunits are identical and the r., subunits are similar but not 
identical. Because of the similarities between the hormones, it was speculated that their 
receptors also would be related (Salesse et al., 1991). Cloning of one member of the 
glycoprotein hormone receptor family (LH/CG (CG is closely related to LH, and binds to the 
LH receptor) receptor; McFarland et al., 1989; Loosfelt et al., 1989) indeed facilitated the 
cloning of other members of the family: the TSH receptor (Parmentier et al., 1989; Libert et 
al., 1989; Nagayama et al., 1989; Misrahi et al., 1990; Akamizu et al., 1990) and the FSH 
receptor (Parmentier et al., 1989; Sprenger et al., 1990; Minegish et al., 1991). 
These glycoprotein hormone receptors have in common a characteristic domain that 
traverses the membrane 7 times, and a N-terminal domain that is involved in specific hormone 
binding and are members of a large super-family of G protein-coupled membrane receptors. 
Through the interaction of the FSH receptor with the GTP-binding protein Gs, FSH binding 
results in activation of adenylyl cyclase, and thereby in increased levels of intracellular cAMP. 
Elevated cAMP levels in turn can activate protein kinase A, and the ensuing protein 
phosphorylation can modify Sertoli cell activities. Recent observations indicated that other 
signal transduction pathways may also be involved in FSH action on Sertoli cells (Grasso et 
al., 1989; 1990; 1991, Gorczynska and Handelsman, 1991). 
Cloning of FSH receptor eDNA (Parmentier et al., 1989; Sprenger et al., 1990; Minegish 
et al., 1991) was rapidly followed by studies on regulation of FSH receptor mRNA expression 
in the ovary and testis (Chapters 4 and 8). As is the case with the LH/CG receptor gene 
(Wang et al., 1991; Frazier et al., 1990) and the TSH receptor gene (Frazier et al., 1990), the 
FSH receptor gene also encodes several mRNAs. Heckert and Griswold (1991) showed a 
predominant 2.6 kb FSH receptor mRNA and a much lower expressed 4.5 kb FSH receptor 
mRNA The expression of both FSH receptor mRNAs is limited to Sertoli cells and the ovary; 
other tissues and cells (epididymis, liver, brain, kidney, spleen, uterus, germ cells) were 
negative. The two mRNA species probably represent different splice or poly-adenylation 
variants from the same gene. It is not yet known whether both FSH receptor mRNAs encode 
lull-length receptors; one of them may encode a truncated receptor form. For the LH/CG 
receptor, using monoclonal antibodies, 3 different proteins were recognized in testicular 
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membrane extracts (Vuhai-Luuthi et al., 1990). One of the proteins lacked the hormone 
binding domain, the second represented the full-length LH receptor and the third protein only 
contained the extracellular domain and is thought to be an extracellular LH-binding protein 
(Wang et al., 1991). 
The expression of FSH receptor mRNAs appears to be very low in the stages VII to X 
of the cycle of the seminiferous epithelium, as measured in isolated seminiferous tubules from 
stage-synchronized rats (Heckert and Griswold, 1991 ). These findings were in agreement with 
studies from Kangasniemi et al. (1990a; 1990b), who reported a decreased binding of FSH, 
resulting in a decreased cAMP response to FSH, at these stages of the spermatogenic cycle. 
Kliesch et al. (1992), however, found almost opposite results using in situ hybridization; a high 
FSH receptor mRNA expression in the stages IX and X of the spermatogenic cycle of the 
seminiferous tubule. Hence, either the in situ hybridization gave erroneous results, or there 
is a marked difference between stage-synchronized Sertoli cells and normal cyclic Sertoli cells. 
In the literature, several reports demonstrate a decreased responsiveness of Sertoli 
cells upon continuous stimulation with FSH (O'Shaughnessy and Brown, 1978; Namiki et al., 
1987; Yoon et al., 1990). This decrease is caused by a desensitization process that involves 
receptor internalisation (O'Shaughnessy, 1980), loss of adenylyl cyclase activity (Verhoeven 
1980) and increased phosphodiesterase activity (Conti et al., 1981; 1983). Regulation of FSH 
receptor mRNA and protein expression may also play a part in the desensitization process. 
The regulation of FSH receptor gene expression in cultured immature Sertoli cells by FSH was 
studied in more detail, as described in this thesis (Chapter 4). 
1.3.2 FSH and spermatogenesis 
There is general agreement that FSH is important for the initiation of spermatogenesis in 
mammals during puberty (Means et al., 1976; Dym et al., 1979; Russell et al., 1987), or for 
the reinitiation of spermatogenesis in hypophysectomized rats or in hibernating species. Its 
role in the maintenance of spermatogenesis in adult monkeys has also been established 
(Weinbauer and Nieschlag, 1991). In adult rats, however, its role is subject to debate. 
Experiments showing a role for FSH in adult animals are difficult to design; ideally, an in vivo 
study, in which FSH and testosterone levels can be regulated completely independent of each 
other, is needed. 
Using hypophysectomized adult rats that were substituted with a highly purified 
preparation of human FSH andjor silastic implants containing testosterone, Bartlett et al. 
(1989) found indications that FSH is needed in addition to testosterone for maintenance of full 
spermatogenic capacity in adult rats. When adult rats were substituted with either FSH or 
testosterone for two weeks following hypophysectomy, testicular weights were decreased by 
45%. Substitution of FSH together with testosterone, however, resulted in almost normal 
testicular weights. Germ cell counts confirmed that loss in testicular weight was due to 
impaired spermatogenesis. This study showed a co-operative action of FSH and testosterone 
in the regulation of spermatogenesis in adult rats. In fact, similar observations concerning 
maintenance of spermatogenesis have been reported 3-4 decades ago (for a review see 
Steinberger et al., 1971) 
Kerr et al. (1992) treated hypophysectomized rats with ethane dimethane sulphonate 
(EDS), an alkylating agent which destroys Leydig cells (Morris et al., 1986). FSH and LH were 
eliminated by hypophysectomy, and testicular testosterone production was completely 
abolished by destruction of the Leydig cells. At the start of this experiment, the animals were 
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substttuted with no hormone, testosterone, FSH or both hormones. Using this model, Kerr et 
al. (1992) could show that testosterone and FSH had independent, synergistic and stage-
dependent effects on spermatogenesis. A problem in this study, however, was that the normal 
spermatogenic function of the testis could not be maintained. 
At the biochemical level, co-operation between FSH and testosterone has been 
observed for androgen receptor expression. Verhoeven and Cailleau (1988) reported that FSH 
increased the concentration of androgen receptors in cultured Sertoli cells. In the present 
thesis, additional biochemical and molecular data are presented that suggest a role for FSH 
in regulation of androgen receptor gene expression in Sertoli cells in the immature rat testis 
(Chapters 2, 3 and 5). 
1.3.3 Androgen receptor 
With the cloning of androgen receptor eDNA (Chang et al., 1988; Lubahn et al., 1988a; 
Trapman et al., 1988), a new impulse was given to studies on the mechanism of action of 
androgens. The availability of androgen receptor eDNA provided tools to study androgen 
receptor mRNA expression, androgen receptor protein structure and function, and to produce 
androgen receptor antibodies. The new techniques and probes, together with the already 
widely used specific ligand binding assays, resulted in new insights in androgen receptor 
regulation. 
Lubahn et al. (1988b) and Tan et al. (1988) were the first to report that androgen 
receptor mRNA expression in rat ventral prostate was increased upon castration of the 
animals (24h). This effect was reversed upon injection of testosterone, 24 h after castration. 
It is clear, therefore, that in the prostate androgens cause down-regulation of androgen 
receptor mRNA expression. Quarmby et al. (1990) showed that down-regulation of androgen 
receptor mRNA expression was not restricted to the ventral prostate. In kidney, brain, 
epididymis and coagulating gland, expression of androgen receptor mRNA was also increased 
upon castration and subsequently decreased after androgen injection. Using the LNCaP cell 
line, androgen dependent down-regulation of androgen receptor mRNA expression could also 
be shown (Quarmby et al., 1990; Tilley et al., 1990; Trapman et al., 1990; Krongrad et al., 
1991). 
Up-regulation of androgen receptor mRNA expression does not necessarily imply that 
androgen receptor protein levels are up-regulated also. In fact, the opposrte seems to occur. 
Fiorelli et al (1989) showed that the androgen receptor content of the ventral prostate in adult 
rats is decreased upon androgen withdrawal. Data on rat penis tissue (fakane et al., 1991), 
and cultured fat pad adipose precursor cells (de Pergola et al., 1990), gave rise to the same 
conclusion. Using LNCaP cells, Krongrad et al. (1991) observed an increased level of 
androgen receptor mRNA that coincided with a decreased level of androgen receptor protein. 
These findings may partly be explained by observations of Syms et al (1985), who reported 
an increased stability of the androgen receptor upon binding to its ligand. Due to this ligand-
induced stability, the androgen receptor protein level may become increased, while androgen 
receptor mRNA expression is decreased. 
Although down-regulation of androgen receptor mRNA and up-regulation of androgen 
receptor protein in the presence of testosterone seems to be a rather general phenomenon, 
there are reports that show a different regulation. In prostatic epithelium from neonatally 
castrated animals, the level of expression of androgen receptor protein was not different in 
the presence or absence ofdihydrotestosterone, measured on day 10 (Husmann etal., 1991). 
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Furthermore, Prins (1989) reported differential regulation of androgen receptor protein in the 
separate lobes of the rat prostate. In ventral prostate, androgen receptors were lost upon 
castration, whereas in lateral prostate, after an initial decrease, the amount of androgen 
receptors was restored to precastration levels. 
Besides studies that provide additional information about differential regulation of 
androgen receptor mRNA and protein expression, there are also some conflicting findings. 
Using monoclonal antibodies, Shan et al. (1990) found that the ventral prostate levels of 
androgen receptor mRNA and protein were elevated in castrated rats. Takeda et al. (1991), 
using other techniques 0mmunohistochemical and ill situ hybridization analysis), different 
antibodies, and a different eDNA probe, reached similar conclusions. It is difficult to interpret 
the information from these two research groups in relation to other data in the literature. It is 
clear, however, that more research is needed to obtain conclusive data. 
In Chapters 5 and 7 of this thesis, data are presented indicating that regulation of 
androgen receptor expression (mRNA and protein) in the rat testis is markedly different from 
the regulation of androgen receptor expression in other rat tissues. 
1.3.4 Androgens and spermatogenesis 
Leydig cells produce large amounts of androgens. Through their actions on Sertoli and 
peritubular myoid cells, androgens drive spermatogenesis (Sharpe, 1987). In the literature, 
several indications can be found that the level of testicular testosterone (measured either in 
the testicular vein, or in whole testis [Maddocks and Sharpe, 1988]) is considerably higher 
than needed for ongoing spermatogenesis (Sun et al., 1989; Awoniyi et al., 1989; Huang and 
Boccabella, 1988). Sharpe (1987) indicated that the techniques used to measure the actual 
lo. vivo testicular testosterone level are far from reliable. Research has continued, using 
different techniques and different approaches, but always resulting in the same outcome: 
spenmatogenesis does not seem to require an exceedingly high local level of testicular 
testosterone (this topic is discussed in Chapter 8). 
In the experiments described in Chapter 7, EDS was used to decrease the testicular 
testosterone level in adult rats. Subsequently, these rats were treated with testosterone, FSH 
or both hormones. Upon specific ligand binding, the androgen receptor becomes transformed 
to a DNA binding form that regulates the expression of androgen dependent genes 
(Mainwaring, 1977; Schrader et al., 1981; Brinkmann et al., 1983). The amount of androgen 
receptor present in the testis, and the degree of transformation of these androgen receptors, 
was measured to determine what amount of testosterone is necessary to occupy and 
transform all androgen receptors. Furthermore, androgen receptor gene expression was 
studied in the testis of animals treated according to different protocols. 
1.4 Methodology 
1.4.1 In vivo versus in vitro 
Part of the experiments described in this thesis were performed ill vivo (animal experiments), 
to try to obtain information on the regulation of the androgen receptor in the testis of 
immature and mature rats. These studies, however, do not yield details on regulation of 
androgen receptor expression in the dtfferent cell types in the testis. This information is of 
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value because, for example, regulation of androgen receptor number in Sertoli cells might be 
of more relevance for spermatogenesis than regulation of the number of androgen receptors 
in peritubular myoid cells. Because Sertoli cells are most directly involved in the regulation of 
spermatogenesis, this cell type was used in most of the in vitro experiments (cell culture 
experiments). However, peritubular myoid cells have also been included in some of the 
experiments. FSH receptor gene expression was studied in vivo in testis from immature rats, 
and in vitro using isolated Sertoli cells. 
In Chapters 2 and 4, isolation methods are described for the isolation of a highly pure 
Sertoli cell population from immature rats, which can be used in a cell culture system. 
Immature rats were used to isolate Sertoli cells, for a number of reasons. First, Sertoli cells 
can be obtained from immature animals at higher purrty and better viability, than from more 
mature animals (Russell and Steinberger, 1989). Second, in these immature animals FSH 
plays an active role in the initiation of spermatogenesis, and Sertoli cells isolated from 
immature rats are much more sensitive to FSH stimulation than Sertoli cells from older animals 
(Steinberger et al., 1975; 1978; Heindel, 1988). Third, in the immature animaJs the ftrst 
spermatogenic wave has just started (Russell et al., 1989), and for that reason the Sertoli cells 
have not yet reached complete a-synchrony with respect to spermatogenic cycle-dependent 
activities (Parvin en, 1982). Therefore, Sertoli cells isolated from immature animals are probably 
a much more homogeneous population than Sertoli cells from adult animals. 
An important consideration with respect to the interpretation of experimental data, is 
the extent to which the cultured cells represent the cells in vivo. Rich et al. (1983) showed, 
using ABP as a functional parameter, that Sertoli cells isolated from 1 0-day-old rats can 
develop in culture to a somewhat more mature Sertoli cell that produces more ASP. This 
increment stops after 10 days in culture; thereafter it reverses. Sanborn et al. (1986) examined 
differences in secreted proteins between cultured Sertoli cells isolated from rats of different 
ages, and found, after 3 days of culture, marked differences in Sertoli cell function in relation 
to the age of the animals that were used to isolate the Sertoli cells from. These data suggest 
that Sertoli cells do not readily revert to a common basal state within a few days of cuiture. 
In the present experiments, isolated Sertoli cells were seeded at a density of 1-2 x 1 O' 
cells per em' in plastic tissue culture flasks, to obtain a monolayer of flattened or slightly 
columnar cells. These cells retain some of the morphological characteristics of Sertoli cells 
located in the seminiferous tubule. When Sertoli cells are cultured on an extracellular matrix, 
however, a more optimal morphology of the Sertoli cells seems to be obtained (Tung and 
Fritz, 1986; Hadley et al., 1985; 1987). Anthony and Skinner (1989) have investigated the 
effect of the extracellular matrix on hormonal regulation of the production of transferrin and 
ABP by cultured immature Sertoli cells. Although the cytoarchitecture of the cultured Sertoli 
cells was significantly improved, they could not show marked effects of the extracellular matrix 
on hormonal regulation of the expression of biochemical markers for Sertoli cell function. For 
comparison, it is of interest to briefly discuss another epithelial cell type that has been cultured 
under various conditions. 
Mammary epithelial cells cultured on floating collagen gel express their differentiated 
properties (production of transferrin and casein) at a much higher level, and for longer periods 
of time, than cells cultured on plastic. Furthermore, the effect of prolactin on a2-casein and 
B-casein mRNA expression and protein synthesis, was less pronounced for the epithelial cells 
cultured on plastic, than for the cells cultured on floating collagen gel (lee et al., 1985). These 
results indicate that the molecular mechanism responsible for hormonal regulation of gene 
expression was intact but less active in the cells cultured on plastic as compared to the cells 
cultured on floating collagen. 
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In this thesis, Sertoli cells were maintained in culture for up to 7 days, without the help 
of collagen or any other extracellular matrix material. In this manner, some of the 
morphological and functional properties of the Sertoli cells may have been lost, but 
biochemical mechanisms can also be studied under these conditions. The results from in vitro 
studies were compared to results obtained from in vivo studies. 
1.4.2 The study of receptor regulation 
In view of the main regulatory roles of androgens and FSH in spermatogenesis, the 
expression of the androgen receptor and FSH receptor genes was chosen as the subject of 
the studies described in this thesis. The regulation of receptor gene expression was studied 
at different levels: gene transcription, mRNA stability and protein expression. 
Transcription of the androgen and FSH receptor genes was studied using two different 
methods. 
1. Transfection: Part of the androgen receptor gene transcription unit (Baarends et al., 1990) 
together with flanking sequences, was cloned in front of a reporter gene, and transfected into 
cultured Sertoli cells or LNCaP cells. The transfected cells were tested for the transcriptional 
response of the constructs to testosterone and FSH. 
2. Nuclear run-on: Transcription of the androgen and FSH receptor genes was allowed to 
continue in vitro in isolated cell nuclei, in the presence of radioactively labelled mRNA 
precursors. The obtained radioactive androgen and FSH receptor mRNAs were hybridized to 
their respective unlabeled cDNAs that were immobilized on blotting paper, and visualized 
using autoradiography. 
Androgen and FSH receptor mRNAs were studied in vivo and in vitro. Coding regions 
of the genes (cDNAs) were labelled and used as probes for androgen and FSH receptor 
mRNAs on Northern or dot blots. The hybridization signals were quantified by densitometer 
scanning and interpreted as direct measurements of the amount of receptor mRNA present 
in the cultured cells or tissues. 
The androgen and FSH receptor proteins were studied, using specific ligand binding 
assays. Radioactively labelled ligands used were: 3H-methyltrienolone {'H-R1881), which is 
a synthetic androgen that binds with high specificity to the androgen receptor (Veldscholten 
et al., 1990a; 1990b), and 1251-FSH, which binds to the FSH receptor. Furthermore, the 
androgen receptor protein expression was also studied using specific mono- and polyclonal 
antibodies. 
1.4.3 The EDS model 
Ethane dimethane sulfonate (EDS) is an alkylating agent that, through an unknown 
mechanism, destroys all Leydig cells in adult rat testes within 36 h after subcutaneous 
injection (Bartlett et al., 1986; Jackson AE et al., 1986; Jackson NC et al., 1986; Kerr et al., 
1986; Molenaar et al., 1986; Morris et al., 1986). Treatment of adult rats with EDS does not 
irreversibly damage the testis (Kerr et al., 1985; Bartlett et al., 1986), and does not result in 
marked testicular defects other than the temporary elimination of Leydig cells (Morris, 1985; 
Verhoeven et al., 1989). Differentiation of a new population of Leydig cells starts 2 weeks after 
the EDS injection. The cells are restored to their normal numbers by 42 days after EDS 
treatment (Kerr et al., 1987), which results in a completely normalized sperm output 3 months 
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after EDS treatment (Jackson and Morris, 1977). 
In Chapter 7, it is described that we have used EDS to destroy Leydig cells, thereby 
curtailing the circulating and testicular androgen concentration in adult rats (Bartlett et al., 
1986). Nuclei from ventral prostate and testis were isolated, to estimate specific R1881 binding 
s~es (Scatchard analysis): The procedure for isolation of the nuclear fraction included tissue 
fractionation under liquid nitrogen (Barberis et al., 1989) and the use of buffers containing a 
high concentration of sucrose (Gorski et al., 1986), in order to reduce loss of nuclear 
androgen receptors. It was observed, however, that unoccupied androgen receptors were not 
present in the nuclear fraction (Brinkmann et al., 1983). These results seem to suggest that 
the unoccupied androgen receptor is not located in the nucleus (Simental et al., 1991). 
However, Husmann et al. (1990) showed, using several different monoclonal antibodies, that 
in the rat ventral prostate in the presence but also in the absence of androgens, the androgen 
receptor is predominantly located in the nucleus. In the present experiments, we have taken 
the poshion that untransformed (unoccupied) androgen receptor molecules, are not in the 
tight nuclear binding form, and therefore are lost from the nuclei upon cell fractionation. To 
enable us to measure the total amount of androgen receptors, the unoccupied androgen 
receptors were transformed to the occupied, tight nuclear binding form. This was attained by 
treatment of the rats whh a very high dose of testosterone (10mg, i.p.) 2 h prior to killing cr-
pulse). Using this approach, the number of occupied androgen receptors (without T-pulse) 
and the total amount of androgen receptors (with T-pulse) could be measured in the nuclear 
fraction. This is illustrated in Fig. 4. 
From now on we will use the term occupied androgen receptor for the receptor that 
is transformed to the tight nuclear binding form. 
The experiment was chosen to last for 5 days, because it had been described that 
during the first 7 days after EDS treatment, in addition to the destruction of the Leydig cells, 
no marked damage to spermatogenesis could be observed (Bartlett et al., 1986). Ventral 
prostate and epididymis were also included in this study, because these organs have been 
reported to react to changing testosterone levels. 
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Fig. 4. The EDS model. A 8 and C represent whole cells; A is the situation in the intact control rat testis, B is 
the situation in the ventral prostate from intact control rats, and C is the situation 5 days after EDS treatment. D, 
E and F represent isolated nuclei from A, 8 and C, respectively. The unoccupied androgen receptors (o) from 
B and C can be transformed to the occupied form ( 3 ) by T-pulse treatment. The unoccupied androgen 
receptors in B and C are lost upon isolation of the nuclei (E and F). T-pufse = testosterone pulse treatment, 
(.-:;:i:V represents testosterone concentration. 
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Summary 
Follicle-stimul:lting hormone (FSH) and testosterone stimulate the production of a variety of proteins 
by immature Sertoli cells. A highly purified Sertoli cell preparation was incubated for 3 days with FSH 
and testosterone. Both androgen receptor protein and mRNA concentrations were markedly increased by 
FSH. Testosterone also increased the androgen receptor protein concentration, but did not increase the 
expression of the androgen receptor mRNA. It is concluded that FSH plays a role in the responsiveness of 
Sertoli cells to testosterone. 
Introduction 
Spermatogenesis is supported by Sertoli cells. 
The two principal hormonal regulators of sper-
matogenesis, follicle-stimulating hormone (FSH) 
and testosterone show a synergistic effect on 
spermatogenesis in immature rats (Russell et aL, 
1987). These hormones are important for Sertoli 
celi maturation (Fritz. 1978) and stimulate the 
production and secretion of a large number of 
different proteins by Sertoli cells (Cheng et aL 
1986). Although the production of many of these 
proteins is stimulated by both FSH and 
testosterone. different mechanisms of hormone ac-
tion are involved. 
Address for correspondence: LJ. B!ok. Department of 
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The regulatory effects of FSH and testosterone 
on spermatogenesis involve stimulation of Sertoli 
cells (Grootegoed et aL, 1977~ Fritz. 1978). It is 
not clear, however. to what extent peritubular 
myoid cells play a role in mediating the hormonal 
sign.a.ls. Skinner and Fritz (1985) reported that 
peritubular cells secrete a protein under the in-
fluence of androgens. which modulates Sertoli cell 
function. 
Recently, Verhoeven and Cailleau (1988) have 
shown that the androgen receptor concentration in 
Sertoli cells from immature rats was increased 2-
to 3-fold after adding testosterone or FSH to the 
cell cultures. In the present experiments. we have 
studied the hormonal regulation of the expression 
of the androgen receptor mRNA and protein in 
rat Sertoli cells. using a highly purified ceil pre-
paration with a minimal number of peritubular 
cells. The present results extend the findings of 
Verhoeven and Ca.illeau (1988) and indicate that 
0303-7207/89 j$03.50 ,,::; 1989 Elsevier Scientific Publishers ireland. Ltd. 
FSH stimulates the androgen receptor concentra-
tion in Sertoli cells through stabilisation of the 
mRNA andjor stimulation of transcription of the 
gene encoding the androgen receptor. 
Materials and methods 
Isolation and culture of Sertoii ce!!s. Testes of 
3-wee:k-old Wistar rats were decapsulated and 
chopped (at a distance of 0.5 mm in two per-
pendicular directions). Subsequently. 10-12 
chopped testes were incubated in phosphate-
buffered saline (PBS: Dulbecco and Vogt. 1954) 
containing 1 mgjml DNase (DN-25: Sigma. St. 1 
Louis. MO. U.S.A.). for 30 min at 37°C in a 100 
ml Erlenmeyer flask. in a shaking waterbath (120 
cyclesjmin). During this treatment. tubule frag-
ments became dissociated from the interstitial cells. 
Blood vessels were taken out using a glass pipette 
and the interstitial cells were removed by 3-fold 
sedimentation at unit gravity for 2 min. in a 
volume of 50 ml PBS containing 5 J.Lg/ml DNase. 
The tubule fragments were subsequently in-
cubated in 20 ml PBS containing 1 mgjml col-
lagenase (CLS-I: Cooper Biomedical. Freehold. 
NJ. U.S.A.), 1 mgjml hyaluronidase (1-S: Sigma) 
and 5 ,ugjml DNase. under the same conditions 
as described above. During this treatment peritub-
ular cells became detached. resulting in partial loss 
of the cells from the tubular wall. After two 
sedimentation steps. the volume was corrected to 
15 ml and the suspension was dounced 5 times. 
using a loose-fitting pestle as described by Oonk 
et al. (1985). The remaining Sertoli cell aggregates 
were washed twice (sedimentation at 7 X g for 2 
min) to remove the dislodged peritubular and 
germ cells. Sedimentation was followed by treat-
ment of the cell aggregates as described above 
with 1 mgjrnl hyaluronidase and 5 J.Lg/ml DNase 
for 30 min. Many remaining peri tubular cells were 
detached during this incubation and were removed 
by washing 3 times. The last wash step was per-
formed using Eagle's minimum essential medium 
(MEM). supplemented with non-essential amino 
acids and antibiotics (fungizone. streptomycin and 
penicillin). The resulting cell preparation was al-
lowed to attach. either in 24-well plates (for esti-
mation of 3H-R1881 binding) or in 25 cm2 culture 
flasks (for RNA isolation). The cells were seeded 
at a density of 1 X 106 cellsjcm:: and incubated 
1 Materials .:l.nd M<:thods. lin<: 7 should read; 
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for 3 days in MEM containing 1% FCS. non-es-
sential amino acids and antibiotics. under an 
atiposphere of 5% CO:: in air. Subsequently. the 
Sertoli cells were subjected to a hypotonic shock 
(0.1 X MEM for 2 min) to remove the remaining 
germ cells (Galdieri et al.. 1981: Oonk and 
Grootegoed. 1987). The cells were then cultured in 
MEM containing non-essential amino acids. anti-
biotics and 0.1% (wjv) bovine serum albumin 
(BSA. fraction Y: Sigma) for 24 h. before the start 
of hormone treatment. 
Hormone treatment. The Sertoli cells were in-
cubated for 3 days in the presence of FSH (10 
ng/ml NIH-FSH-S16) andjor testosterone (1 
,uM). in medium containing 0.1% BSA. The 
medium was replaced daily by fresh MEM con-
taining the hormones. After the hormone treat-
ment. the cells were used either to assay the bind-
ing of 3H-R1881 (NEN Products. Stevenage. Hert-
fordshire, U.K.) or to isolate total RNA. At the 
end of the incubations. the number of peritubular 
cells in the Sertoli cell cultures was estimated 
using cytochemical detection of alkaline phos-
phatase activity, which is present in peritubular 
myoid cells but not in Sertoli cells isolated from 
rat testis (Palombi and DiCarlo. 1988). 
Androgen binding assay. After incubation in 
the presence of hormones. the Sertoli monolayers 
were washed 4 times. each washing for 15 min at 
37°C with MEM containing 0.1% BSA. The cells 
were then treated for 1 h with triamcinolone 
acetonide (4 ,uM). which occupies the pro-
gesterone receptors (Zava et al .. 1979). This was 
followed by an incubation of the cells in the 
presence of 3H-R1881 (7 nM) with or without an 
excess of unlabelled R1881 (10 ,uM), for 2 h at 
37°C. Subsequently. the cells were placed on ice 
and washed 4 times. for 15 min. with ice-cold 
MEM. to remove the free 3 H-R1881. The cellular 
proteins were dissolved in 1 M NaOH and stored 
at -20°C. until 3H-R1881 binding and the total 
protein and DNA content were measured. 
RNA extraction and hybridisation. Total RNA 
was extracted using a guanidinium thiocyanate 
lysis buffer. followed by centrifugation through 
CsCl, phenol extraction and ethanol precipitation 
(Chirgwin et al.. 1979). RNA was blotted on 
Gene-screen (NEF-972: NEN Products) and 
hybridised (stringency: 5 X SSC) with a 0.5 kb 
... ·containing l mgjml trypsin (TRL Worthington. Fr<:<:hold. NJ. U.S.A.) and Z5 14g/ml DNas<: 
(DN-15: SigiiU~. St. Louis. MO. USA.)' . 
28 
( EcoRI-EcoRI) human androgen receptor eDNA 
probe (Trap man et aL. 1988 ). corresponding to a 
part of the steroid-binding domain and the 3' 
untranslated region of the receptor mRNA The 
blots were washed in 0.1 X SSC containing 0.1% 
SDS. for 50 min at 50 ° C. 
Results 
The effects of FSH and testosterone on andro-
gen receptor protein and mRNA were estimated 
using a highly purified Sertoli cell preparation. 
containing less than 0.1% peri tubular myoid cells. 
The presence of peri tubular cells in the Sertoli cell 
cultures was evaluated using an alkaline phos-
phatase staining procedure (Fig. 1). 
After culture in the presence or absence of FSH 
and testosterone for 3 days, the DNA and protein 
content of the culture wells was not changed (not 
shown). The binding of :>H-R1881. however, was 
markedly increased after incubation in the pres-
ence of hormones (Fig. 2) (P < O.OOL compared 
with control: t-test). Testosterone elevated the 
number of androgen binding sites to a lesser ex-
tent than FSH. but testosterone in combination 
with FSH resulted in a cumulative effect (Fig. 2) 
( P < O.OL compared with FSH or testosterone). 
Using the same cell preparation method and 
the same hormone treatment schedule. the expres-
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Fig. 2. Effect of testosterone and FSH on the number of 
androgen receptors in Sertoli ceils. Specific binding of 3H-
R1881 was estimated after 3 days of culture in the absence (C) 
or presence of testosterone (T) and/or FSH. The binding was 
expressed as number of androgen receptors (AR) per celL The 
results represent the me::m- ± SD of four experiments with 
triplicate incubations. 
sion of the androgen receptor mRNA was esti-
mated. In the cultured Sertoli cells a single 
androgen receptor mRNA species of 10 kb was 
observed (Fig. 3). This 10 kb mRNA was also 
detected using total testis RNA (not shovvn). After 
incubation of Sertoli cells in the presence of 
testosterone, the expression of the androgen recep-
tor mRNA was not increased. but rather seemed 
to be slightly decreased. FSH treatment of the 
cells caused a marked increase of the androgen 
receptor mRNA level. 
r .. / 
Fig. 1. Alkaline phO$phatase staining of peritububr cells present in Sertoli cell cultures. A highly purified Sertoli eel! preparation. 
prepared as described in Materi:l.ls and Methods (A). compared with a less pure Sertoli cell preparation. which was prepared using a 
different method (B). The arrowhead~ in the less pure preparation point to contaminating peritubular myoid cells, detected with the 
alkaline phosphau...;;e staining. 
FSH T c 
10 kb AR-
Actin-
Fig. 3. Northern blot analysis of Sertoli cell RNA using a 
human androgen receptor eDNA probe. Total RNA was ex-
tracted from the Scrtoli cells after 3 d:lys of culture in the 
absence (C) or presence of testosterone (T) of FSH. An amount 
of 50 p.g total RNA w:lS .:1pplied per lane. and the blot was 
hybridi:<ed with a human androgen receptor (AR) eDNA probe. 
Hybridisation with a rat actin eDNA probe W:tS used to 
confirm that approximately equal amounts. of RNA were ap-
plied to the different lanes of the gel. 
Discussion 
In the present experiments. 3 H-Rl881 was used 
to estimate the effects of FSH and testosterone on 
the number of androgen binding sites. whereas 
Verhoeven and Cailleau (1988) have used ~H­
mibolerone. On the basis of Kd (0.7 nM). detailed 
saturation curves and binding competition studies. 
Verhoeven and Cailleau (1988) concluded that 
)H-mibolerone binding was indicative for the 
number of androgen receptors per mg protein. A 
similar Kd value was reported for binding of 
3 H-R1881 to the androgen receptor in rat Sertoli 
cells by Buzek and Sanborn (1988). The present 
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findings on hormonal stimulation of the number 
of androgen receptors in Sertoli cells are in agree-
ment vvith the results reported by Verhoeven and 
Cailleau (1988). Furthermore. the concentration of 
the androgen receptor in non-hormone-treated 
cells was similar to the data reported by Buzek 
and Sanborn (1988). However. Verhoeven and 
Cailleau (1988) did observe the effect of 
testosterone on receptor numbers. only after the 
Sertoli cells had been washed and incubated for 15 
h in the absence of testosterone. In the present 
experiments. binding of 3H-R1881 was estimated 
immediately follovving the culture period in the 
presence of testosterone andjor FSH. The bind-
ing was decreased rather than increased. after 15 h 
of incubation in the absence of testosterone (not 
shown). The reason for this discrepancy is not 
clear. 
Northern blot analysis indicated that FSH. but 
not testosterone. caused an increased expression 
of a 10 kb androgen receptor mRNA in the cul-
tured Sertoli cells. Recent data indicate that in 
other cell types testosterone may suppress andro-
gen receptor mRNA expression. Tan et al. (1988) 
reported that a 10 kb androgen receptor mRNA in 
rat prostate was up-regulated after castration. and 
subsequently down-regulated if testosterone was 
administered to the castrated rats. The observa-
tion that testosterone does not increase the expres-
sion of androgen receptor mRN A in cultured 
Sertoli cells is seemingly in contrast with the re-
sults on androgen binding. which showed that 
testosterone enhances the androgen receptor level 
in the Sertoli cells 2- to 3-fold. A possible explana-
tion is that testosterone exerts an effect on the 
translation of the androgen receptor mRNA or on 
the stability of the androgen receptor. In this 
context. it :is of interest that Syms et al. (1985) 
have reported that stimulation of a hamster smooth 
muscle tumour cell line by testosterone resulted in 
a doubling of the half-life of the androgen recep-
tor. 
The Sertoli cell preparation used for the present 
experiments contained only a very low number of 
peri tubular myoid cells. It is very likely. therefore. 
that the effect of testosterone on the androgen 
receptor concentration represents a direct effect of 
testosterone on Sertoli cells. which is not mediated 
by the peritubular cells. 
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The stimulatory effect of FSH on the number 
of androgen receptors per Sertoli cell was corre-
lated with an increased expression of the androgen 
receptor mRNA. However. it is not known whether 
FSH can directly stimulate transcription of the 
androgen receptor gene. Possibly. this FSH effect 
on androgen receptor rnRNA is an indirect effect 
which involves regulation of the transcription of 
other genes by FSH. 
From the present results. it is concluded that 
the molecular mechanism of FSH action on imma-
ture Sertoli cells includes a stimulatory effect on 
androgen receptor mRNA expression. which in 
combination with post-transcriptional effects of 
testosterone may lead to an increased responsive-
ness of the cells to testosterone. This integrated 
hormone action may play a key role in the 
hormonal regulation of the initiation and mainte-
nance of spermatogenesis. 
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CHAPTER 3 
Transient down-regulation of androgen receptor mRNA expression in Sertoli cells by 
follicle-stimulating hormone is followed by up-regulation of androgen 
receptor mRNA and protein 
U Blok, JW Hoogerbrugge, APN Themmen, WM Baarends, 
M Post and JA Grootegoed 
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ABSTRACT 
Cooperative actions of follicle-stimulating hormone (FSH) and androgens on initiation, 
maintenance and restoration of spermatogenesis have been described. In the present 
experiments, regulatory effects of FSH on androgen receptor (AR) gene expression in Sertoli 
cells were studied. 
In immature rats, injection of FSH (i.p., 1 pg/g body weight), resulted in a rapid down-
regulation oftesticular AR mRNA expression (4h), followed by recovery to control level (10 h). 
Using cultured immature Sertoli cells, a similar transient effect on AR mRNA expression was 
observed after addition of FSH (500 ng/ml) or dibutyryl cAMP (0.5 mM). Cycloheximide 
treatment of the cells did not prevent the rapid FSH-induced down-regulation of AR mRNA 
expression, indicating that de novo protein synthesis is not required for this effect. 
Furthermore, using a transcriptional run-on assay, no marked decrease in the rate of AR gene 
transcription was found upon treatment of the cultured Sertoli cells with FSH for 2 or 4 h. This 
demonstrates that the short-term effect of FSH on AR mRNA expression reflects a change in 
mRNA stability. The AR protein level was not markedly affected by the transient decrease in 
AR mRNA expression. 
When immature Sertoli cells were incubated with FSH for longer time periods (24 - 72 
h), both AR mRNA and protein expression were increased. In Sertoli cells isolated from 15-
day-old rats, this increase was higher (mRNA 2- to 3-fold and protein 2-fold) than in Sertoli 
cells isolated from 25-day-old animals. 
The results indicate that FSH plays a complex role in the regulation of androgen receptor 
expression in immature rat Sertoli cells. 
INTRODUCTION 
Follicle-stimulating hormone (FSH), an ·,mportant hormonal regulator of spermatogenesis, 
exerts its effects on germ cell development through regulation of Sertoli cell activities (1-3). 
The addition of FSH to cultured Sertoli cells from immature rats results in various changes in 
synthesis and secretion of a number of proteins (4). In FSH action, the cAMP signal 
transduction pathway plays a central role. The ability of FSH to induce changes in intracellular 
calcium levels, however, has also been documented (5-8). The available information indicates 
that the involvement of the phosphatidyl inositol pathway in FSH action is not very 
pronounced (9-10). 
Testosterone, the other major hormonal regulator of spermatogenesis, is produced by 
Leydig cells and exerts actions on peritubular myoid cells and Sertoli cells (11). Germ cells 
do not express the androgen receptor (12-13). It is likely, therefore, that effects of 
testosterone on spermatogenesis are mediated by peritubular myoid cells and Sertoli cells. 
The androgen receptor is an intracellular protein, which, upon androgen binding, is 
transformed to a DNA-binding form (14). This transformed receptor can regulate the 
expression of androgen-dependent genes (15-16). 
Substitution of either FSH or testosterone to hypophysectomized rats can maintain 
spermatogenesis qualitatively, at approximately 70% of the normal level. Only when both 
hormones are admin"1stered together, quantitatively normal spermatogenesis can be 
maintained (17). From these, and many other experiments (1, 18-20), it has become clear that 
the actions of FSH and testosterone on spermatogenesis show a cooperative effect. 
In long-term stimulation experiments of cultured Sertoli cells from immature rats in the 
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presence of FSH (3 days), the amounts of androgen receptor mRNA and protein were 
elevated (21-23). In the present study, the effects of FSH on expression of the androgen 
receptor gene were examined in more detail, with an emphasis on short-term effects. 
Experiments were conducted using intact immature rats and cultured Sertoli cells isolated from 
these animals. Northern blotting, nuclear run-on transcription experiments and specific ligand 
binding assays were performed to analyze androgen receptor gene expression. 
MATERIALS AND METHODS 
Isolation of Sertoli cells 
Sertoli cells from 15-, 21- or 25-day-old rats were isolated using a method described by 
Themmen et al. (24). The resulting cell population was allowed to attach, at a density of 106 
cells/em', either in 24-well plates (for estimation of 3H-R1881 binding) or in 75 cm2 culture 
flasks (for RNA extraction), for 2 days. The culture conditions were: Eagle's Minimum 
Essential Medium, supplemented with antibiotics and non-essential amino acids (MEM), at 37 
°C, in air containing 5% C02, in the presence of 1% FCS. Subsequently, the cells were 
subjected to a hypotonic shock (0.1 x MEM for 2 min) to remove remaining germ cells (25-
26). The cells were allowed to recover for 24 h in MEM containing 0.1% (w fv) BSA. The cells 
were then cultured in the presence or absence of hormones, in MEM containing 0.1% BSA. 
The experiments were repeated 4 - 5 times, using different cell preparations. Within one 
experiment, all incubations were terminated at the same time (control and hormone-treated). 
The hormone treatment protocols are described in the Results section. 
Alkaline phosphatase staining was used to evaluate the purity of the cell preparations 
(27). When 15-day-old rats were used, 0.5% contamination with peritubular myoid cells was 
observed; when 21- or 25-day-old rats were used, the contamination was below 0.1% (during 
and at the end of the incubations). 
The ligand binding assay was carried out as described by Blok et al. (22) and the RNA 
extraction and hybridization was carried out as described by Blok et al. (28). 
Anova and Tukey's test were used to determine significant differences (p < 0.01). Data 
are expressed as mean .±S.D. 
Nuclear mRNA elongation (run-on) 
Nuclei were isolated from immature Sertoli cells that had been cultured in the presence of FSH 
(500 ngfml) for 0, 2, or 4 h. The whole procedure was carried out at 4°C. The incubation was 
terminated by placing the culture flasks on ice. The cells were washed twice with phosphate-
buffered saline (PBS) and once with Tris buffer (10 mM Tris, 10 mM NaCI and 3 mM MgCI2, 
pH 7.4). Subsequently, the cells were incubated in lysis buffer [0.5% vfv Nonidet P40 (BDH 
Chemicals ltd, Poole, England), 10 mM Tris, 10 mM NaCI and 3 mM MgCI2, pH 7.4] for 20 
min. The cells were detached from the plastic by dynamic shaking. The nuclei and remaining 
whole cells were centrifuged (500 x g, 5 min) and the pellet was washed in lysis buffer. The 
pellet was resuspended in 5 ml sucrose buffer A [0.32 M sucrose (BDH), 3 mM CaCI,, 2 mM 
Mg-acetate, 0.1 mM EDTA, 10 mM Tris, 5 mM dithiothreitol (Sigma), pH 8.0] containing 0.1% 
Triton X-100 (BDH), to lyse the remaining cell membranes. Different protease inhibitors [0.6 
mM bacitracin (Janssen Chimica, Beerse, Belgium) and 0.6 mM PMSF] were added. The 
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suspension was kept on ice for 5 min, and homogenised by 30 strokes with a dounce 
homogeniser (pestle type B, Wheaton Scientific, Millville, N.J., USA). The resulting 
homogenate was mixed with 11 ml of sucrose buffer B [2.05 M sucrose (BDH), 5.0 mM Mg-
acetate, 0.1 mM EDTA, 10 mM Tris, pH 8.0]. The mixture, with a final sucrose concentration 
of approximately 1.4 M, was applied to a 4 ml cushion of sucrose buffer B and centrifuged 
using a Beckman SW 40 Ti rotor (Beckman, Geneva, Switzerland)(48.000 x g, 45 min, O'C). 
This method, using non-ionic detergents to lyse the cells and sucrose gradient centrifugation 
to recover the nuclei, resulted in a very clean nuclear pellet which could be used in the run-on 
assay. The nuclei were resuspended in 1 OO,ul storage buffer (25% glycerol, 5 mM Mg-acetate, 
0.1 mM EDTA, 50 mM Tris, 5 mM dithiothreitol, pH 8.0), frozen in liquid nitrogen and stored 
at -70°C. 
Nuclear elongation was performed essentially as described by Marzluff and Huang (29) 
and Ausubel et al. (30). In short: 25 x 10' nuclei were incubated with ATP, CTP, UTP and [a-
32P]-GTP (3000 Cijmmol; Amersham, Buckinghamshire, U.K.). Sephadex G-50 columns were 
used to separate labelled pre-mRNA from not incorporated NTPs. Labelled RNA (3 x 1 o• cpm) 
was added to 2 ml of hybridization mixture. Plasmid DNA was bound to Biotrans nylon blotting 
filter (ICN Biomedicals, Inc, Irvine, CA, U.S.A.) using a dot blot apparatus (Schleicher and 
Schuell, Dassel, Germany)(10 ,ug plasmid DNA was applied per dot). Plasmids used were: 
pTZ as a control for background hybridization; pTZ-AR-910 (31) and pTZ-0.3A (32) human 
androgen receptor eDNA; pRK-FSHR-NH2 and pRK-FSHR-COOH rat FSH receptor eDNA 
(33); a? /pUC18 rat inhibin eDNA (28); pUC9-Act hamster actin eDNA. The hybridization was 
allowed to carry on for 65 h at 55°C. The blots were washed at 55'C using 1 X sse for 15 min 
in case of pTZ, androgen receptor and FSH receptor run-on assays. lnhibin and actin run-on 
hybridizations were washed with 0.2 X sse containing 0.25% (w /'-') SDS for 45 min at 55°C. 
Blots were sealed in plastic and autoradiographed. The run-on experiments were repeated 
3 times, using 3 different Sertoli cell isolations. 
Experimental animals 
Wistar rats (substrain R-1 Amsterdam) were housed, 6 per cage, in a controlled environment 
with a light cycle of 12L : 12D, and received rat diet ad libitum. Ten animals were injected 
intraperitoneally with FSH (1 ,ug ovine FSH (FSH-S16)/g body weight), dissolved in'0.9% (wjv) 
NaCI containing 0.1% (w fv) bovine serum albumin (BSA, fraction V; Sigma, St. Louis, MO, 
USA). Four control animals received only 0.9% (w jv) NaCI containing 0.1% BSA. The animals 
were sacrificed 2 - 10 h later lor testicular RNA isolation. Other untreated animals were killed 
for Sertoli cell isolation. 
All animal experimentation described in this manuscript were conducted in accord with 
the highest standards of human animal care, as outiined in "Guidelines for Care and Use of 
Experimental Animals". 
RESULTS 
Short-term effects of FSH 
Intact immature rats (21-day-old) were injected with FSH Q.p., 1 ,ug ovine FSH-S16/g body 
weight) and sacrificed 0, 2, 4, 6, 8, and 10 hours after injection, to analyze the amount of 
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androgen receptor mRNA present in the testis (Fig. 1). Within 4 h after injection of FSH, the 
amount of androgen receptor mRNA in the testis was decreased to a very low level (1 0 .±. 6% 
of control; mean.±. SD of 3 animals). At later time points after FSH injection, the amount of 
androgen receptor mRNA returned approximately to control level (Fig. 1). All Northern blots 
were hybridized to a hamster actin eDNA probe, to verify the amount of total mRNA that was 
applied to the lanes on the gel. 
Androgen receptors in the testis are located in different somatic cell types, including 
Sertoli cells. To investigate the effect of FSH on purified Sertoli cells, these cells were isolated 
from 21-day-old rats and cultured in the presence of 500 ngfml ovine FSH-S16, which is 
known to be a maximally stimulating dose (34). It was observed that during the first 5 h after 
FSH administration, the level of androgen receptor mRNA decreased to a hardly detectable 
value (15 .±. 4% of control; mean.±. SD of 5 experiments)(Fig. 2). This low level was rapidly 
restored to control level, between 5 and 8 h of culture in the continuous presence of FSH (Fig. 
2). Similar results were obtained using Sertoli cells isolated from 15- and 25-day-old rats (not 
shown). 
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Fig. 1. Effect of FSH on testicular androgen 
receptor mRNA expression. The 21-day~old rats 
were injected (i.p.) with tpg ovine FSH-S16jg 
body weight and sacrificed 2, 4, 6, 8 or 10 h later. 
Con ""' control; saline injected and sacrificed 4 h 
later. For Northern analysis, 20 pg of total RNA, 
isolated from total testis, was applied per lane 
and analyzed using a human androgen receptor 
eDNA probe and a hamster actin eDNA probe. 
Actin was used to verify the amounts of mANA that 
were applied per lane on the gel. 
Fig. 2. Effect of FSH on androgen receptor mRNA 
expression in cultured Sertoli cells. Sertoli cells 
from 21-day-old rats were cultured for 1, 2, 3, 4, 5, 
6, 7 and 8 h in the presence of ovine FSH-S16 
(500 ngjmt). Con =- control. For Northern analysis, 
20 pg of total RNA was applied per lane and 
analyzed using a human androgen receptor eDNA 
probe. The different lanes were scanned and the 
amount of androgen receptor mRNA was 
determined relative to the control fane (1.00). 
The experiment was repeated 5 times (the bars 
represent the mean ±. SD, whereas the 
autoradiograph is a representative sample from a 
single experiment). * "" significantly different from 
control (p < 0.01). 
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A dose-response curve was produced for FSH-induced androgen receptor mRNA down-
regulation (Fig. 3). The ED50 was approximately 10 ngjml. For comparison; the ED50 for 
several other, non related, effects of FSH on cultured Sertoli cells, including stimulation of 
cAMP production, c-fos expression, glycolysis and inhibin a-subunit expression (34-36), was 
found to be approximately the same. 
The cAMP transduction pathway plays an important role in FSH action. Therefore, 
immature Sertoli cells were also cultured in the presence of dibutyryl cAMP (dbcAMP) or 
forskolin. It was found that both dbcAMP (Fig. 4) and forskolin (not shown) mimicked the 
effect of FSH. 
Incorporation of L-[1-"C]-Ieucine in cultured Sertoli cells treated with cycloheximide (50 
pgjml) was reduced by 98% within 30 min. As shown in Figure 5, this cycloheximide 
treatment stimulated the level of androgen receptor mRNA 1.7 .±. 0.4-fold (mean .±. SD of 4 
experiments). When FSH was added to the cell cultures for 4 h, starting 30 min after 
cycloheximide administration, the amount of androgen receptor mRNA was decreased. The 
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Fig. 3. FSH dose-response cuNe for FSH-
regulated androgen receptor mANA expression. 
Senoli cells from 21-day-old rats were cultured tor 
4 h in the presence of 0.05, o. 1, 0.5, 1, 5, 10, so, 
100and 500 ngjmf ovine FSH-$16. Con= control. 
For Northern analysis, 20 pg of total RNA was 
applied per lane and analyzed using a human 
androgen receptor eDNA probe. The different 
lanes were scanned and the amount of androgen 
receptor mRNA was determined relative to the 
control lane (1.00). 
Fig. 4. Effect of dibutyryl cAMP on androgen 
receptor mRNA expression in cultured Senoli 
ce/Js. Senoli celfs from 21-day-old rats were 
cultured for 1, 2, 3, 4, 5, 6, 7 and 8 h in the 
presence of dbcAMP (0.5 mM). Con = control. 
For Northern analysis, 20 pg of total RNA was 
applied per lane and analyzed using a human 
androgen receptor eDNA probe. The different 
lanes were scanned and the amount of androgen 
receptor mRNA was determined relative to the 
control lane (1.00) . 
The experiment was repeated 4 times (the bars 
represent the mean .±. SO, whereas the 
autoradiograph is a representative sample from a 
single experiment). * = significantly different from 
control (p < 0.01) 
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magnitude of this decrease was comparable to the decrease found after FSH treatment 
without cycloheximide (0.7 units on the Y-axis) (Fig. 5). It can be concluded that de novo 
protein synthesis is not needed for FSH-induced down-regulation of androgen receptor 
mRNA. 
Down-regulation of mRNA expression in general can result from a lowered transcription 
rate andjor decreased mRNA stability. To study androgen receptor gene transcription, 
nuclear RNA elongation experiments (run-on analysis) were performed. Double-stranded 
probes, used to capture the labelled mRNA, can also detect antisense mRNAs. The presence 
of antisense transcripts, however, is not very likely, because only one distinct 10 kb androgen 
receptor mRNA transcript was detected in cultured Sertoli cells and testicular tissue. Recently, 
Faber et al. (32) have given a detailed characterisation of possible androgen receptor gene 
transcripts. Using several probes that were located at different parts of the eDNA, they found 
1 Okb and 7kb transcripts. The 7 kb transcript represents an alternative splice product, that is 
not found in testicular cells, and was detected using a 0.5 kb EcoR1 jEcoR1 human androgen 
receptor eDNA probe. In the present experiments, the same probe was used. A 4 kb 
androgen receptor gene transcript has been described, but this appeared to be a breakdown 
product from the 10 kb androgen receptor mRNA (28). 
Using a nuclear run-on assay, no marked change in transcription rate of the androgen 
receptor gene was observed, after incubation of Sertoli cells for 2 to 4 h in the presence of 
FSH (Fig. 6). Klaij et al. (37) have shown that stimulation of expression of inhibin a-subunit 
mRNA by FSH in Sertoli cells takes place within 2 h. This effect is thought to involve a direct 
effect of FSH on gene transcription (37); the promoter region contains a cyclic AMP response 
element (CRE)(38). In the present run-on experiments, inhibin a-subunit gene transcription 
indeed was elevated by FSH within 2 h (Fig. 6). This represents a positive control. No 
induction or suppression of actin gene transcription was observed (Fig. 6). 
The amount of androgen receptor present in Sertoli cells was measured by specific 
ligand ('H-R1881) binding assay. It was observed that the pronounced down-regulation of 
androgen receptor mRNA did not result in a marked decrease in androgen receptor protein 
(Fig. 7). 
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Fig. 5. FSH regulation of androgen receptor mRNA 
expression in the presence of cyclo-heximide. 
Senoli cells from 21-day·ofd rats were cultured for 
4 h in the presence of cycloheximide (50 pgjml) 
and or ovine FSH·S16 (SOD ngjml). Con = 
control; ex = treated for 4.5 h with 
cycloheximide; FSH = treated for 4 h with FSH; F 
+ CX = 30 min after cyclo-heximide addition, FSH 
was added to the cells for 4 h. For Northern 
analysis, 20 pg of total RNA was applied per lane 
and analyzed using a human androgen receptor 
eDNA probe. The different lanes were scanned 
and the amount of androgen receptor mRNA was 
determined relative to the control lane (1.00) . 
The experiment was repeated 4 times (the bars 
represent the mean .± SO, whereas the auto-
radiograph is a representatNe sample from a 
single experiment). '*' = significantly different from 
control (p < 0.01). """=significantly different from 
cycloheximide treated group (p < 0.01). 
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Fig. 6. Quantitation of the initiation of androgen 
receptor gene transcription in cultured Senoli 
cells. Senoli cells, isolated from 21-day~old rats, 
were cultured in the presence of ovine FSH-$16 
{500 ngjml), for 2 or 4 h. Nuclei were isolated 
and transcriptional run-on experiments were 
performed as described in Materials and 
Methods. Con "' control; AR =- androgen 
receptor; FSH-R =- FSH receptor; lnha = inhibin 
a-subunit; Act "" actin. 
The experiment was repeated 3 times with 
essentially the same results. The autoradiograph 
shows the results from one experiment. 
Fig. 7. Short-term effect of FSH on 3H-R1881 
binding to Sertoli cells. The cells were isolated 
from 21-day-old rats and cultured in the presence 
of ovine FSH-$16 (500 ngjml) for 4, 6 and 8 h. 
Con = control. The experiment was repeated 4 
times (the bars represent the mean.±. SO). 
The short-term effects described herein are seemingly in contradiction to a stimulatory effect 
of FSH on androgen receptor expression in cultured Sertoli cells, described previously (21-23). 
These published observations, however, concern long-term experiments. In the present series 
of experiments, we have incubated Sertoli cells with FSH also for longer time periods {24 - 72 
h). At the end of these incubations, a net increase in androgen receptor mRNA level was 
observed (Fig. 8). This long-term effect of FSH on androgen receptor mRNA expression in 
Sertoli cells was more pronounced in Sertoli cells from 15-day-old rats as compared to cells 
isolated from 25-day-old rats. 
Measurement of the total binding of 3H-R1881 to Sertoli cells from 15-day-old rats 
incubated lor 24-72 h with FSH, revealed a FSH-induced up-regulation of ligand binding (1.8 
.±. 0.2-fold; mean .±. SD of 4 experiments), which was much less pronounced using Sertoli 
cells from 25-day-old rats (Rg. 9). 
ARmRNA 
-I 
3 
< 
li! 
• ~ 2 
§ 
• 
• • 
: ' 
= • .. 
"' 0 
Ca> 24 ,. 
Tlll'le 
••• 
.. 
;j 
••• ~ 
-.. ,. . 
.. 
0: 
' :z: 100 .. 
• ~ ;; •• 
.. 
0: 
0 
... 
-· 
(lo) 
3 
< 
B 
il! 
• ~ 
' ~ 
• • 
: 
= ~ 
"' 0 
Ca> 24 ,. 
(h) 
.... 7U 
.... treatment 
I 
39 
Fig. 8. Long-term effect of FSH on androgen 
receptor mRNA expression. Sertoli cells from 15-
day-old (A) and 25-day-old (B) rats were cultured 
for 24 and 72 h in the presence of ovine F$H-S16 
(500ngjml). Con = control. For Northern analysis, 
20 pg of total RNA was applied per lane and 
analyzed usir.g a human androgen receptor eDNA 
probe. The different lanes were scanned and the 
amount of androgen receptor mRNA was 
determined relative to the control lane (1.00) . 
The experiment was repeated 4 times (the bars 
represent the mean.±. SO, and the autoradiograph 
shows the results from one experiment). * 
significantly different from control (p < 0.01). 
Fig. 9. Long-term effect of FSH on 3H-R1881 
binding to Serroli cells. The cells were isolated 
from 15-day-old (hatched bars) and 25-day-old 
(open bars) rats and cultured in the presence of 
ovine FSH-$16 (500 ngjml} for 24 and 72 h. Con 
= control. The experiment was repeated 4 times 
(the bars represent the mean.±. SD) . 
"'=significantly different from control (p < 0.01). 
Addition of testosterone alone, or on top of FSH addition, to the cultures did not 
significantly change the level of androgen receptor mRNA expression (not shown). However, 
the binding of 3H-R1881 to cells incubated with testosterone was increased 3.2 .±. 0.6-fold 
(mean.±. SD of 3 experiments, not shown). Furthermore, when FSH was added together with 
testosterone to the Sertoli cell cultures, the 3 H-R1881 binding was increased to 4.1 .±. 0. 7-fold 
(mean ±. SD of 3 experiments, not shown). 
DISCUSSION 
Short-term effects of FSH 
FSH administration (i.p.) to immature rats resulted in a rapid, but transient, decrease of 
androgen receptor mRNA expression in the testis. Apparently, the circulating FSH level is not 
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a maximally stimulating dose (39). When highly puriiied immature Sertoli cells were used, a 
similar effect of FSH on androgen receptor mRNA expression was observed. In both 
situations, in vivo and in vitro, the amount of androgen receptor mRNA was decreased to a 
very low level within 4 - 6 h, and then returned to the control level within several hours. The 
circulating FSH levels in vivo were not measured, but it can be expected that these levels are 
very high shortly after FSH injection, while they will return to the normal physiological range 
10 h after FSH injection. To further investigate androgen receptor mRNA expression in the 
continuous presence of a defined dose of FSH, highly purified cultured Sertoli cells from 
immature rats were used. 
The effect of FSH on cultured immature Sertoli cells involves rapid stimulation of the 
cellular cAMP level, which is followed by a decrease within a few hours. This decrease is 
caused by a desensitization process that involves receptor internalisation (24,40), loss of 
adenylate cyclase activity (41) and increased phosphodiesterase activity (42-43). In 
concordance with this, the effects of dbcAMP on Sertoli cells are usually much more 
persistent then the effects of FSH. This was described also lor FSH-induced down regulation 
of FSH receptor mRNA levels in cultured immature Sertoli cells (24), showing a transient effect 
of FSH, but a prolonged effect of dbcAMP. In the present experiments, however, the short-
term effect of dbcAMP on androgen receptor mRNA expression also was transient and 
virtually equivalent to the effect produced by FSH. This transient effect of dbcAMP is difficult 
to explain. Possibly, it involves activation of a second messenger system other than cAMP 
(e.g. a calcium mediated response; 44). 
Addition of cycloheximide, to block protein synthesis, resulted in an increased androgen 
receptor mRNA expression in cultured Sertoli cells. Stabilization of distinct mRNAs is not an 
uncommon event after cycloheximide treatment, and several explanations have been 
suggested (45 - 47). FSH-induced down-regulation of androgen receptor mRNA expression 
did occur also in the presence of cycloheximide. This indicates that de novo protein synthesis 
is not required lor this FSH effect. FSH action may result in activation or de-activation of pre-
existing proteins that are involved in regulation of androgen receptor mRNA expression. 
The results of the run-on experiments indicate that FSH-induced down-regulation of 
androgen receptor mRNA expression in Sertoli cells cannot be accounted lor by a lowered 
rate of gene transcription. It is possible that the stability of the androgen receptor mRNA is 
decreased upon FSH stimulation. Secondary structures in the untranslated regions of mRNAs 
may serve as binding sites lor proteins that are involved in mRNA stability regulation (48). In 
future experiments we will study whether the large 5' and 3' untranslated regions of androgen 
receptor mRNA may play a role in regulation of its stability. 
The amount of androgen receptor protein in cultured Sertoli cells, measured using a 'H-
R1881 binding assay, did not follow the short-term FSH-induced diminution of androgen 
receptor mRNA expression. This can be explained when the hall-life of the mRNA is much 
shorter than the half-life of the protein. Under FSH-induced down-regulation conditions, the 
androgen receptor mRNA showed a calculated half-life of approximately 1 h, while the 
reported half-life for an unoccupied androgen receptor, in the ductus deferens smooth muscle 
tumor cell line DDT,MF-2 is 3.1 h (49). 
Long term effects of FSH 
In Sertoli cells from 15-day-old rats, incubated for 3 days wrth FSH, androgen receptor mRNA 
expression was 2- to 3-lold increased. Using Sertoli cells from 25-day-old rats, only a small 
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increase (less than 1.5-fold) in androgen receptor mRNA expression was observed. 
The effect of age can be explained. Steinberger et al. (50) found that the amount of 
cAMP that is produced by cultured Sertoli cells upon FSH stimulation, decreased with age of 
the animals used for cell isolation. In their 4-day cultures of Sertoli cells isolated from 18-day-
old rats, the FSH-induced cAMP production was 8-fold higher than that in 4-day cultures of 
Sertoli cells from 24-day-old rats. 
The androgen receptor protein concentration (3 H-R1881 binding) closely followed the 
FSH-induced long-term changes in androgen receptor mRNA expression. This indicates that 
the long-term action of FSH is mainly on androgen receptor mRNA expression, rather than 
on mRNA translation andjor receptor stability. The sensitivity of the nuclear run-on assay is 
not sufficient to detect the long-term, relatively small changes in transcription rate. Therefore, 
androgen receptor promoter constructs (51), cloned in front of a reporter gene, are presently 
used by us to study whether FSH regulates androgen receptor gene transcription. 
Incubation of the Sertoli cells in the presence of testosterone pointed to a marked post-
transcriptional effect of testosterone on androgen receptor protein expression (specific ligand 
binding was increased 3-fold by testosterone, without an effect on androgen receptor mRNA 
expression). This observation is in agreement with our previous results using Sertoli cells (22), 
and with results from Syms et al. (49), who reported increased stability of the androgen 
receptor, when occupied with ligand in the ductus deferens smooth muscle tumor cell line 
DDT,MF-2. 
In conclusion, marked effects of FSH on the regulation of androgen receptor expression in 
Sertoli cells were observed. Short-term transient FSH-induced down-regulation of androgen 
receptor mRNA expression takes place i!1 vivo as well as i!1 vitro. However, this down-
regulation i!1 vitro, in cultured Sertoli cells, did not result in a short-term decrease of androgen 
binding to the cells. Long-term stimulation of cultured Sertoli cells with FSH resu~ed in 
elevated levels of both androgen receptor mRNA and protein. It is suggested that FSH plays 
an important role in regulating the androgen receptor concentration in Sertoli cells in the testis 
of immature rats. 
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Summary 
The regulation by FSH (follitropin: follicle-stimulating hormone) of FSH receptor mRNA and protein 
(FSH binding) was studied using cultured Sertoli cells isolated from 21-day-old rats. FSH induced a 
dose-dependent and almost complete down-regulatiOn of receptor mRNA at 4 h after addition of the 
hormone. At subsequent time points (16 hand later) the FSH receptor mRNA levels had returned close 
to control values. The effect of FSH was mimicked by dibutyryl cyclic AMP (dbcAMP) and forskolin. and 
the phosphodiesterase inhibitor methyl-isobutylxanthine (MIX) prolonged the FSH action. These find-
ings indicate that the effect of FSH on its receptor mRNA was mediated by cAMP. A down-regulatory 
effect of FSH and dbcAMP on FSH receptor mRNA was also observed in the presence of the protein 
synthesis inhibitor cycloheximide. suggesting a direct effect of FSH/dbcAMP on the expression of the 
FSH receptor gene. Transcriptional run-on experiments revealed that FSH did not inhibit initiation of 
the FSH receptor gene: hence a post-transcriptional mechanism is involved. Binding of 1:!51-FSH to the 
cultured Sertoli cells was rapidly (4 h) decreased when the cells were incubated with FSH or FSH in 
combination with MIX. This effect can be explained by ligand-induced receptor sequestration. In 
contrast, incubation of Sertoli cells with dbcAMP had no effect on binding of 1:::51-FSH after 4 h. but 
resulted in a 60% loss of FSH binding sites after 24 h. probably caused by decreased mRNA expression. 
In conclusion. FSH receptor down-regulation in Sertoli cells is effected not only by the well-docu-
mented ligand-induced loss of receptors from the plasma membrane, but also involves a cAMP-mediated 
decrease of FSH receptor mRNA through a post-transcriptional mechanism. 
Introduction 
Follicle-stimulating hormone (fo!litropin: 
FSH). a glycoprotein hormone produced by the 
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pituitary gland. is essential for normal reproduc-
tive function. FSH acts on testicular Sertoli cells 
and ovarian granulosa cells. the only cells in the 
body that express a detectable amount of recep-
tors for FSH. It is generally assumed that FSH 
acts through the stimulating GTP-binding protein 
G, on adenylyl cyclase. resulting in increased 
levels of cAMP. although more than one second 
messenger pathway may be involved in the trans-
duction of the FSH signal (Grasso eta\.. 1991). 
Several mechanisms exist to control the level 
of stimulation of Scrtoli cells by FSH. ln the 
hypothalamus·pituitary·testis axis, testosterone 
acts as a major negative feedback regulator of 
FSH secretion (Drouin and Labrie, 1981). and 
the Scrtoli ce!l product inhibin also may play a 
role in this respect (de Jong, 1988). In addition. 
FSH sensitivity of Sertoli cells is regulated at the 
cellular leveL Upon binding of FSH to its reccp~ 
tor and stimulation of the adenylyl cyclase en· 
zymc. the hormone·receptor complex is thought 
to be internalized and transported to an intracel· 
lular compartment, where the bound FSH is de-
graded (Fletcher and Reichert, 1984; Shimizu 
and Kawashima, 1989); there are indications that 
the unoccupied receptor is recycled to the plasma 
membrane (Saez and Jaillard. 1986). Yet another 
mechanism of cellular control of sensitivity is the 
increase of phosphodiesterase activity observed in 
Sertoli cells after stimulation with FSH (Conti ct 
a!., !981. !983). 
In the present study, we investigated the in-
volvement of regulation of FSH receptor mRNA 
expression in the cellular regulation of FSH sen-
sitivity, using cultured Sertoli cells. It was foand 
that the loss of FSH receptors at the plasma 
membrane is the initial site of regulation, while a 
subsequent contribution results from a decrease 
of FSH receptor mRNA expression. 
Materials and methods 
Isolation and culture of Serroli cells. All glass-
ware used for the Sertoli cell isolation procedure 
was sylanized (Oonk et aL. 1985). Sertoli cells 
were isolated from testes of 21-day-old Wistar 
rats (substrain R-1 Amsterdam). Rats were sacri-
ficed using cervical dislocation. and the testes 
were removed and decapsulated. 10-12 testes 
were shaken (120 cycles/min) at 37°C in 20 ml 
phosphate-buffered saline (PBS) (Dulbecco and 
Vogt, 1954). supplemented with 5 p.gjml DNase 
I (type DN25: Sigma, St. Louis. MO. U.SA) 
(PBS/DNase), 1 mgjml collagenase (type CLS; 
Worthington. Freehold, NJ. U.S.A), 1 mgjml 
hyaluronidase (type I-S: Sigma) and 1 mgfml 
trypsin (type TRL; Worthington) in a 100 ml 
Erlenmeyer flask for 20 min. The tubule frag· 
ments obtained by this enzyme treatment were 
washed 4 times with 40 ml PBS/DNase by sedi-
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mentation for 2 min at unit gravity. The volume 
was readjusted to 20 ml PBS/DNase and made I 
mgjml collagenase and I mgjml hyaluronidase. 
and incubated for 20 min as described above. The 
tubule fragments then were washed 4 times (sec 
above). and fragmented further using a dounce 
homogenizer (five strokes) as described by Oonk 
ct a!. (1985). The sma!l fragments were washed 4 
times with PBS/DNase. and once with Eagle's 
minimal essential medium (MEM: Gibco. Grand 
Island, NY, U.S.A) by sedimentation at 100 xg 
for 2 min in a calibrated glass tube to measure 
the cell pellet volume. MEM was supplemented 
with non-essential amino acids. glutamine. fungi-
zone. streptomycin and penicillin (Oonk et aL, 
1985). The cell pellet was resuspended in 9 vol-
umes of MEM with 1% fetal calf serum (FCS; 
Gibco), and plated at a density of 1 ml cell 
suspension per 75 em: culture flask area. The 
cells in the culture flasks were incubated in MEM 
with 1% FCS at 37°C, under 5% CO: in air for 
48 h. To eliminate contaminating germinal cells. 
the Sertoli cell cultures were ex.-poscd to an os-
motic shock. using 10-fold diluted MEM in water 
for 2 min (Galdieri et aL 1981; as modified by 
Toebosch et aL. 1989). Cells were then incubated 
for a further 24 h period in MEM with 0.1% 
(w fv) BSA (bovine serum albumin: fraction V: 
Sigma), followed by the incubations and the ex-
periments described in the Results and Discus-
sion section. The experiments were repeated 2-3 
times. using different cell preparations. 
The Sertoli cell isolation method described 
above yielded a highly purified preparation of 
Sertoli cells. as evidenced by staining of the cul-
tures for alkaline phosphatase activity as de-
scribed by Blok et a!. (1990). The number of 
alkaline phosphatase-positive cells. representing 
peritubular myoid cells (Palombi and Di Carlo. 
1988). was less than 0.1% up to the end of the 
culture period. 
RNA analysis. All general molecular biology 
techniques were carried out as described in Sam-
brook et aL (1989) and Davis et aL (1986). Re-
cently, the eDNA encoding the rat FSH receptor 
was cloned (Sprengel et aL 1990). In a study 
using a PCR approach to obtain the eDNA of the 
TSH receptor. a human partial eDNA clone was 
isolated that was expressed only in ovary and 
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testis (Parmentier ct aL. 1989). This sequence is 
homologous with the rat FSH receptor sequence. 
We have used this human probe (pHGMP09) to 
study the regulation of expression of FSH recep-
tor mRNA in cultured rat Sertoli celts. 
Total RNA was isolated from flash-frozen cells 
(- 80°C) using the LiCI/urca method (Aufray 
and Rougcon. 1980). RNA was separated on 1% 
agaroscjfonnaldchydc gels. and blotted using 
Hybond N..,. nylon membrane filters (Amcrsham. 
·s-Hcrtogenbosch. The Netherlands) or Biotrans 
nylon membrane filters (ICN. Irvine. CA. U.S.A.). 
The blots were hybridized with the :-:-:P-labelled 
pHGMP09 probe for 48 h. After hybridization. 
the blots were washed to a final stringency of 
1 x SSC/0.5% (w jv) SDS (l X SSC ~ 0.15 M 
NaCl. 0.015 M sodium citrate) at 42°C. and 
autoradiographcd using Hypcrfilm-MP film 
(Amersham). The hybridization signals of the 3.5 
kb FSH receptor mRNA band were quantified 
using a BioRad-1D gel scanner (BioRad. Utrecht. 
The Netherlands). Hybridization of the blots with 
an actin probe showed that in all lanes similar 
amounts of RNA were applied. 
125!-FSH binding. 1151-FSH binding was mea-
sured using a whole cell binding assay. essentially 
as described for porcine Sertoli cells by Saez and 
Jaillard (1986). In brief. the attached cells were 
washed twice with 10 mM Tris-HCl pH 7.4. 5 mM 
MgC1 2 • 0.1% (w jv) BSA (TB 7.4) at 37,C and 
once with 10 mM Tris-HCI pH 3.9. 5 mM MgCl.,. 
0.1% (w jv) BSA (TB 3.9) at 4"C to remo;e 
bound FSH from the cell surface. and subse-
quently twice with TB 7.4 at 37 o C. These washed 
cells were incubated for 1 h in 1 ml of TB 7.4 
containing 50.000 cpm 1151-FSH (specific activity: 
135 f.J.Ci/ f.J.g: NEN-Du Pont de Nemours. ·s-
Hertogenbosch. The Netherlands) per well (Co-
star 12-well plate). at 37"C under 5% C0 1 j95% 
air. To remove unbound 115 1-FSH. the wells were 
rinsed twice with TB 7.4 at 4"C. Bound 115 1-FSH 
was recovered by dissociation from the mem-
brane in TB 3.9 for 10 min at 4°C. The super-
natant was collected and the radioactivity was 
determined. Routinely. the remaining cells were 
dissolved in 1 N NaOH to determine the remain-
ing amount of cell-associated 125 1-FSH. Under all 
incubation conditions less than 1% of the added 
125 1-FSH was found in the NaOH lysate. Binding 
assays were performed in triplicate. with non-
specific binding controls in triplicate containing 
500-fold excess of unlabelled ovine FSH (NIH 
Sl6; NIH. Bethesda. MD. U.S.A.). Maximal spe-
cific binding was 3-5% of total added 115 1-FSH. 
Transcriptional ron-on. Transcriptional run-
on experiments were performed essentially as de-
scribed by Marzluff and Huang (1984) and 
Ausubel et a!. (1989). Typically. 25 x 10" nuclei 
were recovered from 100 X 106 Sertoli cells. 
Elongation of the in vivo initiated mRNAs was 
performed in the presence of I 31 P]a-GTP. and 
labelled pre-mRNAs were separated from unin-
corporated nucleotides. Hybrid selection was per-
formed as follows. Plasmid DNA (5 f.J.g of pRK-
FSHR-NH2 and 5 ,_g of pRK-FSHR-COOH. rat 
FSH receptor eDNA (Sprengel et a!.. 1990) for 
determination of FSH receptor pre-mRNAs and 
10 f.J.g pTZ as a control for background hybridiza-
tion) was bound to nylon membrane filter using a 
dot blot apparatus (Schleicher and Schuell. 's-
Hertogenbosch. The Netherlands). The filters 
were hybridized to 3-106 cpm of labeled RNA 
for 65 h at 55 o C. washed at 55" C using 1 X SSC 
for 15 min. and autoradiographed. 
Results and discussion 
A time course study using the cultured rat 
Sertoli cells from 21-day-old rats showed a rapid. 
but transient. down-regulatory effect of FSH on 
FSH receptor mRNA expression (Fig. 1). This 
effect was maximal after 4 h incubation with 
FSH. while the amount of FSH receptor mRNA 
had returned to 80% of control at the 16 h time 
point. The ED 50 of FSH in down-regulating FSH 
receptor mRNA expression was between 5 and 50 
ngjml FSH (Fig. 2). This is close to the ED50 for 
other effects of FSH. such as stimulation of 
cAMP. c-fos expression. aromatasc activity. gly-
colysis and a-inhibin expression (Oonk et a!.. 
1985: Hall et aL. 1988: Toebosch et aL. 1989). 
FSH is thought to act mainly through the 
cA,VlP pathway (Means et a!.. 1976). Concurrent 
with this. the down-regulatory effect of FSH was 
mimicked by dbcAMP (Fig. 3A) and forskolin 
(not shown). This dbcAMP /forskolin induced 
down-regulation was effective at 4 h and per-
sisted up to at least 24 h. The effect of dbcAMP 
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Fig. 1. Time course or th<;: effect of FSH on FSH r~:c<;:ptor mRNA expression in Sertoli cells. Cells were incubated for different time 
periods in the presence of 500 ngjml FSH. Subsequently. the cells were harvested and total RNA was isolated. The FSH receptor 
mRNA levels were a~sessed by Nonhern analysb. using 20 f.l.g of total RNA per lane. The FSH receptor mRNA band was sc:J.nned 
and the resulting optical density (00) measurements were expressed relative to the control value (100%). Inset: Autoradiogram of 
one representative experiment. To lanes 1-9 RNA from cells incubated for 0. 0.5. 1. 2. 4. 8. 16, 24 and 4S h was applied. In the 
graph the combined results of three experiments are represented. Values given <~re means± SD for three experiments. 
at 24 h was r.1ore pronounced than that of FSH 
itself. suggesting that FSH down-regulates the 
activity of the FSH receptor signal transduction 
system. while dbcAMP docs not have such an 
effect. 
Experiments in the presence of the phosphodi-
esterase inhibitor mcthyl-isobutylxanthine (MIX) 
yielded results comparable to those observed us-
ing dbcAMP (Fig. 3A). This indicates that the 
transient FSH effect on receptor mRNA CX"Pres-
sion is related to a transient FSH effect on cAMP 
production. which is explained by increased levels 
of phosphodiesterase activity (Conti eta!., 1981. 
1983). 
The intracellular and secreted amounts of 
cAMP were determined at different time points 
after addition of FSH or FSH in combination 
with MIX (Fig. 4). Treatment with FSH increased 
cAMP rapidly: the maximal intracellular concen-
tration was reached within 15 min. while cAMP 
had returned to control values at 2 h. Secreted 
cAMP levels raised slower, reaching a plateau 
value at 2 h after addition of FSH. Phosphodi-
esterase activity in Scrtoli cells is able to rapidly 
decrease intracellular cAMP concentrations. as is 
evidenced by the effects of MIX (Fig. 4). These 
results confirm earlier observations. that cultured 
Sertoli cells are rapidly desensitized to FSH with 
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Fig. 2. t.ttect ot i-SH dose on the FSH receptor mRNA level 
in Sertoli cells. Cells were incubated for 4 h in the presence of 
different concentrations of FSH. Subsequently, the cells were 
harvested and the FSH receptor mRNA was measured as 
described in the legend to Fig.!. Values given are means±SD 
for three experiments. 
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-Fig. 3. Involvement of the cAMP pathway in the regulation of 
FSH receptor mRNA expression and FSH binding in Sertoll 
cells. A: FSH receptor mRNA. Cells were incubated for 4 h 
(open bars) or 24 h (hatched bars) in the presence of 500 
ngjm\ FSH. 500 ngjml FSH in combination with 0.2 mM 
MIX. or 0.5 mM dbcAMP. Subsequently, the cells were 
harvested and the FSH receptor mRNA was measured as 
described in the legend to Fig. 1. V::tlues given are means±SD 
for three experiments. B: FSH binding. Cells were incubated 
for 4 h (open bars) or 24 h (h:.ttched bars) in the presence of 
500 ngjml FSH. 500 ngjml FSH in combination with 0.2 mM 
MIX. or 0.5 mM dbcAMP. Subsequently, 1::51-FSH binding 
was measured as described in Materials and Methods. Values 
given are means± SD for three experiments. 
respect to cAMP formation (Verhoeven et al.. 
1980. 1981: Oonk et aL 1985). 
In cells treated with the protein synthesis in-
hibitor cycloheximide, FSH receptor mRNA sti!l 
was down-regulated by FSH or dbcAMP, al-
though CX treatment resulted in an overall in-
crease of the receptor mRNA levels (Table 1). 
The latter effect of ex that has been obsetved in 
many other cell types as well (Almendral et al .. 
1988). is probably caused by a general effect on 
transcription andjor mRNA stability (Wilson and 
Treisman, 1988). The present results indicate that 
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Fig. 4. Effect of FSH on cAMP production by Sertoli cells. 
Cells were incubated in the presence of 500 ngjml FSH (open 
symbols) or 500 ngjml FSH in combination with 0.2 mM MIX 
(closed ~ymbols). At different time points. cAMP was deter-
mined in the cells (cellular: circles) and in the medium 
(secreted: triangles) as described previously (Themmen et a!.. 
1986). Values given are means of duplicate determinations of 
total production of cAMP per well. Differences between 
duplicates were not larf!er than 5% of the mean. 
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Fig. 5. Initiation of FSH receptor gene transcription. Sertoli 
cells were incubated for 0. 2 or 4 h with 500 ngjml FSH. 
Nuclei were isolated and transcriptional run-on experiments 
were performed as described in Materials and Methods. C: 
control plasmid without eDNA insert: FSH-R: two plasmid 
DNA~ containing the complete FSH receptor eDNA. 
TABLE 1 
EFFECf OF CYCLOHEXIMIDE ON DOWN-REGU-
LATION OF FSH RECEPTOR mRNA 
Addition 
-ex +CX 
Control 100 328±45 
FSH 5±2 169± 2 
dbcAMP 17+7 215+ 2 
Cells were incubated for 4 h with 50 f.!.&/ml cycloheximide in 
the presence of 500 ngjml FSH or 0.5 mM dbcAMP. Subse-
quently, the cells were harvested and the FSH receptor mRNA 
was measured as described in the legend to Fig. 1. Values 
given are means± SD for three experiments. 
the homologous down~regulation of FSH receptor 
mRNA operates through a direct mechanism 
which does not require de novo protein synthesis. 
The attenuation of FSH receptor mRNA ex~ 
pression in cultured Sertoli cells after incubation 
with FSH or dbcAMP might be the result of a 
rapid decrease in transcription. Transcriptional 
run~on experiments were performed to investi· 
gate this mechanism. No decrease in transcrip-
tion initiation of the FSH receptor gene could be 
observed. using nuclei isolated from Sertoli cells 
that had been incubated for 2 or 4 h in the 
presence of FSH. In the same series of experi· 
ments. initiation of a·inhibin gene transcription 
was consistently induced by FSH (not shown). 
These results indicate that decrease of initiation 
of transcription is not the dominant mechanism 
of FSH receptor mRNA down·rcgulation. 
To study whether the observed down-regu-
lation of FSH receptor mRNA finally resulted in 
down~regulation at the protein level. we have also 
measured FSH receptor binding sites on the cul-
tured rat Sertoli cells (Fig. 3B). First. the binding 
characteristics of the FSH receptor was con~ 
firmed. A Kct of 45 pM and a Bm:c< of 40 fmol 
per mg protein was generated from a straight 
Scatchard plot: these data arc in agreement with 
values from the literature (Fletcher and Reichert. 
1984). Incubation of the cells with either FSH or 
FSH in combination with MIX showed a rapid 
and marked down-regulation of FSH receptor 
number at 4 h. and a further decrease in binding 
sites at 24 h. dbcAMP had no effect at 4 h. but 
had markedly reduced FSH binding after a 24 h 
incubation period. Thus. the early effect of FSH 
on the receptor number is probably not mediated 
by cAMP. but rather reflects a direct effect at the 
plasma membrane. viz. receptor internalization. 
Down-regulation of the FSH receptor number by 
dbcAMP at 24 h can be explained by down-regu-
lation of FSH receptor mRNA expression. 
The results presented above indicate that FSH 
receptor expression is regulated through at least 
two independent mechanisms: a rapid down-regu-
lation of FSH binding. which involves sequestra· 
tion of membrane receptors. and a more slow 
regulation at the post·transcriptional level. The 
latter effect of FSH is mediated by cAMP. 
Exposure of cells to hormones almost invari-
51 
ably leads to hormone-specific desensitization and 
down·regulation of the hormone receptors. The 
responsiveness of cells to hormones can be regu-
lated through several mechanisms. Upon activa-
tion of a GTP-binding protein. the receptor may 
assume a low affmity state ( Cerione et al.. 1984: 
Zhang et a!.. 1991). and rapid phosphorylation 
also has been implicated in receptor desensitiza. 
tion (Benovic et al.. 1987: Leeb·Lundberg et al.. 
1987). These rapid effects are followed by seques· 
tration of the hormone-receptor complex (Lloyd 
and Ascoli. 1983). 
In the case of the FSH receptor. several regu· 
latory mechanisms have been studied. Pulse-chase 
studies with 131 1-FSH in cultured mouse Sertoli 
cells have shown that after hormone binding FSH 
receptors are internalized rapidly (within 50 min). 
and that all 131 1-FSH surface binding has disap-
peared at 100 min (Shimizu and Kawashima. 
1989). Similar results have been obtained using 
125 1-FSH and rat or pig Sertoli cells (Fletcher and 
Reichert. 1984: Saez and Jaillard. 1986). Further~ 
more. a decrease of the activity of the second 
messenger cAMP through activation of phospho-
diesterase has been observed (Conti et al.. 1981, 
1983). In the present paper. we show yet another 
level of regulation of FSH receptor activity. viz. 
the expression of FSH receptor mRNA. 
FSH acts on FSH receptor mRNA expression 
through a post-transcriptional mechanism. rather 
than through regulation of transcription. Both 
regulatory mechanisms have been shown to occur 
for other G-protein coupled receptors. The half-
life of ,81-adrenergic receptor mRNA in DDT 1 ~ 
MF-2 cells, for example. was decreased from 12 h 
to approximately 5 h after treatment of the cells 
with the ,81-adrenergic agonist isoproterenol 
(Hadcock et al.. 1989). Interestingly. it has been 
found that .B:-.·adrenergic receptor gene transcrip~ 
tion is stimulated acutely by cAMP in response to 
short·term agonist exposure (Collins et al.. 1989). 
In the present experiments. a rapid induction of 
FSH receptor mRNA by FSH was not clearly 
observed, although FSH receptor mRNA expres-
sion seemed to be slightly increased (not statisti-
cally significantly different from controls) at 1 h 
after FSH addition (Fig. 1). This will be studied 
further using a more sensitive and quantitative 
solution hybridization method. 
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Similar to our results. it has been shown that 
LHjCG receptor mRNA in mouse MA-10 Ley-
dig tumour cells also is under homologous down-
regulatory control. In these cells. hCG and 8-
bromo-cAMP transiently up-regulated LH/CG 
receptor mRNA. and caused a subsequent de-
cline in mRNA level (Wang et aL 1990. 1991). In 
preovulator;y follicles from hCG-treated imma-
ture rats. the situation is more complex: a low 
concentration of cAMP appeared to induce 
LHjCG receptor mRNA level. whereas a high 
dose of the second messenger inhibited the 
mRNA expression (Scgaloff et al.. 1990). 
In conclusion. we have shown that. quantita-
tively. the primary cause of FSH receptor down-
regulation in Sertoli cells is receptor internaliza-
tion and/or degradation at the plasma mem-
brane: a later contribution results from the loss of 
FSH receptor mRNA. This FSH-induced de-
crease of FSH receptor mRNA expression is me-
diated by cAMP through a post-transcriptional 
mechanism. 
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CHAPTER 5 
Transcriptional regulation of androgen receptor gene expression 
in Sertoli cells and other cell types. 
lJ Blok. APN Themmen, AHFM Peters, J Trapman, WM Baarends, 
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SUMMARY 
Regulation of androgen receptor (AR) mRNA expression was studied in Sertoli cells and 
perttubular myoid cells isolated from immature rat testis, and in the lymph node carcinoma cell 
line derived from a human prostate (LNCaP). Addition of dibutyryl-cyclic AMP (dbcAMP) to 
Sertoli cell cultures resu~ed in a rapid transient decrease in AR mRNA expression (5h), which 
was followed by a gradual increase in AR mRNA expression (24 - 72 h). This effect of 
dbcAMP mimicked FSH action. In peritubular myoid cells, there was only a moderate but 
prolonged decrease during incubation in the presence of dbcAMP, and in LNCaP cells no 
effect of dbcAMP on AR mRNA expression was observed. 
When Sertoli cells or peritubular myoid cells were cultured in the presence of androgens, 
AR mRNA expression in these cell types did not change. This is in contrast to LNCaP cells, 
that showed a marked reduction of AR mRNA expression during androgen treatment. 
In the present experiments, transcriptional regulation of AR gene expression in Sertoli 
cells and LNCaP cells was also examined. Freshly isolated Sertoli cell clusters were 
transfected with a series of luciferase reporter gene constructs, driven by the AR promoter. 
It was found that addition of dbcAMP to the transfected Sertoli cells resulted in a small but 
consistent increase in reporter gene expression (which was interpreted as resulting from AR 
promoter activity); a construct that only contained the AR 5' untranslated region of the eDNA 
sequence, did not show such a regulation. The same constructs, transfected into LNCaP 
cells, did not show any transcriptional down-regulation when the synthetic androgen R1881 
was added to the cell cultures. A nuclear transcription elongation experiment (run-on), 
however, demonstrated that androgen-induced AR mRNA down-regulation in LNCaP cells 
resulted from an inhibition of AR gene transcription. 
The present results indicate that in Sertoli cells and LNCaP cells, hormonal effects on 
AR gene transcription play a role in regulation of AR expression. However, AR gene 
transcription in these cells is differentially regulated. 
INTRODUCTION 
In the mammalian testis, follicle-stimulating hormone (FSH) and testosterone exert co-
operative actions in the inttiation and maintenance of spermatogenesis (Clermont and Harvey, 
1967; Steinberger, 1971; Hansson et al., 1975; Fritz, 1978; Russell et al., 1987; Marshall and 
Nieschlag, 1987; Matsumoto and Bremner, 1989; Bartlett et al., 1989). In general, the quality 
and quantity of spermatogenesis is used as a parameter to evaluate the relative importance 
of FSH and testosterone. Using cultured Sertoli cells, several specific or common actions of 
FSH and testosterone, in particular on protein synthesis, have been observed (Cheng et al., 
1986). Recently, co-operation between FSH and testosterone has been observed on the level 
of androgen receptor (AR) regulation. In cultured immature rat Sertoli cells, long-term (72 h) 
addition of FSH to the culture medium resulted in an increased expression of both AR mRNA 
and protein (Verhoeven and Cailleau, 1988; Blok et al., 1989; Sanborn et al., 1991: Blok et 
al., 1992b). Testosterone addition to the cultured cells did not markedly affect AR mRNA· 
expression, but resulted in increased stabiltty of AR protein (Biok et al., 1989, 1992b). The 
55 
effects of FSH and testosterone on the expression of AR protein appeared to be additive (Biok 
et al., 1989; 1992b). 
Sertoli cells and peritubular myoid cells are an important source of AR protein in the rat 
testis (Takeda et al., 1989; Sar et al., 1990). To obtain more information on regulation of AR 
mRNA expression in these testicular cell types, Sertoli cells and peritubular myoid cells were 
isolated from immature rats and cultured in the presence or absence of FSH, dbcAMP or 
testosterone. LNCaP cells (cell line derived from a lymph node metastasis from a human 
prostate carcinoma; Horoszewicz et al., 1983) were included in this analysis, because 
androgen-induced down-regulation of AR mRNA expression is a more general phenomina, 
which also occurs in these cells (Quarmby et al., 1990; Tilley et al., 1990; Trapman et al1990; 
Krongrad et al., 1991). Northern blotting was performed to analyze the regulation of AR mRNA 
expression in the different cell types. 
Structural analysis of the rat and human AR promoter region (Baarends et al., 1990; 
Faber et al., 1991) did not reveal the presence of consensus sequences that could act as 
cyclic AMP response elements (CRE) through which FSH could regulate AR gene 
transcription. Several glucocorticoid response element (GRE) half-sites were found in the AR 
promoter, but it remains to be established whether these GRE half-sites are functional in the 
regulation of AR gene transcription. To study whether or not regulation of AR mRNA 
expression by FSH (Sertoli cells) and testosterone (LNCaP cells) is caused by changes in AR 
gene transcription, rather than through an effect on mRNA stability, reporter constructs were 
made that contained up to 7 kb 5' upstream sequences of the AR gene start site. These 
constructs were transfected into cultured immature Sertoli cells and LNCaP cells, to test 
regulation of their transcription. Regulation of AR gene transcription by FSH or testosterone 
was also studied using a nuclear transcription elongation (nuclear run-on) assay. 
MATERIALS AND METHODS 
Cell culture for RNA isolation and nuclear run-on 
Sertoli cells were isolated from 15-day-old rats, and cultured as described by Themmen et al. 
(1991). Peritubular myoid cells were obtained from the same testes as the Sertoli cells, as 
follows: The testes were decapsulated and incubated in 20 ml phosphate-buffered saline 
(PBS) containing 5 pgjml DNase (DN-25; Sigma, St. Louis, MO, U.S.A.), 1 mgjml collagenase 
A (Boehringer Mannheim GmbH, Mannheim, Germany), 1 mgjml hyaluronidase (1-S; Sigma), 
and 1 mgjml trypsin (TRL, Cooper Biomedical, Freehold, NJ, U.S.A.), for 25 min at 37°C in 
a 100 ml Erlenmeyer flask, in a shaking waterbath (120 cycles/min). During this treatment, 
interstitial and peritubular myoid cells became dissociated from the seminiferous tubule 
fragments; these fragments were removed by sedimentation at unit gravity for 2 min in 50 ml 
PBS containing 5 pgjml DNase. The supernatant was filtered through a 60 pm nylon filter, and 
centrifuged for 2 min at 7xg. The cells in the supernatant were precipitated by centrifugation 
at 30xg for 2 min. The interstitial and peritubular myoid cells were seeded at a density of 
approximately 3 x 104 cells per em', in Eagle's Minimum Essential Medium (Gibco BRL, 
Middlesex, U.K.), supplemented with antibiotics and non-essential amino acids (MEM; Oonk 
et al., 1985) and containing 10% foetal calf serum (FCS). At the beginning of the culture 
period, the cell preparation contained approximately 50% peritubular myoid cells, as 
determined by alkaline phosphatase staining (Palombi et al., 1989). The cultures were grown 
to near confiuency in 3 days. The purity at that time was higher than 95%. All experiments with 
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peritubular myoid cells were performed in MEM containing 0.1% bovine serum albumin (BSA; 
fraction v, Sigma). The cells were cultured in the presence or absence of hormones as 
indicated in the Results section. 
LNCaP cells (passages 45 - 50) were cultured in RPMI, containing antibiotics (see 
above) and 7.5% FCS, to 50% confluency. To study regulation of AR mRNA expression 
(Northern blotting and nuclear run-on analyses), the cells were cultured in RPM I containing 
7.5% Dextran-coated charcoal-treated FCS (DCC-FCS), supplememed with hormones as 
indicated in the Results section. 
Total RNA was isolated from Sertoli-, peritubular myoid- and LNCaP cells as described 
by Blok et al. (1992a). The nuclear run-on assays were carried out in duplicate as described 
by Blok et al. (1992b). In this assay, the transcription elongation, was allowed to continue for 
30 min in the isolated nuclei, in the presence of labelled mRNA precursors. The mRNAs were 
hybridized to the complete human AR eDNA (frapman et al., 1988; Faber et al., 1991; Jenster 
et al., 1991), and autoradiographed. The films were scanned using a video densitometer (BIO-
RAD, Model 620). 
Isolation and transfection of Sertoli cell clusters 
Tubule fragments obtained from testes from 15-day-old rats in the procedure for isolation of 
peritubular myoid cells (see above), were the source of Sertoli cell clusters that were used for 
transfection. The tubule fragments, cell clusters consisting of Sertoli cells with a few adherent 
germ cells (mainly spermatocytes), were allowed to attach in plastic Petri dishes (60 x 15 mm, 
Nunclon, Roskilde, Denmark), at a density of approximately 3 x 105 cells/em', for 4h before 
transfection. The Sertoli cell clusters were cultured in MEM, at 37°C under an atmosphere of 
5% C02 in air, in the presence of 5% DCC-FCS. 
DNA precipitate was produced using the calcium phosphate method (Chen and 
Okayama, 1987). Per culture dish with 4ml medium, 250 pi precipitate containing 5 pg plasmid 
DNA construct was added, and kept on the cells for 15 h. Subsequently, the cells were 
washed with PBS (without ca•' and Mg.') before being subjected to a 1.5 min shock-
treatment with 15% (vjv) glycerol in PBS (without ca•' and Mg.'). This was followed by two 
wash steps and addition of fresh medium (MEM supplemented with 5% DCC-FCS). After a 
6 h incubation period, the medium was again replaced by fresh medium supplemented with 
or without hormones. The incubations of the Sertoli cells, with or without hormones were 
continued for 24 h because Blok et al. (1992b) have reported a significant increase in AR,RNA 
and protein expression after 24 h of culture in the presence of FSH. In a number of 
experiments, the pCH11 0 B-galactosidase expression plasmid (Pharmacia LKB Biotechnology, 
Uppsala, Sweden) was co-transfected as an internal control. Within one experiment, all 
incubations were terminated at the same time point (control and hormone-treated). The 
hormone treatment protocols are described in the Results section. 
The cells were harvested in 0.5 ml extraction buffer (100 mM Tris pH 7.8, 8 mM MgCI,, 
1 mM dithiothreitol, 15% glycerol, 0.2% Triton X-100). For estimation of lucrrerase activity, a 
small test tube containing 40 pi of this reaction mixture was placed in a luminometer (Pica-lite 
6100; Packard, Downers Grove, IL, U.S.A.), and the reaction was initiated by injection of 10 
pi of 0.5 mM luciferin (Sigma), 50 mM ATP, pH 7. Light emission was measured during the 
first 15 seconds of the reaction Qntegral mode). The transfection experiments were repeated 
4 - 5 times, using different cell isolates and plasmid preparations. The presented luciferase 
activities are from 4 different transfections in one representative experimem. 
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Alkaline phosphatase staining was used to evaluate contamination with peritubular myoid 
cells in the Sertoli cell clusters (Palombi et al., 1989). This contamination was below 3%, and 
the contamination with spermatocytes was approximately 10% (at the end of the 
incubations). 
lNCaP cell transfection 
LNCaP cells were cultured in MEM containing 7.5% DCC-FCS, and transfected as described 
for Sertoli cells). The transfected cells were stimulated for 24 h with hormones, as described 
in the Results section, and harvested to measure the luciferase activity. The translection 
experiments were repeated 4-5 times. The luciferase activities are from 4 different transfections 
in one representative experiment 
Plasm ids 
For construction of most plasmids, the pSLA3 vector was used (van Dijk et al., 1991), that is 
a derivative of pSuperCAT. Several restriction fragments derived from GrAR2 (Baarends et al., 
1990) were subcloned into pSLA3, using standard methods (Sambrook et al., 1989). In a 
number of constructs, an octamer binding protein promoter (mouse Oct-6; kindly provided 
by Dr D. Meijer, Rotterdam, The Netherlands) was used as a minimal promoter (Fig. 1). 
The pSlA3-E3K promoter /reporter construct was generated as follows: A 1.5 kb 
Kpn1/EcoR1 fragment derived from GrAR2, containing the AR promoter and 5' untranslated 
region of the eDNA (-435 to +966) (Fig. 1), was inserted in the Kpn1 and EcoR1 sites of 
pGEM (pGEM-E3K). From this vector, a Cla1 jEcoR1 fragment was isolated and ligated into 
the Cla1/EcoR1 sites of pSLA3. pSlA3-H2/3-E3K was constructed by cloning a 
Hindiii/Hindlll fragment, derived from GrAR2, into the Hindlll site of a Bluescript vector 
(pBLUE-H2/3). A pBLUE-H2/3 Cla1 /Kpn1 fragment (1.3 kb) was placed in front of the E3K 
fragment in pSLA3-E3K On Cla1 and Kpn1 sites). pSlA3-8kb was constructed by integration 
of a 6.5 kb BamH1 /Kpn1 fragment, derived from GrAR2, into the BamH1 and Kpn1 sites in 
front of the E3K fragment in pSLA3-E3K. pSlA3-CRE-tk was constructed by ligation of a 
BamH1/Pvull fragment (containing 2 CRE consensus sequences derived from the human 
flbronectin gene; kindly provided by Dr R. Offringa) into the BamH1 /Sma1 sites of pSLA3-tk 
(van Dijk et al., 1991). To obtain pSlA3-oct, a pGEM7 polylinker region was inserted in front 
of the tk-promoter of the pSLA3-tk vector. A Hindiii/Xho1 fragment containing the Oct-6 
minimal promoter was then cloned into the Hindiii/Xho1 sites of the polylinker region of the 
pSLA3-pl-tk vector (pSLA3-pl-oct-tk). Finally, the tk-promoter was removed from pSLA3-pl-oct-
tk by using Bgiii/Xho1 (pSLA3-oct). pSLA3-oct-E3K was constructed by insertion of the 
Kpn1 /EcoR1 fragment, derived from pSLA3-E3k, into the Sma1 site of the pSLA3-oct. pSlA3-
oct-H3.1 and pSlA3-oct-H3.2 were constructed by cloning both Hindlll fragments [H3.1 (= 
411 bp, containing the AR promoter region) and H3.2 ( = 610 bp, containing a large portion 
of the AR 5' untranslated eDNA sequence)] separately into the Hindlll site of pSLA3-oct. 
pSLA3-oct-GRE was constructed by cloning a Hindlll fragment from pG-29G-tkCAT (Schule 
et al., 1988), into the Hindlll site of the pSLA3-oct plasmid. 
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Fig. 1. AR gene promoterjreporter constructs. Constructs 1 - 4 contain regions of the AR gene promoter 
(Baarends et al., 1990). Construct 5 contains the 5' untranslated region of the eDNA sequence from the AR gene, 
cloned in front of a minimal promoter (Oct-6 promoter). Constructs 6 and 7 are controls for the basal rate of 
luciferase gene transcription. Construct 7 is a positive control for AR-stimulated transcription, and construct 8 
is a positive control for dbcAMP.stimulated transcription. 
RESULTS 
AR mRNA expression 
When Sertoli cells were cultured in the presence of FSH or dbcAMP for 5 h, a rapid but 
transient decrease in AR mRNA expression was observed (Rg. 2a). However, when FSH or 
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dbcAMP was present for longer time periods (72 h), AR mRNA expression became elevated 
to values above the control level (FSH gave a 2.4 .±. 0.2 -fold induction, and dbcAMP a 2.1 
.±. 0.3 -fold induction; mean .±. SD of 4 experiments). Add~ion of the synthetic androgen 
R1881 to the cultures did not result in changes in AR mRNA expression. Actin mRNA 
expression was not significantly affected by the hormone treatments (Fig. 2b). 
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Ftg. 2. Effect of FSH, dbcAMP and R1881 on AR mRNA expression in cultured Sertoli cells. Sertoli cells from 15-
day-old rats were cultured in the presence of ovine FSH-S16 (500 ngjm/), dbcAMP (0.5 mM) or R1881 (10~ M) 
for different time periods. Con = control; 4hR1881, BhR1881, 24hR1881 "" cultured tor 4 h, 8 h or 24 h in the 
presence of R1881; ShdbcAMP, 72hdbcAMP = cultured for 5 h, or 72 h in the presence of dbcAMP; 5hFSH, 
72hFSH = cultured for 5 h or 72 h in the presence of FSH. For Northern analysis, 20 pg of total RNA was applied 
per lane and analyzed using a human AR eDNA probe (A); a hamster actin eDNA probe (8) was used to verify 
whether equal amounts of mRNA were applied to each lane on the gel. 
Peritubular myoid cells showed a small decrease in AR mRNA expression, 5 h and 72 
h after addition of dbcAMP (30% decrease; Rg. 3a). Such a decrease was also observed for 
the actin mRNA level (Fig. 3b), but not for GAPDH mRNA expression (Fig. 3c). Therefore, ~ 
was concluded that dbcAMP had a small inhibitory effect on the expression of both actin and 
AR mRNAs in cultured peritubular myoid cells. This effect, however, was different from the 
transient decrease (5h) and gradual increase (72 h) of AR mRNA expression in dbcAMP-
treated Sertoli cells. Incubation of peritubular myoid cell preparations in the presence of FSH 
had no effect on AR mRNA expression, confirming that this cell preparation did not contain 
a substantial number of Sertoli cells. Addition of R1881 to the cultured peritubular myoid cells 
did not result in changes in the expression of AR mRNA or actin mRNA (Fig. 3a and 3b). 
In LNCaP cells, no short- or long-term regulation of AR mRNA expression by dbcAMP 
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could be observed (Fig. 4a). Addition of R1881 to LNCaP cell cultures, however, did result in 
a marked reduction of the AR mRNA level (Fig. 4a). This contrasts with the absence of an 
effect of R1881 on AR mRNA expression in Sertoli and peritubular myoid cell cultures (Figs. 
2a and 3a). Actin mRNA expression rema·,ned unaltered during the different hormonal 
treatments of LNCaP cells (Fig. 4b). 
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Fig. 3. Effect of FSH, dbcAMP and R1881 on AR mRNA expression in cultured peritubu/ar myoid cells. Per/tubular 
myoid cells from 15-day~old rats were cultured in the presence of ovine FSH-$16 (500 ngjml), dbcAMP (0.5 mM) 
or R1881 (10.a M) for different time periods, as described in the Legend to Fig. 2. For Northern analysis, 20 pg 
of total RNA was applied per lane and analyzed using a human AR eDNA probe (A); a hamster actin eDNA probe 
(B) and a rat GAPDH eDNA probe {C) were used to verify whether equal amounts of mANA were applied to each 
lane on the gel. 
Transfection ol Sertoli cells 
Various methods were examined, to try to transfect primary Sertoli cell cultures. Monolayers 
of Sertoli cells from immature rats, cultured for several days in the presence or absence ol 
hormones, showed very little uptake and expression of various CAT reporter gene-constructs. 
Higher construct uptake was observed using freshly isolated Sertoli cell clusters that were 
transfected shortly after isolation. Furthermore, the sensitivity of the assay was increased by 
using luciferase as a reporter gene; lucile rase-constructs give a 30- to 1 000-fold higher signal 
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than CAT-constructs (de Wet et al., 1985, 1987; Ow et al., 1987). The transfected promoter 
constructs (Fig. 5; constructs 1 - 5) produced a luciferase activity of approximately 10- to 3D-
fold over background. Hormone induced changes in luciferase activity, were interpreted as 
changes in AR promoter activity (de Wet et al., 1987). In some experiments, !i.-galactosidase 
was used as an internal control for transfection efficiency. Different plasmid preparations 
showed approximately 2-fold variation in transfection efficiency. However, no differences were 
observed in !i.-galactosidase transfection efficiency between the dbcAMP, R1881 or control 
incubated cells. 
Because the Sertoli cell clusters were isolated in the presence of trypsin and used within 
4 h after isolation, there was the possibility that FSH receptors were damaged by the 
protease. Therefore, stimulation of transcription of the transfected promoter constructs was 
performed using dbcAMP rather than FSH. As a control, the mouse Sertoli cell line TM4 
(Mather, 1980) was transfected and incubated with FSH. 
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Fig. 4. Effect of FSH, dbcAMP and R1881 on AR mANA expression in cultured LNGaP cells. LNCaP cells from 
passages 45- 50 were cultured in the presence of ovine FSH-$16 (500 ngjml), dbcAMP {0.5 mM) or R1881 (10-s 
M) for different time periods, as described in the Legend to Fig. 2. For Northern analysis, 20 pg of total RNA was 
applied per fane and analyzed using a human AR eDNA probe (A); a hamster actin eDNA probe (B) was used 
to verify whether equal amounts of mRNA were applied to each lane on the gel. 
AR gene transcription 
Several constructs (Fig. 1) were used to study AR gene transcription in Sertoli- and LNCaP 
cells. In transfected Sertoli cells, transcription of the luciferase reporter gene from constructs 
containing AR promoter sequences was increased approximately 50% - 100% by incubation 
of the cells in the presence of dbcAMP (Fig. 5; constructs 1 - 4). This increase was not found 
using construct 5, that contained only 5' untranslated eDNA sequences. A positive control, 
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containing cAMP response elements (CREs), also showed a 1.5 to 2 -fold stimulated 
transcription. In primary Sertoli cell cultures, AR promoter activity was not stimulated by FSH 
(constructs 1 - 4; not shown), most likely due to loss of FSH receptors during the cell isolation 
procedure. However, when these constructs were transfected into TM4 cells, their 
transcription was stimulated approximately 1.5-fold by FSH (not shown). 
The 1.5- to 2-fold stimulation of construct transcription by dbcAMP /FSH in the 
transfected Sertoli cells and TM4 cells indicates that FSH may stimulate the transcription of 
the AR gene in Sertoli cells, through the cAMP pathway. 
Addition of R1881 to the Sertoli cell cultures had no effect on the transcription of the 
transfected constructs (Fig. 5). 
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Fig. 5. Luciferase activity in whole celllysates from transfected Sertoli cells. The Sertoli cells were transtected 
with different constructs (construct numbers are presented below the figure), and cultured in the presence of 
dbcAMP (0.5mM) or R1881 (10-8M). C = control; D = cultured for 24 h in the presence of dbcAMP; A = 
cultured for 24 h in the presence of R1881. The activity of constructs 6 and 7 was very low. The luciferase 
activity was measured in 4 different transtections in one representative experiment. The bars represent the mean 
± SD. 
In nuclear run-on experiments, performed on isolated Sertoli cell nuclei, no marked 
increase in AR gene transcription rate was observed when the nuclei were isolated after 24 
or 72 h of culture of the cells in the presence of FSH (Fig. 7a). 
Transfection of UIICaP cells 
In non-transfected LNCaP cells, cultured in the presence of R1881 for 8 or 24 h, a marked 
inhibition of AR mRNA expression was observed (Fig. 4a). However, LNCaP cells transfected 
with AR gene constructs (Fig. 1; constructs 1 - 5) and cultured in the presence of R1881, did 
not show an inhibition of luciferase transcription (Fig. 6; only the pSlA3-H2/3 construct is 
shown, but all other constructs were also negative). A positive control construct containing 
a glucocorticoid response element, showed a dose-dependent increase in transcription, up 
to 20-fold induction (Fig. 6). From these results, it cannot be concluded that androgen-
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induced down-regulation of AR mRNA expression in LNCaP cells results from decreased AR 
gene transcription. Measurement of transfection efficiency in the different treatment groups 
revealed no significant differences. 
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Fig. 6. Luciferase activity in whole cell lysates from transfected LNGaP cells. LNCaP cells were transfected with 
pSLA3-GR£-oct (a positive control; shaded bars), and with p$LA3-H2j3-E3k (construct 2, an AR promoter 
containing construct; closed bars). After transfection, the cells were incubated for 24 h in the presence of 
different concentrations of R1881 (12 = 10"12M to 7 = 10"7 M). The luciferase activity was measured in 4 different 
transfections in one representative experiment. The bars represent the mean ± SO. 
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Fig. 7. Measurement of the initiation rate of AR gene transcription in cultured Sertoli cells (A) and LNCaP cells 
(B). Sertoli cells were cultured in the presence of ovine FSH~S16 {500 ngjml), for 24 or 72 h. LNCaP cells were 
cultured in the presence of R1881 {1()..8 M), for 8 or 24 h. Nuclei were isolated, and transcriptional run~on 
experiments were performed as described in Materials and Methods. Con = control; 24hFSH, 72hFSH = 
cultured for 24 h or 72 h in the presence of FSH; 8hR1881, 24hR1881 = cultured for 8 h or 24 h in the presence 
of R1881; AR = AR; Act= actin; pTZ = control plasmid. The experiment was repeated 2 times with the same 
results. The autoradiograph shows the results from one experiment. 
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To study whether or not transcription of the native androgen receptor gene, possibly 
containing one or several negative androgen response elements (nARE) far upstream or in 
one of the introns, can be regulated by androgens, a nuclear run-on experiment was 
performed. The results from the run-on assay indicated that AR gene transcription in LNCaP 
cells is subject to moderate down-regulation by androgens (Fig. ?b). Inhibition of AR gene 
transcription rate in LNCaP cells was quantitated by denrsitometric scanning. The measured 
values were 0.86/0.84 after 8 h, and 0.70/0.76 after 24 h of culture in the presence of R1881. 
DISCUSSION 
Differential regulation of AR mRNA expression by FSH, dbcAMP and androgens 
Regulation of AR mRNA expression by FSH is a cell specific event, because Sertoli cells are 
the only cells in the male body that express detectable amounts of the FSH receptors 
(Darrington et al., 1975). We have shown (Biok et al., 1992b) that addttion of FSH to cultured 
immature Sertoli cells resulted in a short-term transient decrease (5 h) in AR mRNA 
expression, that was followed by a long-term increase (24-72 h). Dibutyryl-cyclic AMP 
(dbcAMP) mimicked the FSH effect, indicating that also for this effect cAMP is used as an 
important second messenger to transduce the FSH signal from the Sertoli cell surface to the 
interior of the cell. Obviously, the cAMP signal transduction pathway, activated by G protein-
coupled receptors, is not Sertoli cell specific. Therefore, we have tested whether the addition 
of dbcAMP to other AR containing cells might exert a similar effect on AR mRNA expression. 
In peritubular myoid cells from the testis, a small decrease in AR mRNA expression was 
observed when the cells were cultured in the presence of dbcAMP (5 h and 72 h). In LNCaP 
cells, there was no effect of dbcAMP at all. This contrasts with the marked regulatory effects 
of dbcAMP (or FSH through cAMP) on Sertoli cells. 
With respect to androgen action, AR mRNA expression in LNCaP cells was reduced after 
the addition of androgens to the culture medium. Other authors have observed a similar 
down-regulatory androgen effect, in LNCaP cells (Quarmby et al., 1990; Tilley et al., 1990; 
Trapman et al1990; Krongrad et al., 1991). Furthermore, androgen administration to castrated 
rats down-regulated AR mRNA expression in ventral prostate (Lubahn et al., 1988; Tan et al., 
1988; Quarmby et al., 1990; Blok et al., 1992a), kidney, brain, coagulating gland (Quarmby 
et al., 1990) and epididymis (Quarmby et al., 1990; Blok et al., 1992a). Such a down-
regulatory androgen effect, however, was not found in cu~ured Sertoli and peritubular myoid 
cells (Biok et al., 1989; Sanborn et al., 1991). Furthermore, androgen withdrawal from the 
adult rat testis, by use of the toxic compound ethane dimethane sulphonate that eliminates 
Leydig cells, also did not result in altered testicular AR mRNA expression (Biok et al., 1991, 
1992a). 
The present data underline that regulation of AR mRNA expression in rat testis by FSH, 
dbcAMP and androgens is different, when compared with AR mRNA expression regulation 
in LNCaP cells or several other rat tissues and organs. 
AR gene transcription 
For the short-term (5 h) down-regulation of AR mRNA expression in Sertoli cells by FSH, it has 
been shown that the rate of initiation of AR gene transcription was not markedly changed 
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(Blok et al., 1992b). The FSH/dbcAMP-induced decline in AR mRNA expression seems to be 
the result of a marked decrease in AR mRNA stability (Biok et al., 1992b). 
For the long-term (24- 72 h) FSH-induced stimulation of AR mRNA expression in Sertoli 
cells, and for the androgen-induced decrease in AR mRNA expression in LNCaP cells, AR 
gene transcription was studied in the present experiments. 
Two different approaches were chosen to examine AR gene transcription. First, several 
different AR gene promoter regions were inserted in front of a reporter gene. These constructs 
were transfected into Sertoli and LNCaP cells, which were then incubated in the presence or 
absence of hormones. After 24 h, reporter activity was measured. Second, using a nuclear 
transcription elongation assay (run-on), the transcription initiation rate was measured in FSH-
stimulated Sertoli cells (0, 24 and 72 h), and in androgen-treated LNCaP cells (0, 8, 24 h). 
Stimulation of AR gene transcription by FSH or dbcAMP in Sertoli cells 
Using different constructs that contained the AR gene promoter region, a stimulation of 
construct transcription by dbcAMP was observed in transfected Sertoli cells, that was not 
observed for the construct that contained only the 5' AR untranslated region of the eDNA 
sequence. The transcription of a positive control, aCRE-containing construct, was stimulated 
50%, which is low when compared to a 5- to 7-fold stimulation of the transcription ofthis CRE 
construct when transfected into other cell types (Dean et al., 1989). In LNCaP cells we 
observed a 5-fold increase in transcription of the CRE construct (not shown). 
The results indicate, that there is a small but reproducible increase, induced by dbcAMP, 
in the transcription of the AR promoter containing constructs transfected into Sertoli cells. 
Furthermore, the present results suggest that sequences in the promoter region of the AR 
gene play a role in the stimulatory effect of FSH (dbcAMP) on the transcription of this gene 
in Sertoli cells. Analysis of the sequence of the AR promoter region (Baarends et al., 1990), 
however, revealed no known CRE consensus sequences that could be responsible for the 
observed effects. 
In the current investigations, the transcription of AR promoter containing constructs was 
elevated by only 50 - 100% upon dbcAMP addition to the Sertoli cell cu~ures. These 
differences were judged to small to warrant identification of the sequences that are involved 
in cAMP-induced regulation of AR gene transcription in Sertoli cells by means of mutation 
analysis. 
Inhibition of AR gene transcription by androgens in LNCaP cells 
The general concept of androgen action involves that androgens bind to the AR, that 
subsequently becomes transformed to its DNA binding form and then regulates transcription 
of androgen responsive genes (Schrader et al., 1981; Beato, 1990; Wahli and Martinez, 1991). 
LNCaP cells contain large amounts of AR protein, and these ARs become transformed to the 
tight nuclear binding form in the presence of R1881 (Veldscholte et al., 1990). Furthermore, 
a clear down-regulatory effect of R1881 addition on AR mRNA expression (8 - 24 h) was 
found (Krongrad et al., 1991). In the present experiments, it was investigated whether these 
observations can be explained by a reduced level of AR gene transcription. 
To this end, the AR gene promoter constructs were transfected into LNCaP cells, and 
assayed for their response to androgen treatment. The positive control, a construct containing 
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a glucocorticoid responsive element which can also be regulated by the androgen receptor 
(GRE; SchUie et al., 1988) cloned in front of the Oct-6 minimal promoter, showed a marked 
stimulation oftranscription after androgen addition to the LNCaP cells. The transcription of the 
AR promoter constructs, however, appeared not to be regulated by androgens. Although the 
constructs, contained large portions of the 5' upstream region of the AR gene promoter, these 
experiments do not exclude the possibility that androgen response elements are located in 
other parts of the gene. For example for the C3 gene, encoding a component of prostatic 
binding protein, an androgen response element has been described in the first intron of the 
gene (Ciaessens et al., 1990; Tan et al., 1992). The putative nARE, however, can also be 
located further upstream, in an area of the AR gene that has not been investigated solar. 
Nuclear run-on experiments were performed to investigate whether or not the native gene is 
subject to transcriptional regulation. 
Measurement of the transcription initiation rate of the AR gene in LNCaP cells indicated 
that androgen treatment resulted in a 30% reduction of transcription. Therefore, androgen-
induced inhibition of AR mRNA expression in LNCaP cells may result in part or completely 
from decreased AR gene transcription. 
In conclusion, regulation of the expression of the AR gene in Sertoli, peritubular myoid 
and LNCaP cells differs markedly. In Sertoli cells, FSH/dbcAMP can stimulate AR gene 
transcription, whereas androgens have no effect. In LNCaP cells, dbcAMP has no effect on 
AR mRNA expression, while androgens inhibit AR gene transcription. In peritubular myoid cells 
neither dbcAMP nor androgens were found to have a marked effect on AR mRNA regulation. 
Therefore, it appears that the mode of control of AR gene transcription is cell type dependent. 
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INTRODUCTION 
In mammalian species, testosterone is essential for the maintenance of spermatogenesis, 
while FSH is more important for the initiation of spermatogenesis. However, FSH has also a 
significant role to play in the maintenance of spermatogenesis, in particular in monkeys 
(Clermont and Harvey, 1967; Steinberger, 1971; Hansson et al., 1975; Means et al., 1976; 
Fritz, 1978; Tindall et al., 1984; Russell et al., 1987). 
Bartlett et al. (1989) used hypophysectomized rats that were substituted with no 
hormone, testosterone, FSH or both hormones. Hypophysectomy alone resulted in a 
reduction of pachytene spermatocyte and round spermatid numbers to 20% of the normal 
intact control, and no elongating spermatids were found. When either FSH or testosterone 
was substituted to the hypophysectomized animals, the number of developing germ cells was 
increased, but was still markedly reduced compared to the control. Only when FSH and 
testosterone were administered together, almost normal spermatogenesis was observed. 
In order to remove all androgens from the testis, Kerr et al. (1992) treated 
hypophysectomized rats with ethane dimethane sulphonate to eliminate Leydig cells (Morris, 
1985). In these rats, treatment with FSH together with testosterone could not restore complete 
spermatogenesis. Co-operation between FSH and testosterone in the maintenance of 
spermatogenesis, however, was still evident. 
Co-operation between FSH and testosterone has also been observed on the level of 
androgen receptor (AR) regulation. In Sertoli cells isolated from immature rats, the rate of 
transcription of the AR gene was elevated approximately 75% when the cells were cultured 
in the presence of dbcAMP lor 24 h (Biok et al., 1992c). As a resu~ of this, AR mRNA (Biok 
et al., 1989; Sanborn et al., 1991; Blok et al., 1992b and c) and AR protein (Verhoeven and 
Cailleau, 1988; Blok et al., 1989; 1992b) levels became elevated. A detailed characterization 
of AR regulation by FSH (Biok et al., 1992b) revealed that, besides a long-term (24-72h) 
increase in AR gene transcription, a short-term (5 h) decrease in AR mRNA stability could be 
observed upon addition of the hormone to cultured immature Sertoli cells. This short-term 
decrease in AR mRNA expression was also observed when immature rats were injected with 
FSH (i.p., 1 pgjg bodyweight) and AR mRNA levels were measured in RNA extracted from 
total testis. 
Using monoclonal antibodies, the testicular AR was detected in Sertoli cells, Leydig cells, 
and peritubular myoid cells (Takeda et al., 1989; Sar et al., 1990; Hardy et al., 1991; Ruizeveld 
de Winter et al., 1991). In the adult rat testis, Sertoli cells and peritubular myoid cells are the 
main source of AR protein (Takeda et al., 1989: Sar et al., 1990; Blok et al., 1992a), while in 
the immature rat testis Leydig cells also contain substantial amounts of ARs (Hardy et al., 
1991). AR mRNA has been observed in cultured Sertoli cells (Biok et al., 1989, 1992b and c; 
Sanborn et al., 1991), peritubular myoid cells (Sanborn et al., 1991; Blok et al., 1992c) and 
Leydig cells (Namiki et al., 1991 ). Using specific ligand binding, Grootegoed et al. (19n) and 
Anthony et al. (1989) showed that spermatocytes and spermatids did not contain ARs. 
In view of the aforementioned FSH-induced short-term down-regulation of ARmRNA in 
total testis, we postulated that this down-regulation also might involve AR containing 
peritubular myoid cells. Because Sertoli cells are the only testicular cells expressing FSH 
receptors (Darrington et al., 1975; Darrington and Armstrong, 1979; Bortolussi et al., 1990; 
Heckert and Griswold, 1991), this would imply the action of a paracrine factor, produced by 
Sertoli cells and acting on peritubular myoid cells. In the present investigation, we have used 
cultured immature Sertoli cells and peritubular myoid cells to investigate this putative, 
paracrine interaction that might affect AR mRNA expression in peritubular myoid cells. 
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MATERIALS AND METHODS 
Sertoli cells were isolated from 21-day-old rats, and cultured as described by Themmen et al. 
(1991 ). Per~ubular myoid cells were obtained from the same testes as the Sertoli cells, as 
described by Blok et al. (1992c). Both cell types were cultured in Eagle's Minimum Essential 
Medium (Gibco BRL, Middlesex, U.K.), supplemented with antibiotics and non-essential amino 
acids (MEM; Oonk et al., 1985) containing 1% (Sertoli cells) or 10% (per~ubular myoid cells) 
foetal calf serum (FCS). The medium was replaced by MEM containing 0.1% bovine serum 
albumin (BSA; fraction V, Sigma) 24 h before the start of the incubations, and all incubations 
(5 h) were performed in MEM containing 0.1% BSA, as indicated in Results and Discussion. 
Total RNA was isolated from Sertoli and perttubular myoid cells as described by Blok et 
al. (1992a). The mRNAs were hybridized to 500 bp of the complete human AR eDNA 
(frapman et al., 1988). 
RESULTS AND DISCUSSION 
AR mRNA is present in most tissues and cell types in the male body. Only the spleen (Biok 
et al., 1992a) and immature liver (Song et al., 1991) have been reported to be devoid of 
ARm RNA. In Fig. 1, several tissues and cells from immature rats, and tumour cell lines have 
been analyzed for AR mRNA expression. It was observed that in addition to spleen and liver, 
also spermatids (and spermatocytes, not shown) did not express detectable amounts of AR 
mRNA (Fig. 1). This is in agreement with experiments using specific ligand binding to germ 
cells (Grootegoed et al., 1977; Anthony et al., 1989). In adult testes a low level of AR mRNA 
was found when compared to the AR mRNA level in testes from 21-day-old rats. This may 
partly be caused by the presence of large amounts of non-AR containing spermatids in the 
mature testis (a dilution effect). 
Freshly isolated interst~ial cells (30% Leydig cells), MA-1 0 cells (a mouse Leydig tumor 
cell line; Ascoli, 1981) and H-540 tumour tissue (Cooke et al., 1984) contained a 10 kb AR 
mRNA band (Fig. 1). These findings are in concordance with other observations showing 
immunodetection of AR protein in Leydig cells (fakane et al., 1989; Sar et al., 1990; Hardy 
et al., 1991) and the presence of AR mRNA in purified cultured human Leydig cells (Namiki 
et al., 1991). Cu~ured peritubular myoid cells contained a relatively large amount of AR mRNA, 
compared to the other somatic cell types in the testis. !D. situ hybridization has thusfar not 
been performed on the immature testis, but using antibodies peritubular myoid cells were 
shown to contain a considerable amount of AR protein. Therefore, it is very likely that 
peritubular myoid cells in situ contain a substantial amount of AR mRNA. Furthermore, Sertoli 
cells (either freshly isolated or cultured for 3 days), and TM4 cells (a mouse Sertoli cell line; 
Mather, 1980) also contained AR mRNA (Fig. 1). 
The present data indicate that in the immature rat testis, Sertoli cells, Leydig cells and 
peritubular myoid cells contain androgen receptor mRNA. 
In the Introduction, a factor was postulated, produced by Sertoli cells and acting on 
peritubular myoid cells. In order to investigate the action of this putative paracrine factor, 
peritubular myoid cells were cultured in the presence of Sertoli cell conditioned medium 
(SCeM) for 5 h (medium taken from Sertoli cells after 72 h of culture). A marked seeM-
induced reduction in AR mRNA expression in these peritubular myoid cells was observed 
(Fig. 2b). These findings indicate that the cultured Sertoli cells secrete one or more factors 
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Ag. 1. AR mRNA expression in different cells, tissues and tumour cell lines. Liver, kidney, spleen, ventral 
prostate, epididymis, Leydig celfs, peritubular myoid cells and Sertoli cells were all isolated from 21-day~old rats. 
Spermatids were isolated from 42-day-o/d rats. Leydig cells were freshly isolated; Sertoli cells were either freshly 
isolated or maintained in culture for 3 days; peritubular myoid cells were cultured tor 3 days. H-540 cells were 
cultured according to Cooke eta!. {1979), MA-10 cells according to Ascoli (1981), and TM4 cells according to 
Mather (1980). Equal amounts of total RNA (20 pg) were applied to each lane of the gel and hybridized to a 
probe, containing 500 bp of the human androgen receptor eDNA (Trapman et at., 1988). 
that have an effect on AR mRNA expression in peritubular myoid cells. 
Recently, Schlatt et al. (1992) showed a marked FSH-induced increase in actin 
immunostaining in the testicular peritubular myoid cells of FSH and testosterone treated intact 
juvenile male rhesus monkeys. From these experiments, Schlatt et al. (1992) also postulated 
paracrine communication between Sertoli cells and peritubular myoid cells. In order to obtain 
information on the nature of the paracrine factor(s) that might be involved in the interaction 
between Sertoli cells and peritubular myoid cells, a number of different growth factors (EGF, 
TGFB, insulin, and IGF-1) were added to the peritubular myoid cells. Only the addition of EGF 
(Sh) resulted in a marked reduction in AR mRNA expression, comparable to the reduction 
observed when Sertoli cell conditioned medium was added (Fig. 3a). Furthermore, the 
addition of foetal calf serum (FCS) to the peritubular myoid cells also inhibited the AR mRNA 
expression level (Fig. 3b). 
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Fig. 2. (A) Effect of FSH on AR mRNA expression in immature testis. Immature rats were injected with vehicle 
(Con) or FSH (i.p., 1 pgjg body weight) and killed 6 h later; (B) Effect of SertoH cell conditioned medium on 
androgen receptor mRNA expression in peritubufar myoid cells. Peritubular myoid cells were cultured in the 
presence of 100, 50, 25, 10, 5, 2.5 or 0% Sertoli cell conditioned medium for 5 h. Equal amounts of total RNA 
(20 pg) were applied to each lane of the gel and hybridized to a probe containing 500 bp of the human 
androgen receptor eDNA (Trapman et a/., 1988). 
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Fig. 3. Effect of growth factors (A) and fetal calf serum (B) on AR mRNA expression in peritubutar myoid cells. 
(A) Peritubular myoid cells were cultured in the presence of EGF, TGFB, insulin, and IGF~I for 5 h, (B) Peritubular 
myoid cells were cultured in the presence (FCS) of absence (Con) of 10% fetal calf serum. Equal amounts of 
total RNA (20 pg) were applied to each Jane of the gel and hybridized to a probe containing 500 bp of the 
human androgen receptor eDNA (Trapman et at., 1988). 
EGF effects on the testis are of interest because EGF has been reported to play a 
significant role in spermatogenesis. In mice, it was reported that sialoadenectomy (removal 
of the submandibular glands, which are important sources of EGF) resulted in impaired 
spermatogenesis (Tsutsumi et al., 1986). When EGF was substituted in physiological 
concentrations to the sialoadenectomized mice, spermatogenesis returned to normal. This 
result, however, could only partly be reproduced by Russell et al. (1990), who found only 
small effects of sialoadenectomy. Currently, an important role is postulated for locally 
produced EGF and EGF-Iike substances. Holmes et al. (1986) reported the production of 
EGF-Iike substances by Sertoli cells, and Skinner et al. (1989) found that TGFa was one of 
the EGF-Iike Sertoli cell products. TGFa binds to the EGF receptor and is reported to have 
a number of similar biological activities as EGF (Derynck, 1986). EGF receptors have been 
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reported to be present on all somatic cells in the testis (Skinner et al., 1989; Suarez-Quian et 
al., 1989; Suarez-Quian and Niklinski, 1990; Stubbs et al., 1990; Foresta et al., 1991). 
Therefore, it is possible that EGF, secreted by the Sertoli cells upon FSH injection, is 
responsible for the reduction of ARmRNA in other testicular cells. However, there is 
considerable redundancy of the biologica activities of various growth factors, indicating that 
other growth factors may be involved. 
The effect of Sertoli cell conditioned medium and EGF on AR mRNA expression in 
peritubular myoid cells could be mimicked by fetal calf serum (FCS; Fig. 3b). Skinner et al. 
(1989) also observed that the effects of EGF and TGFa on peritubular myoid cell proliferation 
were mimicked by fetal calf serum (FCS). Isolated and cultured peritubular myoid cells show 
active proliferation in the presence of serum. Therefore, decreased AR mRNA expression 
might be correlated with cell proliferation. Future experiments will be performed to investigate 
whether the putative paracrine factor secreted by Sertoli cells, may stimulate peritubular myoid 
cell proliferation. 
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Summary 
Effect of testosterone deprivation on expression 
of the androgen receptor in rat prostate, 
epididymis and testis 
L. J. BLOK.J. M.S. BARTLETT'.J. BOLT-DE VRIES. 
A. P. N. THEMMEN.A. O.BRINKMANN. 
G. F. WEINBAUER'. E. NlESCHLAG' and 
J. A. GROOTEGOED Department of Endocrinology and 
Reproduction. Medical Faculty, Erasmus University Rotterdam, 
The Netherlands and* Institute of Reproductive Medicine of the 
University, MUnster. Germany 
Adult rats were treated with ethane dimethane sulphonate (EDS) to eliminate the 
Leydig cells. This treatment resulted in very low levels of testosterone in the blood 
and in the testis. Furthermore. histological evaluation of spermatogenesis showed 
no marked differences between control and EDS-treated animals. 
In the ventral prostate, 5 days after EDS-treatment. a 4.0 ± 0.3-fold up-
regulation of androgen receptor (AR) mRNA was observed. together with a 2.2 ± 
0.2-fold increase in actin mRNA. In the epididymis. a 2.0 ± 0.5-fold increase in AR 
mRNA level was observed. without a change in actin mRNA leveL Jn the testes of 
EDS-treated rats. the AR mRNA level was not changed (1.02 ± 0.17-fold of 
controls). and there was also no change in actin mRNA level at 5 days after 
EDS-treatment. These results indicate that AR mRNA expression in the ventral 
prostate and epididymis is regulated differentially by testosterone when compared 
to regulation in the testis. 
Testicular androgen binding sites were assayed by Scatchard analysis of the 
binding of 3H-R1881 to a nuclear fraction. that was isolated by a method which 
involved the use of liquid nitrogen and high sucrose buffer. The number of specific 
binding sites per testis in EDS-treated rats with testosterone-implants. remained 
unaltered compared to control rats (9.1 ± 1.4 pmol/testis). In these rats. 20% of the 
normal testicular testosterone level was sufficient to maintain the androgen recep-
tor in a tight nuclear binding (transformed) form. In testes from EDS-treated rats 
without testosterone-implants. the AR did not fractionate into the nuclear fraction: 
however. the total testicular AR content in these animals was close to control 
levels. as measured by nuclear 3H-R1881 binding after receptor transformation 
through injection of a high dose of testosterone (10 mg) 2 h before killing the rats 
(testosterone pulse). In the different experimental groups. FSH was not required to 
maintain the total testicular AR content (ligand binding). 
Correspondence: Dr L J. Blok. Department of Endocrinology and Reproduction. Medical Faculty. 
Erasmus University Rotterdam. P.O. Box 1738. 3000 DR Rotterdam. The Netherlands. 
Immunoprecipitation and Western blotting of the testicular AR using specific 
monoclonal and polyclonal antibodies indicated that the total testicular amount of 
immunodetectable AR protein in long-term testosterone deprived rats was very 
low when compared to that in control rats or rats with testosterone-implants. This is 
in disagreement with results obtained in the ligand binding assay. and may point to 
a structural modification of the AR in the testis that possibly occurs in the pro-
longed absence of androgens. 
Keywords: androgen receptor, epididymis. follicle-stimulating hormone (FSH). 
prostate. testis. testosterone. 
Introduction 
During fetal and postnatal life. androgens play a crucial role in male development. 
In androgen-dependent tissues. testosterone and dihydrotestosterone interact with 
the androgen receptor and regulate a number of different processes. It is generally 
thought that. upon androgen binding, the receptor is transformed to a tight nuclear 
binding form. that regulates the transcription of a number of genes (Mainwaring. 
1977: Schrader eta! .. 1981: Brinkmann eta!., 1983). With respect to the expression 
of the androgen receptor gene itself. it is known that in the ventral prostate, a well 
studied androgen-dependent tissue. androgen receptor mRNA and protein levels 
are both regulated by androgens. The number of androgen receptors is decreased 
in the absence of androgens (measured by 3H-ligand binding). whereas under the 
same experimental conditions the amount of androgen receptor mRNA is in-
creased (Fiorelli eta/ .. 1989; Quarmby eta! .. 1990). This has also been observed for 
LNCaP cells (lymph-node carcinoma derived from the prostate) (Krongrad et al.. 
1991). 
In the testis, testosterone plays a role in the initiation and maintenance of 
spermatogenesis (Clermont & Harvey. 1967: Steinberger. 1971). In addition. it is 
clear that FSH is involved in the initiation of germ cell development in the 
immature testis (Steinberger. 1971: Fritz. 1978; Russell et al.. 1987). and has some 
role to play in the maintenance of spermatogenesis in adult rats, non-human 
primates and the human male (Matsumoto & Bremner. 1987; Marshall & Nies-
chlag. 1987; Bartlett eta/ .. 1989). 
Regulation of the expression of the androgen receptor in the testis in vivo is not 
documented extensively. Most of the data derives from studies of isolated testicular 
cell types. Buzek & Sanborn (1988) have described an increase in androgen 
receptor protein (ligand binding). during postnatal testicular development. in 
Sertoli cells and Leydig cells but not in peritubular myoid cells. deduced from 
measurements using isolated and cultured cells. In cultured Sertoli cells from 
immature rats. Verhoeven & CaiHeau (1988) and Blok eta!. (1989) have shown an 
additive stimulatory effect of testosterone and FSH on androgen receptor protein 
("H-mibolerone or 3H-Rl881 binding). Androgen receptor mRNA expression in 
these cells. however. was stimulated only by FSH but not by testosterone (Blok et 
al.. 1989). 
In the present study. EDS was used to deprive adult rats of Leydig cells and 
thereby of testosterone. as described by Bartlett eta/. (1986). EDS treatment was 
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followed by administration of either no hormone, or testosterone and/or FSH, for 5 
days. to study regulation of androgen receptor expression in the testis. when 
compared to that in the ventral prostate and epididymis. Data on androgen recep-
tor mRNA expressiOn were obtained using Northern and dot-blot analysis. Ex-
pression and transformation of testicular androgen receptor protein was studied by 
3H-R1881 binding, and by immunoprecipitation and Western blotting. 
Materials and methods 
Animals 
All animals were housed, 2-4 per cage, in a controlled environment at 25°C with a 
light cycle of 12L: 12D. and received rat diet ad libitum. 
Experimental design 
Ten groups of animals were included in this study. The intact control group (n = 5, 
Group 1) was treated with vehicle alone, and one group of intact animals (n == 5, 
Group 2) received 10 mg testosterone, as a suspension in saline (i.p.) 2 h prior to 
killing (testosterone-pulse). The other groups (five rats in each group) (Groups 
3-10) were all treated with 75 mg kg- 1 EDS (i.p.) in DMSO/H20 (1:3. v/v). These 
animals were subjected to one of the following treatments: 
(a) injection with saline. 
(b) testosterone-implant: a total of 15 em (3 x 5 em) silastic implants filled with 
testosterone (i.d. = 3,35 mm. o.d. = 4.65 mm: Dow Corning International 
Ltd .. Dusseldorf. F.R.G.). 
(c) injection with FSH: twice daily injection of a purified preparation of human 
FSH (5 IU per injection. i.e. 10 IU per day: Fertinorm, Serono. Freiburg. 
F.R.G.). The purity of the FSH preparation has been assessed previously 
(Bartlett eta/.. 1989). 
(d) testosterone-pulse; single injection of 10 mg testosterone (i.p.) 2 h prior to 
killing. 
The following groups were formed. receiving one or a combination of these 
treatments: 
Group 1: Control: 
Group 2: Control + testosterone-pulse: 
Group 3: EDS: 
Group 4: EDS + testosterone-pulse: 
Group 5: EDS + testosterone-implant: 
Group 6: EDS + testosterone-implant + testosterone-pulse: 
Group 7: EDS + testosterone-implant + FSH: 
Group 8: EDS + testosterone-implant + FSH + testosterone-pulse: 
Group 9: EDS + FSH: 
Group 10: EDS + FSH + testosterone-pulse. 
The experimental groups 1-10 were maintained under these treatment pro-
tocols for 5 days. after which all animals were killed by decapitation in a rando-
mized design. From all animals. serum and testes were obtained for hormonal 
analysis. weighing. histological evaluation and determination of androgen receptor 
mRNA and protein. Ventral prostates and epididymides were weighed and used 
for androgen receptor mRNA analysis. The tissues were flash-frozen in liquid 
nitrogen within 2-3 min of killing the rats. Data on androgen receptor mRNA and 
protein eH-R1881 binding and Western blotting) were obtained from pooled 
testes. Three nuclear fractions. used for Scatchard analysis of 3H-Rl881 binding 
were prepared for each experimental group. In addition. 3H-R1881 binding data 
and immunoprecipitation data of Groups 1 and 3 were obtained for five individual 
animals. 
Hormone assays 
Serum and testicular testosterone were measured by luminescence-immunoassay 
(LIA) following ether extraction as described previously (Bartlett et al .. 1989). The 
mean intra-assay variations were 5.8 and 4.9% and the inter-assay variations were 
4.8 and 7.9% in the ranges 10-12 and 20-25 nmoll- 1 respectively. Serum LH and 
FSH were measured by radioimmunoassay using reagents kindly supplied by the 
NIADDK (Bethesda MD. U.S.A.). The standard preparations used were FSH-
RP-2 and LH-RP-1; tracers were prepared from LH-I-6 and FSH-I-6. and the 
antisera were anti-rLH-S-9 and anti-rFSH-S-11. The limit of detection in all assays 
was 1.6 ng ml- 1 • For each hormone. all samples were analysed in a single assay, 
and the intra-assay variation was 6.5% for LH and 9.2% for FSH. 
RNA exrraction and hybridization 
Total RNA was extracted from frozen ventral prostate, epididymis or testicular 
tissue in a solution containing 3 M LiCI and 6 M ureum. a method which allows for 
extraction of large mRNAs (Auffray & Rougeon. 1980). followed by extractions 
with phenol and chloroform. Total RNA was precipitated in ethanol containing 
0.16 M sodium acetate, and stored in 70% ethanol at - 20°C. RNA was separated 
by electrophoresis (3 h. 40 rnA) in a denaturing agarose gel (0.7% agarose; Sigma. 
St. Louis, MO, USA) containing ethidium bromide (0.1 mg 150 ml- 1 gel). The 
RNA was blotted (overnight) onto a Biotrans nylon membrane (ICN, Irvin, CA, 
U.S.A.) (Davis eta! .. !986). The blots were fixed and hybridized (48 h. 42'C). in a 
hydridization solution containing 45% v/v formam ide (J. T. Baker B. V., Deventer. 
The Netherlands). 0.5% w/v sodium dodecyl sulfate, 10% Denhardts solution 
(0.1% w/v Ficoll, 0.1% w/v polyvinylpyrrolidone and 0.1% w/v bovine serum 
albumin), 10 mM phosphate buffer. 15% Dextran sulphate (Pharmacia LKB 
Biotechnology. Uppsala, Sweden) and 100 mg 1- 1 Salmon sperm DNA (Sigma). 
Androgen receptor mRNA was hybridized to a 0.5 kb (EcoR1-EcoR1) human 
androgen receptor eDNA probe (Trapman et al.. 1988). This probe corresponds to 
a part of the steroid binding domain and the 3' untranslated region of the human 
androgen receptor mRNA. Because a heterologous probe was used. the blots were 
washed at low stringency; 1 X sec (150 mM NaCI and 15 mM Na-citrate) with 
0.25% sodium dodecyl sulphate for 40 min at 42°C before autoradiography (Hyper-
film-MP, Amersham International pic. Little Chalfont, Buckinghamshire, U.K.). 
The films were scanned using a video densitometer (BIO-RAD. model 620). The 
results represent the mean ± SD of three different blots. 
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Isolation of nuclei 
Testes were pulverized under liquid nitrogen (Barberis eta!.. 1989). The resulting 
powder was suspended on ice in 5.5 ml homogenization buffer A (0.32 M sucrose. 
10 mM Hepes. 15 mM KCL 0.15 mM spermine. 0.5 mM spermidine (Sigma). 0.1% 
(v/v) Triton X-100 and 4 mM EDTA. pH 7.6). Proteolytic breakdown was inhibited 
by addition of different protease inhibitors: 0.6 mM bacitracin (Janssen Chimica. 
Beerse. Belgium). 0.6 mM PMSF and 0.25 mM leupeptin (Sigma). Triton X-100 
(0.1% v/v) was added to facilitate cell lysis. and milk protein (I% w/v) (Elk. DMV 
Campina BV .. Eindhoven. The Netherlands) was added to decrease proteolytic 
breakdown of nuclear proteins. The nuclear suspension was kept on ice for 5 min. 
homogenized (30 strokes) in a dounce tissue grinder (Wheaton Scientific. Millville, 
N.J., USA) and mixed with 11 ml homogenization buffer B (buffer A, but contain~ 
ing 2 M sucrose and 10% v/v glycerol). The mixture. with a final sucrose concentra-
tion of 1.44 M. was applied to a 4 ml cushion of homogenization buffer B and 
centrifuged using a Beckman SW 40 Ti rotor (Beckman. Geneva. Switzerland) 
(48000 g. 45 min. OOC). The nuclear pellet was used for estimation of nuclear 
androgen binding (Gorski eta/ .. 1986). 
Estimation of nuclear 3 H~RI881 binding 
Nuclear proteins were extracted from the isolated nuclei using a high-salt buffer 
(0.5 M NaCl in 40 mM Tris buffer. containing 10% glycerol and 1 mM EDTA. pH 
8.5) in the presence of protease inhibitors as described above. and kept on ice for 
1 h. Subsequently. the nuclear lysate was centrifuged (100000 g. 30 min. ooc) to 
pellet DNA and non-exrractable materiaL and the supernatant was treated with 
Dextran-coated charcoal to remove steroids. The charcoal-treated supernatant was 
then pre-incubated for 30 min at 6°C with a 500-fold excess of triamcinolone 
acetonide (Sigma), to block binding of androgens to progesterone receptors (Zava 
era!.. 1979). Subsequently, 50 ~I portions of the supernatant were incubated with 
different concentrations o!-'H-R188! (0.25. 0.5. 1.0. 2.0. 4.0. 8.0. !6.0 and 32.0 
nM; specific activity: 81.8 Ci mmol- 1) (NEN research products, Stevenage. Hert-
fordshire. U.K.). with or without a 100-fold excess of non-radioactive Rl881 (NEN 
research products) to estimate specific ligand binding. Samples were incubated for 
72 hat 6°C to allow exchange between bound and free ligand: this incubation was 
terminated by precipitation of proteins with protamine sulphate (Organon B.Y .. 
Oss. The Netherlands) (4.5% v/v in 40 mM Tris buffer containing 10% v/v glycerol. 
1 mM EDTA and 10 mM dithiothreitol. pH 8.1). The precipitate was washed four 
times with 40 mM Tris buffer and dissolved in 0.5 ml Soluene (Packard Instrument 
Company Inc .. Downers Grove. IL U.S.A.). The samples were counted after 
addition of 10 ml scintillation fluid (Ultima Gold. Packard. Groningen. The 
Netherlands). Bm .. x 3.nd Ku of androgen binding were estimated from Scatchard 
plots. 
Androgen receptor detection using antibodies 
Testes from Groups 1 and 3 were pulverized under liquid nitrogen (Barberis era/., 
1989). The resulting powder was suspended in I ml high salt buffer (0.5 M NaCI. 40 
mM Tris. 10% glyceroL 1 mM EDTA. pH 8.5) in the presence of different inhibi-
tors of proteolytic breakdown (0.6 mM bacitracin and 0.6 mM PMSF). Immunopre-
cipitation and Western blotting was performed using the same methods and anti-
bodies as described by VanLaar et al. (1991). 
Testicular histology 
Testes were fixed in Bouins solution. dehydrated. embedded in Paraplast (Lancer 
Ltd .• Oxford. U.K.) and stained with periodic acid-Schiffs reagent and haema-
toxylin. 
Statistics 
Data were analysed using one-way and multi-factor analysis of variance and 
Tukey's test to determine significant differences. 
Results 
Ventral prosrate, epididymis and testis weights 
EDS ± hormone treatment did not result. within 5 days. in any change in body-
weight (not shown). Ventral prostate weight was increased or decreased. according 
to changes in circulating testosterone (Tables 1 and 2). Paired epididymal weight 
showed no significant change between the groups (Table 1). Paired testes weight 
was decreased slightly in EDS-treated rats not receiving testosterone (Table 1). 
Table 1. Weight of the ventral prostate. epididymis and testis in animals treated with EDS and 
substituted with testosterone (T) and/or FSH 
Organ weight (mg) 
Group No. Treatment Paired testes Ventral prostate Paired epididymides 
(I. 2) Control 3103:!:: 155 501 ± 12.1 12.80 ± 86 
(3. 4) EDS 2.854- ± 1 04-. 2.95 ± 6S• 1186 ± 2.73 
(5. 6) EDS +T 3073 ± 104- 664 ± ,,. 1191±153 
(7. 6) EDS+T+FSH 32.12. ± 32.4 732 ± 158* 12.88 ± 199 
(9. 10) EDS + FSH 2.856 ± t77• 2.90 ± 60• 1168±318 
EDS - killed 5 days after EDS treatment: T - substitution with testosterone for 5 days (15 em 
silastic implants): FSH ""' substitution with FSH for 5 days (2. X 5 IU injected per day). Results 
represent mean ± SO of 10 rats (the d:lta of the groups treated or not treated with a T-pulse were 
combined). 
·P<O.Ol. compared with Control group. 
Histological evaluation of spermatogenesis showed no marked differences be-
tween control animals (Groups 1 and 2) and EDS-treated animals (Groups 3-10) 
(not shown). 
Hormone levels in the serum and testis 
In Group 3 animals. 5 days after EDS-treatment. the serum level of testosterone 
was undetectable (<0.3 nmoll- 1). When EDS-treated animals were substituted 
with testosterone using silastic implants. the serum testosterone concentration was 
approximately 6-fold higher than the control level (Group 5). The testosterone-
pulse treatment (10 mg. i.p. injection). given 2 h prior to killing the animals. 
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resulted in a serum testosterone concentration which was up to 50-fold higher than 
the control level (Table 2). 
Table 2. -'~H-RISSJ binding data and post-mortem hormonal parameten; from animals treated with 
EDS and substituted with testosterone and/or FSH 
Testicular 
FSH Serum T testosterone Nuclear AR 
Group number and treatmenr (ng ml- 1) (nmoll- 1) (nmol r- 1) {%) 
I. Control 8.1 ± 1.8 7.4 ± 6.0 165.0 ± 114.4 100 ± 16 
2. Control + T-pulse 6.6 ± 7.'2 470.0 ± 110.0 400.3 ± 95.7 104 ± 21 
3. EDS 13.3 ± 3.7* <0.3* 7.6 ± R.r <S•** 
4. EDS + T-pulsc 10.1 ± 1.7* 555.0 ± 87.0 '258.0 ± 9s.o·· 97 ± 17 
5. EDS + T '2.3 ± 0.6* 45.3 ± 8.1 * 36.1 ± 3.5* 81 ± 11 
6. EDS + T + T-pulse '2.6 ± 0.9* 409.0 ± 163.0 263.5 ± 43T* 113 ± 24 
7. EDS+T+FSH 8.7 ± 0.9 38.4 ± 8.1* 38.5 ± 4.5* 132 ± 35 
8. EDS + T + FSH + T-pulse 7.5 ± 1.0 510.0 ± 160.0 3J4.3 ± 64.8 .. 139 ± 13 
9. EDS + FSH 19.3 ± 2.7* 0.4 ± 0.4" 2.8 ± 4.5* <5 
10. EDS + FSH + T-pulse 17.2 ± 2.4" J49.0 ± 77.2 308.6 ± 60.0*~ 78 ± 9 
EDS = killed 5 days afrer EDS treatment: T = substitution with testosterone for 5 days (15 em silastie 
implants): FSH = substitution with FSH for 5 days (2 x 5 IV injected per day). T-pulse = testOsterone 
injection (10 mg) 2 h prior tO killing. The FSH and T values represent mean ± SO of five rats, with * = 
significantly different from Control group (P<O.Ol). and** =significantly different from Control+ 
T-pulse group (P<O.Ol). 
The nuclear 3H-Rl88l binding (Nuclear AR) was estimated in triplicate using three different prepara-
tions of testicular nuclei obtained from pooled left testes of five rats (mean ± SD): however, the 
androgen receptor data of Groups 1 and 3 represent me;J.n ± SD of five different animals. with ••• = 
significantly different from Comrol group (P<0.02). 
The testicular testosterone concentration. estimated 5 days after EDS-
treatment (Groups 3 and 9). was very low. Testosterone substitution by implant 
raised the testicular level of testosterone to approximately 20% of that in controls 
(Groups 5 and 7). Testosterone-pulse treatment (2 h), caused a net increase in the 
testicular testosterone concentration of approximately 200-300 nmoll- 1 • both in 
the absence or presence of a testosterone-implant (Table 2). 
Serum levels of FSH were increased in Group 3 (Table 2), presumably as a 
result of the absence of negative feedback of testosterone on the pituitary gland. In 
EDS-treated animals substituted with testosterone for 5 days (Groups 5 and 6), the 
serum FSH concentration was decreased to 30% of the control value. When 
testosterone substituted animals also received FSH injections. the circulating FSH 
concentration. measured 12 h after the last injection of FSH. was comparable to 
the control value (Table 2). There were no effects of FSH treatment on testicular 
or blood levels of testosterone. 
Androgen receptor mRNA 
Expression of androgen receptor mRNA was estimated in ventral prostate. epi-
didymis and testis. These tissues contained a 10 kb androgen receptor mRNA, and 
in addition a minor 4-5 kb band was observed on Northern blots (Fig. la). The 10 
kb band represents the intact androgen receptor mRNA. with a length that is in 
agreement with the length of the cloned cDNAs and the genomic organization of 
the androgen receptor (Changer al .. 1988: Baarends era!.. 1990). A 4-5 kb band 
has also been observed by other authors. and was thought to represent a specific 
hybridization (Tan eta/ .. 1988: Lubahn et al.. 1989: Quarmby et al .• 1990: Tilley et 
al .. 1990: Gaspar et al .. 1990). The following observations indicate that the 4-5 kb 
RNA band. in the present experiments. however. is a breakdown product of the 10 
kb androgen receptor mRNA. First. spleen RNA. which is thought to contain a 
very low amount of androgen receptor mRNA. showed virtually no binding of the 
probe to either band. Second. when RNA from ventral prostate was incubated for 
an increasing period of time at room temperature. the androgen receptor mRNA 
was nicked, presumably at a specific site, as shown by a shift in hybridization from 
the 10 kb androgen receptor mRNA band to the 4-5 kb RNA band (Fig. 1a). Dot 
blot analysis of the prostate mRNA preparation. containing both 10 and 4-5 kb 
RNA species. revealed no differences in hybridization intensity between the diffe-
rent samples (Fig. 1b). The above validates the use of dot-blot analysis of total 
RNA to estimate androgen receptor mRNA expression. 
A pronounced change in androgen receptor mRNA level was observed in 
ventral prostate from animals treated with EDS and not substituted with testoster-
one for 5 days: the mRNA level was elevated 4.0 ± 0.3-fold (Groups 3, 4. 9 and 10) 
(Fig. 2a). However. this 4-fold increase was accompanied by a 2.2 ± 0.2-fold 
10 kb 
4-5 kb 
20 JJ9 
10 JJ9 
5 JJ9 
2.5 JJ9 
a 
b 
Fig. 1. Northern (a) and dot-blot (b) analysis of total RNA extracted from spleen and ventral prostate. 
The ventral prostate RNA (35 !J,g) was kept for 0. 2, 6. 24. 36 and 4S h at room temperature. For 
Northern analysis, 35 !J.g of total ventral prostate and spleen RNA was applied per lane and analysed 
using a human androgen receptor eDNA probe (:J.). For the dot-blot analysis (b). 20 !J.g RNA was 
applied to the filter in a two-fold dilution series and analysed using a human androgen receptor eDNA 
probe. 
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elevation of actin mRNA (Fig. 3a). Ethidium bromide staining of 28S and ISS 
rRNA showed that equal amounts of total RNA were applied to each lane of the 
gel (not shown). Changes in the cellular composition of the prostate may play a role 
in this up-regulation of actin mRNA expression (see Discussion). Therefore. actin 
mRNA levels were not used to correct androgen receptor mRNA levels in the 
ventral prostate. Special care was taken to apply equal amounts of total RNA to the 
gel lanes and dot blots. 
In animals substituted with testosterone-implants following EDS-treatment. the 
androgen receptor mRNA level in ventral prostate was suppressed to slightly below 
control levels. Testosterone-pulse treatment (2 h prior to killing of the animals) did 
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fi~. 2. Hormonal regulation of androgen receptor mRNA expression in ventral prostate (a), epididy-
mis (b) and testis (c). Rats were treated as follows: Tp = testosterone injection (10 mg) 2 h prior to 
ki!ling: EDS = killed 5 days after ED$-treatment: T = substitution with testosterone for 5 days (15 em 
si\astic implants); FSH = substitution with FSH for 5 days (2 x 5 IU injected per day). For dot blot 
analysis. 20 ~g total RNA was applied to the filter in a two-fold dilution series and analysed using a 
human androgen receptor eDNA probe. 
not result in a change in androgen receptor mRNA expression when compared to 
groups not receiving a testosterone~pulse (Fig. 2a). 
In the epididymis. a 2.0 ± 0.5·fold increase of the androgen receptor mRNA 
level was Qbserved in EDS-treated animals not substituted with testosterone (Fig. 
2b). No change in actin mRNA level was observed for the epididymis (Fig. 3b). 
In the testis, no marked alteration of androgen receptor mRNA expression was 
observed (Fig. 2c). Scanning of the dot blot showed a similar amount of androgen 
receptor mRNA in control animals (LOO ± 0.18) and EDS-treated animals not 
substituted with testosterone (1.02 ± 0.17). No change in actin mRNA was 
observed for the testis (Fig. 3c). 
• 
a 
b 
c 
Fig. 3. Up-regulation of actin mRNA level in ventral prostate. The rats were treated as described in the 
legend to F1gure 2. Total RNA was extracted from ventral prostate (a), epididymis (b) and testis (c). A 
total of 35 1-1-g RNA was applied per lane (Northern blot) and analysed using a hamster actin eDNA 
probe. 
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Testicular androgen receptor: ligand binding 
To study the biological variation between individual animals, nuclear fractions 
were prepared from the left testis of five control animals (Group 1) and five 
EDS-treated rats (Group 3) (10 nuclear preparations). The binding measured by 
Scatchard analysis in these nuclear preparations was 9.1 ± 1.4 pmol/testis (Control: 
n = 5) and <0.5 pmol/testis (EDS: n = 5) (Fig. 4). The statistical difference 
between control and EDS-treated groups was significant (?<0.02). To allow 
repeated determinations of mRNA (dot blot) and androgen receptor protein 
('H-R1881 binding and Western blot) in the same tissue, all further experiments 
were carried out using pooled left testes from five animals in each group. 
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Fig. 4. Specimen Scatchard plots of specific -'H·RlSSl binding to total testicular nuclear extracts. The 
Kd value was estimated using two different nuclear extracts from two control animals. Specific binding 
was expressed as the ratio bound/free and plotted as a function of ~H-RlSSl bound. 
In control animals and in EDS-treated animals that received a testosterone-
implant (Groups 1 and 5), the levels of :-H-RlSSl binding in the nuclear fraction 
were within the same range. When these groups were treated with the 2 h testoster-
one-pulse (Groups 2 and 6) no marked changes in 3H-R1881 binding could be 
observed in comparison with Groups 1 and 5 that had not received a testosterone-
pulse (Table 2). 
In EDS-treated animals that did not receive a testosterone-implant (Groups 3 
and 9). there was little or no 3H-RI881 binding detectable in the nuclear extracts 
(significantly different from control~ ?<0.02). However. after treatment with the 
2 h testosterone-pulse (Groups 4 and 10). the 3H-Rl8Sl binding activity was 
recovered in the nuclear extract (Table 2). 
FSH administration to EDS-treatcd animals (Groups 7-10) did not give rise to 
significant changes in the amount of 3H-Rl881 binding in the nuclear extracts 
(Table 2). 
Testicular androgen receptor: immunoprecipitarion 
Immunoprecipitation of testicular androgen receptors followed by Western blot-
ting, revealed a 116 kD androgen receptor protein. Using an aspecific monoclonal 
antibody (raised against the murine FOS-protein) for the immunoprecipitation 
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Fig. 5. Western blot analysis of the androgen receptor. The o.ndrogen receptor was immunoprecipitated 
from lg tissue. EDS = testis from animals killed 5 days ::tfter EDS·treatmcnt. Control= control testis. 
Asp McAb =control testis immunoprecipitated using an aspccific antibody (antibody against the murine 
FOS protein). Spleen =spleen tissue. 
step. no such protein band was observed. Furthermore. no androgen receptor 
protein was detected in spleen (Fig. 5). 
In testes from EDS-treated rats. only a very small amount of androgen receptor 
protein was detected when compared to testes from control rats using immunopre-
cipitation and Western blotting (Fig. 5). Injection of a high dose of testosterone 2 h 
before killing of the rats (testosterone-pulse), did not result in a higher amount of 
immunodetectable androgen receptor protein in testes from EDS-treated rats 
(Group 4: EDS + Tp). Animals that received a testosterone-implant after EDS-
treatment (Groups 5-S). showed a level of immunodetectable androgen receptor 
that was comparable to the level found in control animals (not shown). These 
results seem to indicate a loss of immunodetectable testicular androgen receptor in 
the long-term absence of testosterone. 
The outcome of the immunodetection experiments is in disagreement with the 
results obtained in the -'H-Rl8~H binding experiments. showing no marked loss of 
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total androgen receptor (nuclear ligand binding after testosterone-pulse treat-
ment). 5 days after EDS-treatment. in rats not carrying a testosterone-implant. 
Discussion 
Androgen receptor mRNA in ventral prostate. epididymis and testis 
Treatment of adult rats with EDS and substitution for five days with testosterone. 
caused changes in ventral prostate weight that corresponded with the serum con-
centration of testosterone. This is in agreement with findings using castrated rats 
(Deklerck & Coffey. 1978: Huttunen eta! .. 1981). and it is concluded that elimina-
tion of Leydig cells using EDS has an effect on the ventral prostate comparable to 
that of castration. Changes in tissue weight or cellular composition can give rise to 
difficulties in the interpretation of data. In the present experimental design, altera-
tions in ventral prostate weight and composition were expected because the ventral 
prostate is an androgen-sensitive organ that responds rapidly to androgen depriva-
tion. The duration of the period of androgen deprivation was limited to 5 days. to 
prevent marked alterations of the weight of the testis or the composition of the 
seminiferous epithelium. 
Often. actin mRNA is used as a control to verify whether equal amounts of total 
mRNA are applied per lane on the gel. In the ventral prostate, however. the 
amount of actin mRNA (per total RNA) turned out to be influenced by the 
concentration of circulating testosterone. This may be caused by changes in cellular 
composition of the ventral prostate tissue upon testosterone deprivation (Deklerck 
& Coffey, 1978: Huttunen et al .. 1981). These changing levels of actin mRNA have 
not been reported by other authors (Tan et al .. 1988: Lubahn eta!.. 1989: Quarmby 
eta! .. 1990: Shan et al.. 1990). In the presentation of our results we felt that it might 
not be justifiable to use actin mRNA levels to correct for the efficiency of androgen 
receptor mRNA extraction from the ventral prostate. 
In the epididymis. a two-fold up-regulation of the amount of androgen receptor 
mRNA was observed. without a change in actin mRNA leveL 
Together with data from the literature (Tan eta! .. 1988: Lubahn eta! .. 1989: 
Quarmby eta!.. 1990: Shan eta!.. 1990). the present results indicate that testoster-
one down-regulates its own mRNA in a number of tissues (ventral prostate. 
epididymis. brain. kidney) and in at least one cell line (LNCaP. Quarmby et al .. 
1990: Krongrad et al .. 1991). Down-regulation of androgen receptor mRNA ex-
pression by testosterone. however, is not a general phenomenon. Blok eta/. (1989). 
using cultured immature rat Sertoli cells. and Husmann eta/. (1991). studying 
prostate tissue from immature neonatally castrated rats. have shown that. under 
certain experimental conditions. androgen receptor mRNA levels are not regulated 
by testosterone. In the present experiments. in testes from adult rats. no testoster-
one-dependent change in androgen receptor mRNA expression was observed. 
In future experiments. we will use androgen receptor gene promoter constructs 
(Baarends eta!.. 1990) to study regulation of androgen receptor gene expression in 
different cell types. Such studies may provide further evidence that regulation of 
androgen receptor gene transcription in testicular cells. is regulated differentially 
when compared to. for example. prostate cells. 
Androgen receptor protein in testis: specific 3 H-RJ881 binding 
For estimation of specific 3H-R1881 binding sites (Scatchard analysis). a nuclear 
fraction was isolated from total testis. The procedure for isolation of the nuclear 
fraction included tissue fractionation under liquid nitrogen (Barberis er al .. 1989) 
and the use of buffers containing a high concentration of sucrose (Gorski eta!_, 
1986). in order to reduce loss of nuclear androgen receptors. Using this method. 
and applying various ways to inhibit proteolysis. 9.1 ± 1.4 pmol of androgen 
binding was observed per testis (mean ± SD of five control adult rats). This is 
higher than the total amount of androgen binding observed by Buzek & Sanborn 
(1988). in a nuclear fraction from adult rat testis. 
EDS-treated rats with a testosterone-implant for 5 days. had a testicular testos-
terone level of approximately 20% of the control value. The level of 3H-R1881 
binding to the testicular nuclear fraction of these testosterone-substituted animals. 
however. remained unaltered compared to control animals. This suggests that a 
testicular testosterone level as low as 20% of the control value is sufficient to 
maintain a normal level of transformed androgen receptor (as measured by specific 
3H-R1881 binding). Sharpe eta!. (1988) have evaluated spermatogenesis in EDS-
treated rats substituted with a testosterone ester for 3 weeks. These authors found 
that a testicular testosterone level of 24% of control was sufficient to maintain 
spermatogenesis. which is in agreement with the present findings. Using the EDS-
model and the method to estimate nuclear androgen receptors described herein. it 
will be possible to study what testicular testosterone concentration is needed to 
transform the androgen receptor to an active tight nuclear binding form. Such a 
study may yield information concerning the relationship between testicular testos-
terone concentration and maintenance of spermatogenesis. and the transformation 
and activity of the androgen receptor. 
In EDS-treated animals that had not received a testosterone-implant. very low 
binding of 3H-R1881 in the nuclear fraction was observed. These results might 
suggest that the unoccupied androgen receptor is not located in the nucleus. 
Simental eta!. (1991) found that in COS cells. rransfected with androgen receptor 
eDNA. the unoccupied androgen receptor was located in the perinuclear region. 
However. Husmann eta!. (1990) reported nuclear localization of the androgen 
receptor in the presence as well as in the absence of ligand. Discussion about the 
subcellular localization of the unoccupied androgen receptor may not have ended. 
In the present experiments. we have taken the position that untransformed 
(unoccupied) androgen receptor molecules. that are not in the tight nuclear binding 
form. are lost from the nuclei upon cell fractionation. Therefore. rats in the 
different experimental groups were treated with a very high dose of testosterone 
(10 mg) 2 h prior to killing (testosterone-pulse). to transform unoccupied androgen 
receptors to the occupied, tight nuclear binding form. Using this approach, the 
number of occupied androgen receptors (without testosterone-pulse) and the total 
amount of androgen receptors (with testosterone-pulse) could be measured in the 
nuclear fraction. The results show that. even in EDS-treated rats that did not have 
a testosterone-implant. testicular androgen receptors were still present. These 
receptors became transformed to a tight nuclear binding form upon testosterone-
pulse treatment. and then fractionated into the nuclear fraction. 
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The serum FSH level was low in EDSwtreated rats with a testosterone-implant. 
Therefore, FSH was also administered to the experimental groups. FSH treatment 
had no effect on testicular androgen receptor mRNA. and only minor effects on the 
androgen receptor protein level were observed. This does not correspond with data 
on cultured Sertoli cells. in which up-regulation of androgen receptor mRNA as 
well as protein by FSH has been reported (Verhoeven & Cailleau. 1988: Blok eta! .. 
1989). However. this can be explained. because the present study has measured 
total testicular androgen receptor in adult animals. rather than androgen receptor 
in cultured Sertoli cells from immature rats. 
The present results on 3H-R1881 binding seem to indicate that the untrans-
formed androgen receptor in the testis does not show decreased stability in the 
prolonged absence of testosterone. This result is rather surprising, in view of 
reports that testosterone exerts an effect on the stability of the androgen receptor in 
various cell culture systems (Grino et al .. 1990~ Syms et al .. 1985). Therefore. the 
presence of androgen receptor protein was also studied using Western blotting. 
Androgen receptor protein in testis: irnrnunodetection 
Using monoclonal and polyclonal androgen receptor antibodies in immunopreci-
pitation and Western blotting. a 116 kD band was observed in the adult rat testis. 
Using the same method and the same antibodies. human LNCaP cells were found 
to contain a slightly smaller (110 kD) androgen receptor protein (van Laar et al .. 
1991). This was confirmed in the present experiments. The controls presented 
herein suggest strongly that the 116 kD band represents the rat androgen receptor. 
An intriguing discrepancy was observed between the results from the ligand 
binding and the immunoprecipitation experiments. Using immunoprecipitation. 
the animals subjected to prolonged testosterone deprivation (Groups 3. 4. 9. 10). 
showed very low levels of immunodetectable androgen receptor protein. even after 
testosterone-pulse treatment. However. :-H-Rl881 binding data. using nuclear 
preparations from these groups. showed the presence of high levels of untrans-
formed receptors. Apparently. the antibodies bind poorly to the androgen receptor 
from long-term testosterone depleted testes. This result indicates that the 
untransformed form of the androgen receptor in the testosterone-deprived testis 
may undergo a structural modification. which does not occur in the presence of 
testosterone. 
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Supplement' to Chapter 7. 
In Chapter 7, immunoprecipitation and Western blotting of the androgen receptor was 
performed to confirm the maintenance of the androgen receptor protein in testosterone 
deprived testis. Using monoclonal and polyclonal antibodies directed against the N-terminal 
domain of the human androgen receptor (van Laar et al., 1991), a 116 KD band was observed 
(Fig. 5). In this supplement, the Western blot of the immunoprecipitated testicular androgen 
receptor from the experimental groups 1-10 is shown (Fig. 6). 
In animals treated with EDS and receiving testosterone implants (groups 5-8), a 
comparable level of immunoprecipitable androgen receptor was observed as in control 
animals (groups 1-2) (Fig. 6). However, animals treated with EDS but not receiving 
testosterone implants (groups 3, 4, 9, 1 0), had very low levels of immunoprecipitable 
androgen receptor. It should be noted that the Western blot represents immunoprecipitation 
from total testis homogenates, so that loss of androgen receptor from the nuclear fraction 
does not have an influence on the outcome of the experiments. 
The discrepancy between the results from the ligand binding (Chapter 7; Table 2) and 
immunoprecipitation experiments (Figures 5 and 6) can not readily be explained. Using a 
monoclonal antibody directed against the C-terminal domain ofthe human androgen receptor, 
the same results were obtained. Moreover, immunoprecipitation of the androgen receptor 
from nuclear lysates, which were used in the ligand-binding assay, also yielded the same 
results. Apparently, the antibodies poorly bind to the androgen receptor from testosterone 
depleted testis (also not after retransformation, 2 h after injection of a high dose of 
testosterone). This may point to a permanent structural modification of the untransformed 
androgen receptor that occurs in the prolonged absence of testosterone. One other point of 
consideration is that the antibodies were directed against the human androgen receptor. It 
is possible that even small structural changes in the rat androgen receptor protein, occurring 
upon prolonged testosterone deprivation, may result in loss of receptor-antibody recognition. 
1 The information in this supplement has been published as part of an article in the Proceedings of the Eighth 
International Congress on Hormonal Steroids, The Hague, The Netherlands, September 1990 
(Biok W, Bartlett JMS, Bolt-de Vries J, Themmen APN, Brinkmann AO, Weinbauer GF, Nieschlag E and 
Grootegoed JA {1991) Regulation of androgen receptor mRNA and protein in the rat testis by testosterone. J 
Steroid Biochem Malec Bioi 40:343-348) 
96 
KD 
205 
116 
97 
66 
45 
J.? 
, 
• ,, 
0 
1 2 
,, 
,, 
' 
s• q s" 
3 4 5 
,. 
,, i' ,<t ,, 
' ' ' 
,. 
' 
,<t 
s• ? 
• 
q s• s" 
6 7 8 9 10 
Fig. 6. Western blot analysis of the androgen receptor immunoprecipitated from total testis lysates. IQ 
testosterone injection {10 mg) 2 h prior to killing; EDS ~ killed 5 days after EDS treatment; I = substitution with 
testosterone for 5 days (15 em si/astic implants); FSH = substitution with FSH for 5 days (2 x 5/U injected per 
day). 
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CHAPTER 8 
GENERAL DISCUSSION 
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8.1 Testosterone 
Testosterone and FSH are important hormonal regulators of mammalian spermatogenesis 
(Chapter 1 ). In the next paragraphs, the emphasis will be on the role of testicular testosterone 
in rat and monkey. 
8.1.1 The testicular testosterone concentration and spermatogenesis in adult rats 
Leydig cells produce large amounts of testosterone. This results in a high testicular 
testosterone concentration as measured when the steroids are extracted from total testis 
tissue, or when the testosterone concentration is determined in interstitial fluid, seminiferous 
fluid, or in testicular venous blood. In adu~ rats, the measured testicular testosterone 
concentration is approximately 20· to 50-fold higher than the testosterone concentration in 
serum and in peripheral organs (testicular testosterone concentration: 150 • 500 nM; 
circulating testosterone concentration: 5 -15 nM, taken from references discussed below). 
Whether or not the high testicular testosterone level is a prerequisite for normal 
spermatogenesis, is a question which many investigators have tried to answer in the past 
decades, using different approaches. In the next paragraphs we have summarized some of 
these reports. 
1. Cunningham and Huckins (1979) have injected adult rats daily with testosterone. As 
a result of this treatment, the circulating LH level was reduced to undetectable values, and the 
testicular testosterone level declined to below 10% of normal. After 39 days of treatment, they 
observed qualitatively and almost quantitatively normal spermatogenesis (qualitatively = all 
germ cell types are present; quantitatively = development of normal numbers of all germ cell 
types, so that the sperm counts will be normal). The FSH levels were reduced only by 30% 
as a result of the treatment. Their general conclusion was that, in the presence of very low 
testicular testosterone levels, complete spermatogenesis could persist. 
2. Zirkin et al. (1989) reported that in similar experiments at least 20% of the normal 
intact testicular testosterone concentration was necessary to maintain a normal daily sperm 
production during 8 weeks of treatment. In these animals the FSH levels were reported to be 
reduced by 50%. 
3. Huang et al. (1987) and Sun et al. (1989) extended the experiments of Cunningham 
and Huckins (1979) by substituting hypophysectomized adult rats with increasing amounts 
of testosterone, lor respectively 13 and 7 weeks. Sun et al. (1989) found that testicular 
testosterone levels of around 10% of the normal control values could qualitatively maintain 
spermatogenesis. When the testicular testosterone levels were increased, spermatogenesis 
was improved, but normal sperm counts could never be achieved (Sun et al., 1989). Huang 
et al. (1987) found that 25% of the normal testicular testosterone concentration could maintain 
qualitatively normal spermatogenesis at a maximal level. FSH could not be detected in these 
animals. 
4. Active immunisation of adult rats against GnRH resulted in undetectable concentrations 
of circulating testosterone, LH and FSH. As a result, spermatogenesis became impaired. 
Readministration oitestosterone to the GnRH-immunized adult rats (silastic implants, resulting 
in a testicular testosterone level of 20% of normal), resulted in a restart of spermatogenesis, 
and after 8 weeks normal sperm counts were observed (Awoniyi et al., 1989). Maintenance 
of spermatogenesis, measured under similar conditions was also complete (Awoniyi et al., 
1992). The FSH levels in these animals were very low or undetectable. 
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5. When EDS-treated animals were substituted with testosterone for 3 or 10 weeks 
(Sharpe et al., 1988a and b), spermatogenesis could be maintained if the testicular 
testosterone level was maintained above 25% of normal intact testicular testosterone 
concentrations. FSH levels dropped to respectively 50% of normal or just above the detection 
level in these experiments. Sprando et al. (1990) found that 8 weeks after EDS treatment, 
spermatogenesis could only qualitatively be maintained by testosterone substitution, but not 
quantitatively; the sperm counts were decreased by 30%. 
6. Bartlett et al. (1989) substituted hypophysectomized rats with FSH (twice-daily injections 
with 51U human FSH) and testosterone. In these animals the testicular testosterone level was 
decreased to below 5% of the normal intact value, while spermatogenesis was almost 
quantitatively maintained. When only FSH or testosterone was substituted, spermatogenesis 
was markedly reduced. 
The above summarized reports agree that normal testicular testosterone concentrations 
are at least 4- to 5-fold and perhaps 10- to 20-fold higher than needed for spermatogenesis. 
Biochemical data supporting the view that a very high testicular testosterone level is 
not a prerequisite for normal spermatogenesis came from experiments using cultured 
testicular cells. Buzek and Sanborn (1990) found that binding of ligand to androgen receptors 
in cultured Sertoli and peritubular myoid cells, reached a maximum at testosterone 
concentrations around 3 nM (Kd = 0.7 nM). This indicated that 3 nM testosterone saturates 
the androgen receptor and generates a maximal androgen signal in the cultured cells. In the 
testis, the testosterone concentrations are 50- to 150-fold higher. Of course, the conditions 
in the testis in vivo are very much different from those in cultured testicular cells in vitro, but 
the fact remains that the testicular androgen receptor does not seem to need high local 
testosterone levels to transduce the androgen signal. In the following paragraphs (and in 
Chapter 7) further biochemical data are provided, from in vivo experiments, that support the 
hypothesis that the normal testicular testosterone concentration is far in excess over that 
required for spermatogenesis. 
In Chapter 7, we have varied circulating and testicular testosterone levels, and 
measured the occupancy of the androgen receptor (the EDS model used in these 
experiments has been described in detail in Paragraph 1.4.3 and in Chapter 7). In Table 1 
(ventral prostate data) and in Table 2 (testis data) some of the results from these studies are 
summarized. 
It was observed that in ventral prostate, under control conditions in intact animals, only 
40% of the androgen receptors was occupied with ligand. Furthermore, we observed that the 
occupancy of the androgen receptor with ligand (Table 1; occupied AR %/g) became higher, 
concomitant with the increase of circulating levels of testosterone, and was lowered following 
a decrease in circulating levels of testosterone. This fits the observation that in ventral prostate 
in vivo, epithelial cell numbers and to a lesser extent stromal cell numbers are regulated by 
an increase or decrease in circulating testosterone (DeKlerk and Coffey, 1978; Huttunen et 
al., 1980). 
Occupied androgen receptors can bind to consensus DNA sequences and regulate 
gene transcription (Beato et al., 1990; Wahli and Martinez, 1991). This means that with an 
increase in occupancy from 40% to 100%, more androgen receptors become active as 
transcription factors. In the ventral prostate, an example of transcriptional regulation of a gene 
by changes in circulating testosterone is the androgen receptor gene (Fig. 1 ). When the 
androgen level is increased by substituting testosterone after EDS treatment, the androgen 
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receptor mRNA expression is decreased, and vice versa Dn Chapter 5, strong indications are 
provided for transcriptional regulation of the androgen receptor gene by androgens). 
Table 1. Androgen receptor content of ventral prostate 
Treatment Serum T Occupied AR Total AR Prost. 
nM %(g %/g weight g 
Control 7.4±6.0 42.3 100 501 ±121 
EDS <0.3 <5 56 295± 68 
EDS + T-implant 45.3±8.1 110 112 664± 65 
Serum T = the concentration of serum testosterone; Occupied AR =percentage of androgen receptors that are 
transformed to the tight nuclear binding form; Total AR = total amount of androgen receptor as a percentage 
of the control, expressed per gram tissue; Prost. weight g = ventral prostate weight in grammes; EDS = 
sacrificed 5 days after EDS treatment; T-implant (or 1) = substitution with 15 em silastic testosterone implants 
for 5 days. The androgen receptor (AR) data represents the mean of two experiments. 
Con EDS EDS+T 
'"~' •w,w 
Fig. 1. Regulation of androgen receptor mRNA expression in adult rat ventral prostate by different levels of 
testosterone. Total tissue RNA was extracted in duplicate. For hormonal and biochemical parameters, and for 
the legend, see Table 1. 
In the adult rat testis (Table 2) the situation is different. Under control conditions, the 
androgen receptor is fully occupied with ligand and probably has attained its maximal capacity 
to regulate gene transcription. This situation does not change when the testicular testosterone 
concentration is decreased to 20% of normal. 
These data indicate that all androgen actions in the testis mediated via the nuclear 
androgen receptor can be fully maintained at a testicular testosterone concentration of 20% 
of the normal intact control concentration. It is expected (and currently investigated) that this 
level can be further decreased to 5 - 10% of control. 
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Table 2. Androgen receptor content of testes. 
Treatment Testicular T Occupied AR Total AR Testes 
nM %jg %jg weight g 
Control 165 ±114.4 100±16 104±21 3103±155 
EDS 7.6± 8.7 <5 97±17 2854±104 
EDS + T-implant 36.1 ± 3.5 81 ± 11 113±24 3073±104 
Testicular T = the concentration of testicular testosterone; Occupied AR = percentage of androgen receptors 
that are transformed to the tight nuclear binding form; Total AR = total amount of androgen receptor as a 
percentage of the control, expressed per gram tissue; Testes weight g = paired testes weight in grammes; EDS 
= sacrificed 5 days after EDS treatment; T-implant = substitution with 15 em silastic testosterone implants for 
5 days. For serum testosterone concentrations see Table 1. More details are provided in Chapter 7. 
8.1.2 Androgen effects not mediated via nuclear receptors 
Some of the experiments summarized in Paragraph 8.1.1 indicate that the testis needs at least 
5 to 10% of its normal testosterone concentration for quantitative maintenance of 
spermatogenesis. Yet, this testosterone level is considerably higher than the circulating 
testosterone level and possibly also higher than the testosterone level needed to occupy all 
testicular androgen receptors. The question is how this difference in testosterone requirement 
between the testis and for example the ventral prostate can be explained? 
In the ventral prostate the active androgen is dihydrotestosterone (DHT), which binds 
with a much higher affinity to the androgen receptor than testosterone (Wilbert et al., 1983). 
In the adult testis, there is no high rate of conversion of testosterone to DHT, and it is 
hypothesized that testosterone acts as the active androgen (Baker et al., 1977). This 
difference may account partly for the fact that the testis needs more testosterone than the 
ventral prostate, but other factors may be involved. 
In this paragraph, data are presented that suggest the existence of an androgen 
receptor located on the cell plasma membrane, that binds androgen with a moderate affinity 
(10.8M), and subsequently rapidly affects calcium andjor cAMP levels in the cell. For other 
steroids similar mechanisms have been proposed. 
Koenig et al. (1989) examined the early response of heart myocytes to administration 
of testosterone and found an acute effect on calcium influx and distribution in the cells, 
induced by testosterone concentrations of1 - 10 nM. One of the first effects of the calcium 
infiux was the activation of ornithine decarboxylase (1 min), resulting in a rapid increase in 
polyamine concentration (2 min) and a somewhat delayed increase in the uptake of 
horseradish peroxidase, 2-deoxyglucose and a-aminoisobutyrate (markers respectively for 
endocytosis, amino acid transport and hexose transport). The polyamines are thought to 
trigger the stimulation of endocytosis, hexose transport, and amino acid transport. The 
testosterone-induced calcium influx and the resulting effects in the myocytes could be blocked 
by EGTA (calcium chelator), La+ 3 (calcium antagonist), or verapamil (calcium transport 
blocker). The calcium ionophore A23187 mimicked the testosterone effects on the myocytes. 
Effects of testosterone administration on intracellular calcium have also been 
documented for LNCaP cells. Steinsapir et al. (1991) observed a rapid calcium infiux (2 min) 
upon stimulation of LNCaP cells with a synthetic androgen (1o·•- 10·" M mibolerone). 
102 
There is some evidence thatthe described effects oftestosterone on intracellular calcium 
in myocytes and LNCaP cells are mediated via a protein that may resemble the androgen 
receptor. With respect to the calcium influx in myocytes, Koenig et al. (1982) observed steroid 
specificity, hormone concentration dependency, and the absence of the effect in testicular 
feminized (Tim) mutant mice in which the androgen gene is defect. Steinsapir et al (1991) 
showed inhibition of androgen-induced calcium influx by the antiandrogen hydroxyflutamide 
(10'6M). However, this putative plasma membrane androgen receptor is most likely not 
identical to the cloned nuclear androgen receptor. 
Non-nuclear receptor mediated effects of androgens are not extensively studied solar, 
but there are reports of non-nuclear actions of other steroids. Estrogen (estradioi-17B) 
administration to uterine endometrial cells, lor example, resulted in enhanced calcium uptake 
over a 10-30 min period (Pietras and Szego, 1975). Furthermore, progesterone addition to 
sperm was found to initiate calcium uptake, and consequently to induce the acrosome 
reaction (Osman et al., 1989). Recently, Blackmore and Lattanzio (1991) have found 
indications for a progesterone receptor on the plasma membrane of the sperm head. In 
oocytes, progesterone also causes a rapid increase in calcium uptake (Moreau et al., 1980; 
Wasserman et al., 1980). 
The non-nuclear actions of 1 ,25-dihydroxy-vitamin 03 (vit-O) have been studied more 
thoroughly (Nemere and Norman, 1991). An altered calcium and phospholipid metabolism in 
reaction to vit-O administration has been reported in a great number of cells in different 
species: intestinal and colonic epithelium, kidney tubules, muscle cells, lymphoid cells, 
mammary tissue, hepatocytes and osteoblasts (for a review, see Nemere and Norman, 1991 ). 
On the basis of the studies on vit-O, Nemere and Norman (1991) postulated a model for non-
nuclear receptor mediated steroid actions on calcium homeostasis in cells, involving steroid 
binding sites on the plasma membrane (Fig. 2). 
Other support lor the existence of steroid hormone actions on the plasma membrane 
comes from studies on sex hormone binding proteins. Sex hormone binding protein (SBP or 
SHBG) is a protein that binds testosterone and OHT with moderate affinity (Kd ol1 - 10 nM) 
and 17B-estradiol (E2) with a lower affinity. SBP is present in the plasma of many species, but 
is reported to be absent in mature rat and mouse plasma (other plasma proteins may bind 
androgens and estrogens in these species). For SBP, two specific binding places on the 
plasma membrane have been reported [Kd = 2 x 10·• M and 1.5. x 10·' M (Hryb et al., 
1989)]; 1251-SBP binding has been demonstrated in isolated membranes from decidual 
endometrium, benign prostatic hyperplasia and LNCaP cells. Most data indicate that the 
steroid-bound SBP binds with very high affinity (Kd = 1 o·" M) to the membranes (Natalja et 
al., 1990; Avvakumov et al., 1986). Rosner et al. (1991) reported, however, that the unliganded 
SBP also binds to LNCaP cell membrane with a high affinity. Upon addition of OHT (1 0 nM, 
15 min) to LNCaP cells preincubated with SBP, the cAMP content of the cells was increased 
by approximately 50% (calcium influx has not been studied so far). As a control, OHT was 
added to LNCaP cells not preincubated with SBP, and no effects on cAMP content were 
observed. Hence, SBP acts as a mediator of this steroid hormone effect on the plasma 
membrane. 
Taking all these data together, there are grounds to consider androgen actions which 
do not directly involve the nuclear androgen receptor. However, for the testis, these theories 
are highly speculative and thusfar lack experimental proof. It is therefore too early to postulate 
the existence of functional plasma membrane androgen receptors in the testis, which might 
explain the need for relatively high levels of testicular testosterone for ongoing 
spermatogenesis. 
~ 
CC ~ Ga CHANNEL 
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Fig. 2. Model for steroid action not mediated via nuclear receptors. The hypothesis which is suggested includes 
a possible direct interaction of the steroid with Ca +:> channels, or receptor mediated activation of Ca +:> channels 
through G proteins, formation of cAMP or activation of protein kinases. Please note that the receptor is in the 
plasma membrane. (Part of a figure from Nemere and Norman, 1991). 
8.1.3 Regulation of male fertility 
The development of a hormonal method for male contraception has been the subject of much 
research that started more than a decade ago (Swerdloff et al., 1978). In the course of clinical 
experiments, it became clear that it may be difficult to develop a male contraceptive that will 
prove useful for large groups of people. Good male contraceptives should combine several 
characteristics: 
the blockade of male fertility must be complete but also reversible, 
male secondary sexual characteristics must be maintained, 
there should be no side effects, 
and the contraceptive should be long acting and easy to apply (user friendly). 
At the moment, several studies are being undertaken to test or develop hormonal 
methods to suppress sperm production (Waites, 1990). These studies focus on three main 
aspects. First, suppression of the secretion of the gonadotropins; second, the maintenance 
of normal androgen levels in the circulation without re-stimulating spermatogenesis; and third, 
the evaluation of the fertilizing capacity of residual sperm (in case the hormonal treatment 
does not achieve azoospermia). 
A central point in these investigations is the testosterone concentrations in the circulation 
and in the testis. Circulating testosterone should be sufficiently high to maintain male 
secondary sexual characteristics, whereas testicular testosterone levels should be markedly 
decreased to reduce spermatogenesis. As is indicated in Paragraph 8. i .1, the testicular 
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testosterone level may not always be a true indication of androgen action. Therefore, 
measuring androgen receptor occupancy in peripheral organs and in the testis of treated 
animals can provide fundamental information about the biological activity of the androgen 
levels in these organs. 
One group of investigational drugs studied in the context of male contraception are 
GnRH antagonists. A brief summary of the studies is given below. 
GnRH antagonists bind to the pituitary GnRH receptor (Heber et al., 1982), but do not 
stimulate gonadotropin release. Furthermore, GnRH antagonist binding prevents GnRH 
binding to the receptor, and consequently LH and FSH release is inhibited. Because of low 
LH levels, the testicular testosterone production is also reduced. When GnRH antagonist was 
injected daily during 10 weeks in the non-human primate Macaca fascicularis, complete loss 
of sperm production was achieved (Bind Akhtar et al., 1985; Weinbauer et al., 1984; 1987; 
1988). When antagonist treatment was stopped, sperm production returned to the normal 
intact level within 12 weeks. During treatment with GnRH antagonist, circulating LH and 
testosterone concentrations were decreased to very low levels. The low testosterone 
concentration, however, was not sufficient to maintain male secondary sexual characteristics. 
In order to support male secondary sexual characteristics, GnRH antagonist treatment 
requires testosterone substitution. Unfortunately, in monkeys receiving both antagonist and 
androgen at the same time, some sperm production was detected (Weinbauer et al., 1988). 
It remains to be established what the fertilizing capacity is of this residual sperm. Sperm 
counts, however, could be reduced to zero, introducing a delay of 6 weeks between the start 
of GnRH antagonist treatment and the start of testosterone substitution (Weinbauer et al., 
1989). The idea behind this treatment is that spermatogenesis can not be re-initiated by a 
relatively low concentration of testosterone alone; FSH is required in addition to testosterone 
to initiate spermatogenesis. 
An interesting observation in the experiments of Weinbauer et al. (1988) was that the 
testicular testosterone levels of the GnRH antagonist-treated monkeys (measured 15 weeks 
after the start of the GnRH antagonist treatment) did not fall below 30% of the normal value, 
although circulating LH and serum testosterone levels were very low. Furthermore, substitution 
of circulating testosterone (to maintain sexual characteristics) had no significant effect on this 
testicular testosterone level. 
As described in Chapter 7, a residual testosterone level was also observed in the testis 
of EDS-treated rats (7.6 ±. 8.7 nM testosterone; Table 2). When we measured androgen 
receptor occupancy, this residual testosterone did not transform a measurable amount of 
androgen receptors to the tight nuclear binding form. In other words, the remaining 
testosterone seems to represent an inactive pool with respect to receptor binding. In the testis 
of GnRH antagonist-treated monkeys, the same analysis might be carried out to determine 
whether the remaining testicular testosterone (30%) indeed represents an inactive testosterone 
pool, with respect to transformation of testicular androgen receptors. 
8.2 FSH 
FSH and testosterone are both involved in the regulation of spermatogenesis. For androgens, 
we have discussed (8.1) that testosterone levels in the testis are so high that, within a broad 
range of concentrations (20% to 1 00%) the activity of the androgen receptor as a transcription 
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factor may remain at its maximum. About the actual FSH level in the testis, not much 
information is available. The circulating FSH levels have been described to be relatively low 
from day 5 to day 15 after birth. Thereafter, the concentration starts to increase approximately 
3-fold (around day 40) and subsequently returns to a lower value (Ketelslegers et al., 1978). 
Most studies concerning the role of FSH in spermatogenesis use methods to reduce the level 
of FSH to almost zero and then substitute with high amounts of FSH. 
In the experiments described in Chapter 4, we have injected intact 21-day-old rats with 
FSH 0-P· injection with 1 pgjg bodyweight ovine FSH) and observed marked effects of this 
single injection on androgen and FSH receptor mRNA expression in the whole testis (Fig. 3). 
A B Con 2 4 6 8 111 Con 2 4 6 8 10 
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Fig. 3. (A) Effect of FSH on testicular androgen receptor mRNA and {B) FSH receptor mRNA expression. The 21-
day-old rats were injected (i.p.) with 1 pg ovine FSH-$16/g body weight and sacrificed 2, 4, 6, 8 or 10 h later. 
Con = control; saline injected and sacrificed 4 h later. For Northern analysis (A:androgen receptor mRNA), 20 
pg of total RNA, isolated from total testis, was applied per lane and analyzed using a human androgen receptor 
eDNA probe. For RNase-protection (B: FSH receptor mRNA) 10 pg of total RNA was used to hybridize with a 400 
bp FSH receptor probe. The FSH receptor mRNA data have not been published so far. 
These effects offer no explanation lor the function of FSH in spermatogenesis, but the 
observations do illustrate that FSH stimulation of immature Sertoli cell activity io. vivo is not at 
its maximum. 
8.2.1 Regulation of gonadotropin receptors 
The pituitary gonadotropins are key hormones in the regulation of gametogenesis and 
steroidogenesis in the gonads. In this paragraph, the regulation of FSH and LH receptors in 
ovary and testis will be discussed. In Chapter 1, we have described similarities between FSH 
and LH, and between their receptors. It may therefore be expected that there exist certain 
conformities in the regulation of both receptors. 
In the literature, several reports describe that ovarian gonadotropin receptors, in 
particular the LH receptor, are highly regulated when follicles are recruited, mature, ovulate 
and luteinize (Richards, 1980). During maturation of the follicle, there is a large increase in LH 
receptor expression, which is followed by a marked decrease after the preovulatory LH surge. 
During the ensuing luteinisation, LH receptor expression is increased again. FSH receptor 
expression is less pronounced, and differences in expression between stages of follicle 
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development are not so evident (Richards, 1980). 
Regulation of the expression of LH and FSH receptor mRNAs during the estrous cycle 
was studied using ill situ hybridisation (Camp et al., 1991). In ovaries from immature rats, it 
was observed that FSH receptor mRNA expression is confined to the granulosa cells, while 
LH receptor mRNA is only found in thecal cells. Upon maturation ofthe follicle (either induced 
by hormone stimulation, but also during the estrous cycle), a high level of LH receptor mRNA 
was found in granulosa cells. Using cultured granulosa cells, it appeared that FSH was 
responsible for this marked stimulation of LH receptor mRNA expression (Piquette et al., 
1991). After the ovulation-inducing preovulatory LH surge, but also when ovulation was 
stimulated with human chorionic gonadotropin (LaPolt et al., 1991 and 1992), LH receptor 
mRNA expression in granulosa cells was rapidly decreased to below the level of detection. 
The situation in the corpora lutea is variable; in some corpora lutea LH receptor mRNA is 
expressed, but other corpora lutea did not show this mRNA. In the thecal and interstitial cells, 
the expression of LH receptor mRNA is only moderately increased during the days before, 
and on the day of the preovulatory LH surge (metestrus, diestrus and proestrus). 
The expression of FSH receptor mRNA is much lower, and the regulation less articulate 
than the LH receptor mRNA expression and regulation in the ovary (Camp et al., 1991). 
Furthermore, FSH receptor expression in the adult ovary is restricted to the granulosa cells, 
while the LH receptor is expressed in most ovarian cell types (not in the oocyte). 
For the testis, LH receptor regulation has been studied using the MA-1 0 mouse Leydig 
cell tumor cell line as a model (Wang et al., 1991). Addition of LH to the culture medium of 
these cells resulted in a rapid decline in ligand binding, due to internalization of the receptor, 
which was followed by a decrease in LH receptor mRNA and protein expression. These 
results are not very different from the results concerning FSH regulation of FSH receptor 
expression in cu~ured Sertoli cells (discussed in 8.2.2), that showed a rapid desensitization 
of FSH signal transduction and a decrease in FSH receptor mRNA and protein expression. 
From these results, it is suggested that some aspects of the regulation of the LH and 
FSH receptor expression in the testis and ovary involve similar mechanisms. 
8.2.2 FSH regulation of androgen and FSH receptor expression in the testis 
Using cultured Sertoli cells from immature rats, the ill vivo down-regulatory effect of FSH 
injection on androgen and FSH receptor mRNA expression in immature rat testis could be 
mimicked. It is known that cAMP plays a significant role in the signal transduction of FSH. In 
concordance with this, a rapid decrease in androgen and FSH receptor mRNA expression in 
Sertoli cells was also observed after addition of dibutyryl cAMP (dbcAMP) to the culture 
medium. In the here discussed experiments, we have used dbcAMP to stimulate the Sertoli 
cells in order to avoid refractoriness to FSH stimulation due to receptor internalization 
(for details on these effects see Chapters 1 and 5). 
Following the rapid down-regulation of FSH receptor and androgen receptor mRNA 
within the first 5 h of culture in the presence of dbcAMP, clear differences between the 
regulation of androgen and FSH receptor mRNA expression became apparent. Androgen 
receptor mRNA expression was restored to control levels after 7 - 8 h, and gradually 
increased when the culture time was extended to 72 h. In contrast, the FSH receptor mRNA 
expression level remained reduced at approximately 40% of the control level during cu~ure 
in the presence of dbcAMP (Rg. 4a). 
Using cycloheximide, an inhibitor of protein synthesis, it was found that de novo protein 
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synthesis was not a prerequisite for the FSH/dbcAMP-induced decrease in androgen and 
FSH receptor mRNA expression. Nuclear transcription run-on experiments indicated that the 
decline in androgen receptor mRNA expression was not the result of decreased androgen 
receptor gene transcription. Similarly, the decline in FSH receptor mRNA expression was not 
caused by a decreased rate of FSH receptor gene transcription. 
It can be postulated, therefore, that FSH, using cAMP as the predominant second 
messenger, activates (one or more) short-lived and preexisting proteins, that through an 
unknown mechanism decrease the stability of the androgen and FSH receptor mRNAs. 
After this initial phase, the androgen receptor mRNA expression is restored to control 
level and then slowly increased (increased gene transcription), whereas the FSH-receptor 
mRNA expression reaches a new steady state at approximately 40% of the control value (no 
increase of the rate of gene transcription). 
The rapid FSH/dbcAMP-induced changes in FSH and androgen receptor mRNA 
expression were not immediately translated into corresponding differences at the protein level 
(Fig. 4b). For the androgen receptor there are indications that the protein stability is much 
higher than the mRNA stability (Chapter 3). Therefore, rapid and marked differences in mRNA 
expression are translated slowly into small differences in protein expression. The FSH receptor 
has not been thoroughly studied in this respect. 
Since the short-term down-regulation of androgen receptor mRNA expression was of no 
major consequence for receptor regulation, one may ask the question what might be the 
physiological relevance of this FSH-induced down-regulation. As far as we know, in Sertoli 
cells such a short-term effect of FSH has only been observed for androgen and FSH receptor 
mRNAs, and not for other mRNAs. For example actin and GAPDH mRNAs are not regulated 
by FSH, whereas cAMP-dependent protein kinase subunit mRNA (Oyen et al., 1988) and c-fos 
mRNA expression (Hallet al., 1988) are transiently increased after FSH addition to the cells. 
For inhibin a-subunit mRNA, a prolonged increase in mRNA expression was described {Kiaij 
et al., 1990). 
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Fig. 4. Regulation of androgen and FSH receptor mANA (A) and protein (B) expression in cultured Senoli cells 
in the presence of dbcAMP; extrapolation of the results described in Chapters 3 and 4. 
Within certain limits, subtle short-term down-regulation of androgen and FSH receptor 
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mRNA expression may play a role in physiology. However, when we inject extra FSH in 
immature rats, or when we add FSH to Sertoli cells in culture, the cells are exposed to a high 
dose of hormone. This high FSH dose may accelerate processes that, in vivo under 
physiological conditions, take place at a much lower rate. 
Sertoli cells stimulated for longer periods of time with FSH or dbcAMP show a good 
correlation between androgen receptor mRNA and protein levels, and between FSH receptor 
mRNA and protein levels. It is speculated that under normal physiological conditions, FSH 
plays a long-term regulatory role in the testicular expression of androgen and FSH receptors 
in immature rats. 
8.3 Interaction between peritubular myoid cells and Sertoli cells 
The importance of the interaction between stromal (mesenchymal) and epithelial cells was 
recognized many years ago (Grobstein, 1953). A classical experiment in this respect is the 
analysis of androgen-induced mammary epithelial regression in mice (Kratochwil and 
Schwartz, 1976). In male mouse embryos, mammary epithelial development is totally inhibited 
by androgens that are secreted by the fetal testes (Ohno, 1979). This inhibition takes place 
irrespective of the presence of functional or dysfunctional androgen receptors in the 
regressing epithelial cells. However, the presence of normal functional androgen receptors in 
the underlaying mesenchymal tissue is essential. From these experiments, it was concluded 
that developmental effects of androgens on mammary epithelial gland tissue were mediated 
via the underlaying mesenchyme (Cunha et al., 1983; Kooistra, 1991). 
The concept of epithelial cell development, modulated by androgen-induced factors from 
mesenchymal cells, has also been recognized in the prostate. The development of the 
prostate from urogenital sinus tissue, and the maintenance of its adult structure and function, 
fully depends on the presence of functional androgen receptors and sufficient amounts of 
androgens. During fetal prostate development, the role of the mesenchyme in modulating 
androgen effects on epithelial cell growth and development is evident, because the 
mesenchymal cells contain androgen receptors whereas the epithelial cells do not (Shannon 
and Cunha, 1983; Takeda et al., 1985; Husmann et al., 1991). 
Irrespective of the presence of androgens, the prostate epithelial cells begin to express 
androgen receptors starting at day 4- 6 after birth (Cunha et al., 1983). In order to study the 
role of the mesenchyme in development and maintenance of the epithelial cells in the prostate 
after birth, tissue recombinants were made between mesenchymal and epithelial cells of 
urogenital sinus origin, derived from normal intact animals or animals expressing defective 
androgen receptors (testicular feminized animals; Tfm). The tissue recombinants were 
implanted into intact male hosts and allowed to grow to mature structures. Wild-type 
mesenchyme/Tim epithelial recombinants and wild-type mesenchyme/wild-type epithelial 
recombinants were analized. 
It was observed that in all cases, differentiated epithelial cells developed next to 
fibroblasts and smooth muscle cells of mesenchymal origin. Furthermore, the secretory 
products of the wild-type mesenchymejTfm epithelium structures were highly similar to 
secretory products from normal intact prostates (Cunha and Chung, 1981; Norman et al., 
1986; Sugimura et al., 1986). Androgen deprivation, resulted in comparable changes in 
histology in recombinant and normal prostate tissue cu~ures. It is clear that during prostate 
development, but also in the adult prostate, a number of epithelial characteristics is regulated 
by androgens via the stromal (mesenchymal) cells. 
109 
In the testis, the importance of cell-cell interactions has also been recognized. Here we 
will focus on the interaction between the peritubular myoid cells and the Sertoli cells as an 
example of a mesenchymal-eptthelial interaction. 
In the fetal testis, Sertoli cell clusters are surrounded by peritubular cell sheaths. With 
the onset of spermatogenesis, the peritubular cells develop towards a more mature 
appearance, while the Sertoli cells stop dividing and start differentiating to their adult form. The 
development of the peritubular myoid cells is dependent on androgens, but also on FSH 
(Bressler and Ross, 1972). It is clear that the action of FSH is mediated via the Sertoli cells. 
Sertoli cells co-operate on a structural level wtth peritubular myoid cells, in forming a 
complex intracellular matrix in between the two cell types. This extracellular matrix consists 
of components produced by Sertoli cells and produced by peritubular myoid cells (Skinner 
et al., 1985) and provides structural integrity for the tubules and assists in the maintenance 
of an efficient blood-testis barrier (Dym and Fawcett, 1970). Furthermore, extracellular matrix 
components have also been reported to play a significant role in regulating the biological 
activities of growth factors (Ruoslahti and Yamaguchi, 1991). 
On a regulatory level, it seems that androgen stimulation of Sertoli cells is partly 
achieved via the peritubular myoid cells. Peritubular myoid cells have been reported to secrete 
an important protein which modulates Sertoli cell function: PmodS (Hutson and Stocco, 1981; 
Skinner and Fritz, 1985a and b) (see also Paragraph 1.1.2). The production and secretion of 
PmodS by cultured peritubular myoid cells is increased upon stimulation with androgens. 
When Sertoli cells are cultured in the presence of semi-purified PmodS, the production of 
transferrin and androgen binding protein is markedly increased. Here we can obseNe a 
certain analogy with the described effects of androgens on the prostate: the action of 
androgens on androgen receptor containing epithelial cells (Sertoli cells) is modulated by the 
effect of androgens on mesenchymal cells (perttubular myoid cells). 
In Chapter 6, a putative Sertoli cell factor which might play a role in the interactions 
between Sertoli cells and peritubular myoid cells, is described. At this early stage of the 
investigations to characterize the putative paracrine factor, it is difficult to speculate on its role 
in physiology. 
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SUMMARY 
Sertoli cells play an important role in the regulation of spermatogenesis and are referred to 
as the nursing cells of the germinal epithelium. FSH and testosterone, the main regulatory 
hormones of spermatogenesis, act on Sertoli cells. FSH acts directly, because the Sertoli cell 
is the only cell type in the male body expressing FSH receptors. Germ cells do not express 
androgen receptors and androgen action on spermatogenesis, therefore, involves androgen 
action on Sertoli cells. Androgen receptors are also present in testicular peritubular myoid 
cells, and it is likely that these cells also play a role in the regulation of spermatogenesis by 
androgens. 
In this thesis, investigations are described on the regulation of FSH receptor and 
androgen receptor gene expression in the testis in relation to spermatogenesis. Expression 
of the receptor genes was studied at the level of gene transcription, and by estimation of 
mRNA and protein concentrations. 
In Chapters 2, 3 and 5, it is shown that FSH can regulate androgen receptor gene 
expression in testicular cells. When FSH was added to the medium of cultured Sertoli cells 
from immature rats, two effects on androgen receptor mRNA expression were observed: 
-first, there was a short-term (5h) down-regulation of the amount of androgen receptor 
mRNA, caused by a decreased androgen receptor mRNA stability. Androgen receptor protein 
expression was not affected, because this down-regulation of mRNA was transient and the 
androgen receptor protein has a longer half-life than the androgen receptor mRNA. 
-second, there was a long-term (24-72h) up-regulation of androgen receptor mRNA and 
protein expression, caused by an increased rate of androgen receptor gene transcription. 
A short-term (4- 6h) down-regulatory effect on androgen receptor mRNA expression was also 
observed in testes of immature rats, after the rats had been injected with FSH. This indicates 
that io. vivo Qn intact testes), FSH may exert similar effects on androgen receptor gene 
expression as observed io. vitro (using cultured Sertoli cells). 
Peritubular myoid cells, together with Sertoli cells, are a substantial source of androgen 
receptor mRNA and protein in the testis. Since we observed a marked short-term reduction 
in androgen receptor mRNA expression in total testis of FSH-injected immature rats, it was 
speculated that Sertoli cell factors might reduce androgen receptor mRNA levels in peritubular 
myoid cells. In Chapter 6, it is shown that in peritubular myoid cells, cultured in the presence 
of Sertoli cell-conditioned medium, the androgen receptor mRNA expression indeed became 
reduced. Peritubular myoid cells cultured in the presence of EGF or 10% FCS showed a 
similar decrease in androgen receptor mRNA expression. 
Experiments dealing with the regulation of FSH receptor gene expression in Sertoli cells 
are described in Chapters 4 and 8. Initial down-regulation of FSH receptor mRNA expression, 
4 - 6h after addition of FSH to cu~ured Sertoli cells (but also in the testes of FSH injected 
immature animals), showed similarities to the regulation of androgen receptor mRNA 
expression. The rapid FSH-induced decrease in FSH-receptor mRNA expression did not 
involve inhibition of FSH receptor gene transcription, but rather mRNA stability, and did not 
affect the protein level. 
When FSH was added to the cultures for longer time periods (24 h), FSH receptor 
mRNA and protein levels were reduced. In the literature, desensitization of cultured Sertoli 
cells generated by the continuous presence of high doses of FSH has been described as 
resulting from receptor internalization upon ligand binding, and decreased second messenger 
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activity through activation of phosphodiesterase activity. The current results indicate that 
diminished FSH receptor gene expression also plays a role in Sertoli cell desensitization by 
FSH. 
When immature Sertoli cells were cultured in the presence of testosterone, androgen 
receptor protein stability was markedly increased (Chapters 2 and 3). Androgen receptor 
mRNA expression in cultured Sertoli cells (and perrtubular myoid cells), however, was not 
affected by the addition of testosterone to the culture medium (Chapters 2, 3 and 5). In 
Chapters 7 and 8, it is described that androgen receptor mRNA expression in the testis was 
also not affected in the prolonged absence of testosterone in vivo (5 days). These 
experiments indicate that in vivo 0n the rat testis), and in vrtro (in cultured rat Sertoli and 
perrtubular myoid cells), androgen receptor mRNA expression is not affected by androgens. 
This contrasts with results from experiments using other cell types, described in the following 
paragraph. 
When LNCaP cells were cultured in the absence of androgens, an increased androgen 
receptor mRNA expression was observed, which was found to be caused by an increased 
rate of androgen receptor gene transcription (Chapter 5). In Chapters 7 and 8, in in vivo 
experiments, androgen receptor mRNA expression in the ventral prostate and epididymis was 
markedly increased upon androgen deprivation and lowered upon androgen resubstitution 
0n the literature, there are similar observations described for other organs). These 
experiments indicate that androgen receptor gene transcription in ventral prostate (and also 
in LNCaP cells) and in epididymis, in contrast to transcription of this gene in the testis, is 
regulated by androgens. 
Androgen receptor protein expression in the testis (Chapter 7) was measured by specific 
ligand binding in isolated nuclei. In addrtion to occupied androgen receptors, also the total 
amount of androgen receptors was measured. When the testicular testosterone concentration 
was experimentally reduced to a very low level, androgen receptors became unoccupied, but 
the total amount of androgen receptor protein (measured by ligand binding assay) remained 
at the control level. The interaction of unoccupied androgen receptors wrth antibodies, 
however, was altered, indicating a structural modification of the receptor molecule in the 
prolonged absence of androgens. From these results it was concluded that in vivo (as was 
also observed in vitro, in cultured Sertoli cells), androgen receptors are unstable in the 
prolonged absence of ligand. 
Another important observation described in Chapter 7, is that a testicular testosterone 
level of 20% of the control level is sufficient to occupy all androgen receptors, which is in 
agreement with experimental data showing that the normal testicular testosterone level is at 
least 4- to 5-fold higher than what is needed to maintain spermatogenesis. 
FSH and testosterone are involved in regulation of spermatogenesis. FSH is required for the 
initiation and re-initiation of spermatogenesis, while testosterone alone can maintain 
spermatogenesis. In the experiments described in this thesis, it is observed that regulation of 
FSH and androgen receptor gene expression may play an important role in the regulation of 
spermatogenesis by FSH and testosterone. 
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SAMENVATTING 
Sertoli cellen zijn van essentieel belang veer regulatie van de spermatogenese. Het 
functioneren van Sertoli cellen wordt in belangrijke mate bepaald door de hormonen FSH en 
testosteron. Van FSH is bekend dat dit hormoon een directe invloed uitoefent op de Sertoli 
eel, omdat dit de enige eel in het mannelijk lichaam is die FSH receptoren tot expressie 
brengt. Aangezien Sertoli cellen androgeen receptoren bevatten kan ook testosteron direct 
inwerken op Sertoli cellen. Germinale cellen bevatten geen androgeen receptoren. Naast 
Sertoli cellen zijn de androgeen receptor bevattende peritubulaire myoid cellen, indirect, 
betrokken bij de regulatie van spermatogenese. 
In dit proefschrift wordt ingegaan op de regulatie van de expressie van het FSH receptor 
gen en het androgeen receptor gen in relatie tot de regulatie van de spermatogenese. De 
expressie van beide genen werd onderzocht op het niveau van gen transcriptie, alsmede door 
het meten van mRNA en eiwit concentraties. 
In Hoofdstukken 2, 3 en 5 is beschreven wat het effect is van FSH toediening aan 
gekweekte Sertoli cellen op de expressie van het androgeen receptor gen. Twee effecten op 
androgeen receptor gen expressie werden gevonden: 
-ten eerste nam de hoeveelheid androgeen receptor mRNA, door destabilisatie van het 
mRNA, binnen 5 uur af tot bijna nul. De hoeveelheid androgeen receptor eiwit veranderde niet, 
omdat de halfwaarde tijd van het androgeen receptor eiwit veel grater is dan van het 
androgeen receptor mRNA. 
- ten tweede nam in de periode 24 - 72 uur na FSH toediening de hoeveelheid 
androgeen receptor mRNA en eiwit toe, door stimulatie van androgeen receptor gen 
transcriptie. 
Een korte termijn effect (4 - 6 uur) van FSH toediening op androgeen receptor mRNA 
expressie in gekweekte Sertoli cellen bleek oak op te treden in de gehele testis wanneer 
immature ratten werden ingespoten met FSH. Dit resultaat kan betekenen dat FSH io. vivo (in 
de intacte testis) de androgeen receptor gen expressie op eenzelfde manier kan regelen als 
io. vitro 0n gekweekte cellen). 
Naast Sertoli cellen bevatten oak peritubulaire cellen androgeen receptoren. Gezien de 
observatie dat in rattan gelnjecteerd met FSH de androgeen receptor mRNA expressie in de 
gehele testis werd geremd, ligt het voor de hand te veronderstellen dat Sertoli cellen 
een factor produceren die androgeen receptor mRNA expressie in de peritubulaire myoid 
cellen kan reduceren. In Hoofdstuk 6 zijn experimenten beschreven die Iaten zien dat 
androgeen receptor mRNA expressie in peritubulaire myoid cellen inderdaad werd 
gereduceerd, wanneer deze cellen warden gekweekt in aanwezigheid van Sertoli eel 
geconditioneerd medium. Wanneer de peritubulaire myoid cellen werden gekweekt in 
aanwezigheid van EGF of 10% FCS, werd eenzelfde effect op de androgeen receptor mRNA 
expressie waargenomen. 
Zeals beschreven in de Hoofdstukken 4 en 8, word! oak de FSH receptor gen expressie 
in Sertoli cellen gereguleerd door FSH. De korte termijn regulatie {4- 6 uur) van FSH receptor 
mRNA expressie in gekweekte Sertoli cellen (maar eveneens in de testes van FSH behandelde 
ratten) vertoont gelijkenis met de regulatie van androgeen receptor mRNA expressie. Wanneer 
FSH werd toegediend aan Sertoli cellen in kweek nam de FSH receptor mRNA expressie snel 
af. Deze afname werd niet teruggevonden in het gemeten FSH receptor eiwit niveau, en was 
niet het gevolg van een afname in transcriptie snelheid van het FSH receptor gen. 
116 
Langdurig stimuleren van Sertoli eel kweken door FSH (24 uur), resulteerde in een 
afname in de FSH receptor mRNA en eiwit niveaus. In de literatuur wordt beschreven dat deze 
desensitizatie van Sertoli cellen door langdurige kweek in aanwezigheid van FSH, het gevolg 
is van receptor intemalisatie door ligand binding en verminderde second messenger activiteit 
doortoegenomen fosfodiesterase activiteit. De hier beschreven resultaten wijzen erop dat FSH 
receptor gen expressie ook een rol speelt bij de desensitizatie van Sertoli cellen door FSH. 
Wanneer testosteron werd toegevoegd aan immature Sertoli cellen in kweek, nam de 
stabiliteit van het androgeen receptor eiwit toe (Hoofdstukken 2 en 3), maar de hoeveelheid 
androgeen receptor mRNA in gekweekte Sertoli cellen (en peritubulaire myoid cellen) 
veranderde niet. In Hoofdstukken 7 en 8, wordt beschreven dat in afwezigheid van testosteron 
in vivo (5 dagen), androgeen receptor mRNA expressie in de testis ook niet veranderde. Uit 
deze experimenten blijkt dat, in vivo (in de ratten testis), maar ook in vitro (in gekweekte ratten 
Sertoli en peritubulaire myoid cellen), androgeen receptor mRNA expressie niet wordt 
beinvloed door androgenen. Dit is in tegenstelling tot bevindingen met andere cellen en 
weefsels, beschreven in de onderstaande paragraaf. 
Wanneer LNCaP cellen werden gekweekt in afwezigheid van androgenen nam de 
androgeen receptor mRNA expressie toe. Ott is het gevolg van een verhoogde transcriptie van 
het androgeen receptor gen. In in vivo experimenten, beschreven in Hoofdstukken 7 en 8 
hebben we een soortgelijke observatie gedaan; in de ventrale prostaat en in de epidydimis 
van testosteron gedepriveerde ratten nam de androgeen receptor mRNA expressie significant 
toe (soortgelijke observaties zijn in de literatuur ook beschreven voor andere organen). Deze 
resultaten geven aan dat in de ventrale prostaat (en ook in LNCaP cell en) en in de epididymis, 
in tegenstelling tot de testis, androgeen receptor gen transcriptie wordt gereguleerd door 
androgenen. 
Door middel van een specifieke ligand-bindingsassay konden de androgeen receptoren 
in geisoleerde kernen uit de testis worden gemeten. Naast de bezette receptoren is ook het 
totaal aantal receptoren gemeten. Uit de experimenten blijkt dat wanneer de testiculaire 
testosteron concentratie werd verlaagd tot een zeer laag niveau, aile androgeen receptoren 
onbezet raakten. Het totale aantal aanwezige androgeen receptoren echter, bleef gelijk. 
Detectie van receptoren die tangere tijd onbezet waren, met behulp van antilichamen, was niet 
mogelijk, hetgeen wijst op een structurele verandering in het receptor molecuul. 
In dezelfde reeks experimenten werd ook gevonden dat een testiculair testosteron 
niveau van 20% van het normale niveau voldoende was om aile aanwezige androgeen 
receptoren in de testis te bezetten. Deze resultaten wijzen er op dat het normale testiculaire 
testosteron niveau zeker 4 tot 5 maal hoger is dan nodig voor het handhaven van 
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